Advances in organometallic and protein chemistry by Ryan, C.P.
i 
 
 
 
 
 
ADVANCES IN ORGANOMETALLIC 
AND PROTEIN CHEMISTRY 
 
 
Christopher Patrick Ryan 
 
Department of Chemistry, University College London 
 
Doctor of Philosophy 
 
 
 
 
 
 ii 
 
 
 
 
 
DECLARATION 
The work described in this thesis is the work of the author and has not previously 
been submitted to this or any other university for any other degree. 
 
 
Christopher Patrick Ryan 
June 2010 
   iii 
 
ACKNOWLEDGEMENTS 
First I would like to thank my supervisor Prof. Steve Caddick for giving me the 
opportunity  to  carry  out  a  variety  of  exciting  research,  and  for  his  enthusiasm, 
motivation and support throughout my PhD. Second I would like to thank Prof. Nik 
Kaltsoyannis for his invaluable help concerning all things DFT related. 
I would also like to thank past and present members of the Caddick group for making 
my time at UCL as fun as it was; in particular Jack, James, Mark, Nuj, Tom and 
Vijay. I would also like to thank Dr. Jamie Baker, Richard Fitzmaurice, Alex Lewis, 
Frank King, Tom Sheppard, Mark Smith and John Wilden for all the excellent help 
and advice they gave me. 
A big thank you goes to Dr. Abel Aliev for his continued interest and help with all 
NMR related issues and to Dr. Lisa Harris for her invaluable Mass Spec support. 
Finally I would like to thank my family, friends and housemates for their support 
throughout my studies. 
   iv 
 
ABSTRACT 
This  thesis  describes  two  areas  of  scientific  investigation.  The  first  contains  a 
description  of  a  study  on  the  synthesis  of  biotinylated  and  fluoresceinylated 
bromomaleimide based reagents. Upon synthesis, the ability of these reagents to add 
reversibly  to  cysteine  containing  proteins  is  investigated  by  a  series  of  LCMS 
experiments. A single point mutant (L111C) of the SH2 domain of the Grb2 adaptor 
protein, containing a single cysteine residue, is chosen as an ideal protein for study. 
Thus biotinylated and fluoresceinylated mono and dibromomaleimide reagents are 
added to Grb2 at 0°C, 21 °C and 37 °C for 2 h at pH 7 and 8 to give protected Grb2-
bromomaleimide  adducts  in  high  yield  and  removed  using  100  eq  of  beta-
mecaptoethanol for 4 h to return original Grb2 protein intact. Reversibility is shown 
to be abolished by hydrolysis of the maleimide motif, a process more prevalent in the 
fluoresceinylated and dibrominated maleimide reagents than for the biotinylated and 
monobrominated  reagents.  LCMS  is  used  to  investigate  the  insertion  of  these 
reagents reversibly into the single disulfide bridge of somatostatin, a process shown 
to be complete within 1 h at 21 °C and pH 6. Reduction using 100 eq of  beta-
mecaptoethanol  is  shown to  take place within  1 h. Additionally no hydrolysis is 
observed at pH 6, suggesting that with careful control of pH, reversibility of the 
bromomaleimide reagents can be switched on and off. 
The  second  part  of  the  thesis  contains  a  study  on  mechanistic  aspects  of 
organopalladium  catalysis,  particularly  the  factors  affecting  the  final  reductive 
elimination  stage  of  the  palladium  catalysed  alkyl  amination  reaction.  DFT 
calculations have been used to obtain a number of energy level diagrams for the 
potential  energy  surface  of  Pd(IBu)(neopentyl)(morpholide),  the  three  coordinate 
palladium complex believed to be the species from which reductive elimination takes 
place.  From  this  it  has  been  found  that  two  different  pathways  are  available; 
reductive elimination or morpholide promoted C-H activation of the neopentyl motif, 
the latter of which was favoured. The reaction pathway for reductive elimination 
from  Pd(IBu)(neopentyl)(morpholide)  is  compared  with 
Pd(IBu)(phenyl)(morpholide),  Pd(PCyp3)(neopentyl)(morpholide)  and 
Pd(IBu)(methyl)(morpholide), to show that the phenyl system is considerably lower v 
 
in  energy. The energy  requirements  for  (i) reductive elimination, (ii) morpholide 
promoted  C-H  activation  and  (iii)  β-hydride  elimination  from  Pd(IBu)(2-
dimethylpropyl)(morpholide) are compared, and shown to be in the order of energy 
(i)>(ii)>(iii). Additionally, the rate of reaction increases as the number of available 
reaction  sites  increases,  again  making  reductive  elimination  the  least  favoured 
process. 
Offline  ESI(+)-MS  analysis  have  been  used  to  monitor  the  reaction  progress  of 
Pd(IBu)(neopentyl)(morpholide) and Pd(IBu)(phenyl)(morpholide) three coordinate 
complexes.  Whilst  transient  palladium-bound  species  can  be  observed  for 
Pd(IBu)(phenyl)(morpholide),  for  Pd(IBu)(neopentyl)(morpholide)  this  is  not  the 
case, an artefact of the superiority of the sp
2 phenyl system over the sp
3 alkyl system. 
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1 Post translational modification of cysteine 
1.1 Protein modification 
Proteins  are  responsible  for  the  majority  of  functional  attributes  of  all  living 
organisms. They act as building blocks of the cell structure and as catalysts in the 
metabolism of cells. Furthermore, signal transduction within and between cells, as 
well as cell morphology and stability, are dependent on a large number of proteins. 
Many  of  these  functions  are  dependent  on  post-translational  modifications  (e.g. 
glycosylation or lipidation) at specific sites of the proteins involved.
1 
A post translational modification (PTM) is a chemical modification of a protein after 
its translation and can be thought of as one of the later steps in protein biosynthesis 
for many proteins. The PTM of amino acids extends the range of functions of the 
protein by attaching different chemical groups such as phosphates, acetates, lipids 
and carbohydrates, which changes the structure and reactivity of the amino acids. 
Being  able  to  mimic  this  action  in  the  laboratory  is  thus  very  desirable  from  a 
medicinal and therapeutic perspective and much research has gone into developing 
such strategies.  
For a reaction in the laboratory to be of general use in protein modification, it must 
selectively modify a residue of interest in the presence of hundreds of competing side 
chains  of  the  unprotected  polypeptide.
2  This  selectivity  must  also  be  realised  in 
conditions  required  to  prevent  denaturation;  aqueous  media,  low  to  ambient 
temperature, and at or near neutral pH. The reactions must also tolerate salts and 
surfactants needed for protein stability and the reactions must be rapid to achieve full 
conversion. 
Of the twenty two different amino acids that are commonly found in proteins, there 
are ten that may in principle be derivatised at their side chains, since these amino 
acids possess functional groups (figure 1).
3  
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Figure 1. The ten canonical amino acids. 
The most chemically reactive of these groups are the amines and thiols (scheme 1). 
Aldehydes,  for  instance,  can  be  coupled  with  exposed  amines  on  the  lysine  and 
arginine residues of the protein
4,5 and then reduced with sodium borohydride or other 
reagents to form a stable secondary amine linkage. Alternatively epoxides can be 
employed  as  the  amine  reactive  electrophile  which  have  the  advantage  of  the 
resultant products being relatively stable to hydrolysis at neutral pH, allowing easier 
handling of the materials but slower or incomplete coupling.
5 Amides can also be 
formed from the reaction of activated acid with amine. 
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Scheme 1. Common modifications of amine and thiol amino acid side chains. X = NH2, SH.  
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Of  all  the  chemical  groups  present  in  the  ten  amino  acids  above,  the  thiols  of 
cysteines are found to be most reactive and are considered better targets for site-
specific labelling than the amines of the amino terminus and lysine side chains. It has 
been  shown  that  conjugate  addition  strongly  favours  the  thiolate  group  at 
physiological pH (6.5-7.5) since under these conditions the amines of lysine and 
arginine are predominantly protonated: a result of the lower pKa of cysteine (8.3) 
compared  with  lysine  (10.5)  and  arginine  (12.0).  Maleimides,  for  instance,  react 
approximately  1000  times  faster  with  thiols  than  with  amines  at  neutral  pH  and 
below.
6 Additionally as proteins generally have very few surface-exposed cysteine 
residues,
7 it is possible to achieve site-selective modification, especially if the protein 
of interest is engineered to remove all but one surface cysteine residue or to insert a 
single cysteine on the surface where none previously existed.
8-10 If no free cysteine is 
available, then any present disulfide bridge could take its place, although this would 
first need to be reduced to form the free sulfhydryls before reaction with any cysteine 
modifying  reagent.  To  these  ends,  reducing  agents  such  as  2-
mercaptoethylamine.HCl  (MEA),  β-mercaptoethanol  (BME),  tris(2-
carboxyethyl)phosphine (TCEP) or dithiothreitol (DTT) have all been used.
11 
1.2 Reactions for cysteine modification 
Cysteine  can  be  considered  very  useful  for  introducing  protein-modifying  agents 
such as fluorophores,
12,13 cross linkers
14,15 and peptide/DNA cleavage reagents
16,17 
including ʱ-halocarbonyl bound iron-chelate
 (section 1.2.3) into proteins.
18 Today a 
variety  of  cysteine  modifying  reagents  are  available  from  a  number  of  leading 
biochemical companies (e.g. Pierce, Aldrich) with even more being synthesised in 
laboratories around the world for specific applications. The main reaction types that 
are  employed to  modify cysteine residues are alkylation,  disulfide formation and 
oxidation and these are considered in turn (scheme 2).  
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Scheme 2. Reactions for cysteine modification. 
1.2.1 Oxidative elimination 
The oxidative elimination of cysteine has been shown to be a useful tool for the 
removal of sulfur to give the unsaturated amino acid dehydroalanine, Dha 1.
2,19 The 
simplest  method  for  formation  of  1  is  the  oxidation  in  air  to  give  the  disulfide 
species, followed by elimination with base. In many instances, simply mixing of 
cysteine in basic buffer open to air would be enough to carry out the transformation, 
although reaction times can be slow and dimer formation a potential problem. More 
recent  desulfurisations  rely  on  the  addition  of  cysteine  to  an  electrophile,  where 
elimination of hydrogen from the intermediate would give Dha 1 (scheme 3). 
N
H
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N
H
O
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N
H
S
O
H
NH
O
O
Br
NH
O
O
Base
 
Scheme 3. An example of a new method for the desulfurisation of cysteine, using bromomaleimide.  
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From 1 a considerable number of chemical transformations have been carried out to 
derivatise  the  structure  further,  such  as  Pd  and  Rh  catalysed  reactions,
20-23 
hydroboration
24  and  alkylation.
19  Recent  efforts  have  focused  on  finding  milder 
conditions  to  carry  out  these  desulfurisations,  with  o-
mesitylenesulfonylhydroxylamine
2 (MSH 2) and then bromomaleimides
25 3 finding 
use (figure 2).  
S
O O
O
NH2 NH
O
O
Br
3 2  
Figure 2. Reagents recently used in the desulfurisation of cysteine to dehydroalanine (Dha), MSH 2 and bromomaleimide 3. 
1.2.2 Disulfide exchange 
Compounds possessing a disulfide group have been shown to take part in disulfide 
exchange reactions with other thiols. This process involves attack of the thiol at the 
disulfide,  breaking  the  S-S  bond,  with  subsequent  formation  of  a  new  mixed 
disulfide containing a portion of the original disulfide compound 5 (scheme 4).
26 If 
the thiol is present in excess, the mixed disulfide can go on to form a symmetrical 
disulfide consisting entirely of the thiol reducing agent, thus completely reducing the 
original disulfide to free sulfhydryls. However, if an excess of thiol is not used, the 
mixed disulfide is the end product. 
N
H
SH
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4
N S
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R1
5
+
H
N S
N
H
S
O
S
R1
 
Scheme 4. Disulfide exchange of cysteine using pyridyl disulfide 4. 
Many activated or activating reagents for disulfide exchange are available today and 
it is through these reagents that disulfide modification for functional purposes has 
become  common.  A  popular  reagent  is  pyridyl  dithiol  4  (figure  3).  This  readily 
undergoes  an interchange reaction with  a free sulfhydryl to  yield a single mixed 
disulfide product. The presence of a good leaving group not capable of taking part in  
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further reactions, in this case pyridine-2-thione, is key to success of these reactions. 
Another  well  known  reagent  is  5,5-dithiobis(2-nitrobenzoate)  (Ellman’s  reagent 
7).
27,28 This reagent is predominantly used to measure protein cysteine content and as 
a way of blocking free thiol groups. 
7 4
O2N
HO2C S
S
NO2
CO2H
N S
S
R1
 
Figure 3. Pyridyl thiol 4 and Ellman’s reagent 7, two common reagents used in disulfide exchange reactions. 
An additional factor that has made disulfide exchange such a popular modification is 
the reversibility it affords. Therefore treatment  of disulfides with reducing agents 
such as dithiothrietol (DTT 8), β-mercaptoethanol (BME 9) or 2-mercaptoethylamine 
(MEA  10)  results  in  reduction  of  the  disulfide  to  give  back  free  cysteine.  This 
process works in two stages. First, one molecule of the reducing agent (8, 9 or 10) 
undergoes  disulfide  exchange,  cleaving  the  disulfide  and  forming  a  new,  mixed 
disulfide 13. In the second stage, another molecule of the thiol cleaves this new 
mixed  disulfide,  releasing  a  free  sulfhydryl  and  forming  a  molecule  of  oxidised 
reducing agent 15 (scheme 5). 
11
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SH
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Scheme 5. Reduction of disulfides, in this example using BME 9. 
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1.2.3 Alkylation 
Of  all  the  potential  reagents  for  cysteine  modification,  ʱ-halocarbonyls,  such  as 
iodo
29  and  chloroacetamides,
30  were  among  the  first  reagents  used  for  the  direct 
alkylation of cysteine in 1935 and have remained useful and commercially available 
still today (scheme 6). They allow the direct displacement of the halide centre by the 
soft nucleophilic sulfhydryl group and have been used to produce mimics of natural 
asparagine-linked glycoproteins
31 to assess homogenously glycosylated samples of 
human  erythropoietin.
32  They  have  also  been  used  as  DNA/peptide  cleavage 
reagents,  such  as  ʱ-halocarbonyl  bound  iron-chelates,  which  induces  cleavage  at 
cysteine upon treatment with H2O2/ascorbate.
16,17 
N
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O
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Scheme 6. Cysteine modification using ʱ-halocarbonyls. 
Aminoethylation of cysteine using aziridine is another example of alkylation and has 
been used for over half a century for the conversion of cysteine to lysine mimics.
33,34 
The aziridine functional group is a small ring system composed of one nitrogen and 
two  carbon  atoms,  whose  highly  hindered  nature  lends  strong  reactivity  towards 
nucleophiles.  Sulfhydryls  will  react  with  aziridine-containing  reagents  in  a  ring-
opening process to form a thioether bond 17 (scheme 7). In slightly alkaline pH the 
reaction is highly specific although in aqueous solution the major side reaction is 
hydrolysis.
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Scheme 7. Aminoethylation of cysteine to form methylated lysine mimic.  
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The conjugate addition of cysteine to Michael acceptors such as vinyl sulfonates, 
maleimides  and  related  ʱ,β-unsaturated  systems  has  also  been  established  as  a 
reliable way of alkylating cysteine and have emerged as the reagents of choice in 
these reactions. They have been shown to be very fast, reliable and robust in their 
selective  alkylation  of  the  cysteine  side  chain.  Of  these  reagents,  however,  the 
maleimide functional group is of paramount importance due to its highly specific 
affinity for free sulfhydryl groups. The double bond of maleimide may undergo an 
alkylation reaction with sulfhydryls to form stable thioether bonds 18 (scheme 8). 
This  reaction is  specific for sulfhydryl  groups  in  the pH range 6.5-7.5, whilst  at 
higher pH values some cross-reactivity with amino groups is known to take place. 
Additionally,  when  a  sufficient  quantity  of  SH  groups  have  been  alkylated,  the 
reaction may be followed spectrophotometrically by the decrease in absorbance at 
300 nm as the double bond reacts and disappears. 
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Scheme 8. Reaction of cysteine with maleimide. R = H, Me, Et. 
The maleimide group can undergo hydrolysis to an open maleimic acid form that is 
unreactive toward sulfhydryls,
26 which can also occur after sulfhydryl coupling to the 
maleimide 19 (scheme 9). This ring-opening reaction typically becomes faster with 
increasing pH. Hydrolysis is also dependant on the type of chemical group adjacent 
to the maleimide motif. For example, the cyclohexane ring of SMCC 20 provides 
increased stability to maleimide hydrolysis due to its steric effects and its lack of 
aromatic  character.  However,  the  adjacent  phenyl  ring  of  MBS  21  allows  much 
greater rates of hydrolysis to occur at the maleimide ring (figure 4).  
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Scheme 9. Hydrolysis of maleimide ring. 
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Figure  4.  SMCC  (Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate)  20  and  MBS  (m-maleimidobenzoyl-N-
hydroxysuccinimidyl ester) 21. 
1.3 Maleimides as reagents in protein modification 
1.3.1 Fluorescent probes 
The fluorescent labelling of peptides and proteins is usually performed through either 
the side chain amino group of a lysine residue or the side chain sulfhydryl group of a 
cysteine residue, using commercially available linkers.
35 The key requirement when 
incorporating these fluorescent tags on to the protein of interest is to find a site of 
modification  that  will  not  adversely  affect  the  proteins  function.  Sulfhydryls  are 
smaller in number compared to amine side groups and tend to be situated away from 
the proteins active site. This is due to the evolutionary pressure associated with not 
having a highly  reactive amino acid  residue at  a biologically important site  of a 
protein; modification of this highly reactive residue could change the function of the 
protein, adversely affecting the cells  chances of  survival. The smaller number of 
sulfhydryl  residues  and  their  position  in  the  protein  means  that  their  directed 
modification usually helps to preserve activity in the fluorescent probe complex. 
Fluorescein-5-maleimide 22 is one such fluorescent probe containing a sulfhydryl 
reactive  maleimide  group  on  its  lower  ring  structure  (figure  5).  Addition  of  this 
reagent to sulfhydryl containing proteins under physiological conditions results in  
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derivatives possessing fluorescent properties characteristic of fluorescein molecules: 
excitation  wavelength  =  490  nm;  emission  wavelength  =  515  nm,  in  the  green 
spectral region. 
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Figure 5. Fluorescein-5-maleimide 22. 
Fluorescein-5-maleimide  22  has  been employed in  many experiments,  such as  in 
labelling the transmembrane glycoprotein H-2K
κ on both N and C terminal regions to 
investigate molecular structure,
36 in the determination of two different conformations 
of the protein actin
37 and the investigation of the calcium-dependent ATPase protein 
structure of the sarcoplasmic reticulum.
38 
1.3.2 Blocking agents and the inhibition of cellular processes 
It has been known for a long time that disulfide bond formation between cysteine 
sulfhydryls is critical for protein structure and function.
39 However, the sulfhydryl 
group is among the most highly reactive of nucleophiles found in biological systems 
and undergoes covalent reactions rapidly with most of the reactive groups utilised in 
protein modification and conjugation.  To prevent  this  from  happening  it is  often 
necessary to block these sites and render them inert to further reaction. Two types of 
cysteine  modifying  reagents  are  employed  as  blocking  agents  today;  permanent 
(maleimide group) and reversible (disulfide exchange). 
N-Ethylmaleimide 23 (NEM) is one such permanent reagent which reacts with and 
blocks sulfhydryl groups by formation of stable thioether bonds (figure 6).
40 It has 
found use in the modification of sulfhydryl groups essential in the interaction of ATP 
with its regulatory site(s) in transport ATPases such as the (Na
+,K
+)-ATPase
41 and 
inactivation  of  the  clathrin-coated  vesicle  (H+)-ATPase.
42  N-Methylmaleimide  24 
(NMM), another irreversible blocking agent, has been found to completely abolish  
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KATP channel activity if applied to the cytoplasmic face of membrane patches from 
skeletal muscle.
43 
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Figure 6. Irreversible sulfhydryl blocking agents; N-ethyl maleimide 23 (NEM) and N-methyl maleimide 24 (NMM). 
1.3.3 Bifunctional reagents 
There are two main types of bifunctional reagent used in bioconjugation chemistry 
today:  those  with  the  same  function  group  at  either  end  of  the  molecule 
(homobifunctional) and those with different functional groups (heterobifunctional). 
Major  sulfhydryl  reactive  homobifunctional  reagents  in  use  include  1,8-bis-
maleimidotriethyleneglycol  25  and  1,11-bis-maleimidotriethyleneglycol.  These 
contain a maleimide group at either end of the reagent and allow cross linking with a 
variety of sulfhydryl containing molecules. However, here lies an inherent problem 
in their applicability: the potential for dimer formation 27, i.e. the cross linking of 
homobifunctional  reagents  with  two  molecules  of  sulfhydryl  containing  protein, 
often  results  in  a  complex  reaction  mixture,  low  in  yield  of  the  wanted 
monofunctionalised protein 26 (scheme 10).  
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Scheme 10. Potential dimer formation of sulfhydryl reactive homobifunctional reagents. 
Heterobifunctional reagents do not exhibit any dimer formation and as a result play a 
key  role  in  many  bioconjugate  reactions  due  to  the  greater  control  afforded  to 
product  formation.  The  most  popular  heterobifunctional  reagents  are  those  that 
contain amine-reactive and sulfhydryl-reactive ends (figure 7). The amine reactive  
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group is usually an active ester, most often an NHS ester, whilst the sulfhydryl-
reactive  portion  may  be  one  of  several,  in  this  case  a  maleimide  motif.  These 
reagents are very good for the selective and controlled addition of substrates to either 
end of the reagent. The NHS ester end of the reagent can react with primary amine 
groups on proteins to form stable amide bonds, whilst the maleimide functionality 
allows for reaction of sulfhydryls at the other end. The nature of the reactive groups 
allows for highly controlled cross-linking procedures to be performed. 
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Figure 7. Heterobifunctional reagents; succinimidyl-4-(-p-maleimidophenyl)butyrate (SMPB) 28 and sulfosuccinimidyl-4-(-p-
maleimidophenyl)butyrate (sulfo-SMPB) 29. 
A major use of heterobifunctional reagents is in the preparation of antibody-enzyme 
and  hapten-carrier  conjugates,  such  as  those  found  in  Enzyme-Linked 
ImmunoSorbent Assays (ELISA). ELISA is a biochemical technique used mainly in 
immunology to detect the presence of an antibody or an antigen in a sample. The 
procedure for this process is relatively simple; first an unknown amount of antigen is 
affixed to a surface and then a specific antibody is washed over the surface so that it 
can bind to the antigen. This antibody is linked to an enzyme, so that addition of a 
second substance to the antigen-antibody-enzyme conjugate would illicit some sort 
of detectable signal (e.g. fluorescence). 
Taking the HIV ELISA (HIV enzyme immunoassay) as an example; a plastic plate 
containing a series of wells, each about 1.0 cm high and 0.7 cm in diameter, is first 
coated with inactivated HIV antigens. A patient’s serum is then applied to the plate 
to  which  the  HIV  antigens  have  previously  been  attached.  If  the  patient  is  HIV 
positive, then their serum will contain antibodies to HIV, and these antibodies will 
bind to the HIV antigens attached to the plate. The plate is then washed to remove all 
other components of the serum, leaving only the HIV antibodies bound to the HIV 
antigens.  Following  this,  a  specially  prepared  secondary  antibody  is  added.  This 
secondary  antibody  is  usually  an  anti-human  immunoglobulin  (anti-human  Ig)  
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coupled to an enzyme (usually horseradish peroxidase, β-galactosidase or glucose 
oxidase) and is designed to bind specifically to other human antibodies, in this case 
the HIV antibodies. 
Therefore upon addition of this secondary antibody, the plate will contain an enzyme 
whose concentration is proportional to the amount of secondary antibody bound to 
the HIV antibody-antigen conjugate. A substrate for this enzyme can then be applied, 
so that catalysis by the enzyme leads to a change in colour.  In the case of  HIV 
ELISA  studies,  horseradish  peroxidase  (HRP)  is  used;  HRP  reacts  with  its 
fundamental substrate H2O2 to form a stable intermediate that will dissociate in the 
presence  of  certain  electron  donors  (ascorbate,  cytochrome  c,  ferrocyanide), 
oxidising the donor and creating a colour change in the process. The optical density 
of this colour change can then be measured, and compared to both.negative (healthy) 
and positive (HIV sufferer) controls, to determine whether the patient is infected with 
HIV. 
Maleimide-containing heterobifunctional reagents, such as SMCC 20, are relevant 
because they have been used in the synthesis of the antibody-enzyme conjugates 31 
used in ELISA studies (scheme 11), including the peroxidase-conjugated anti-human 
immunoglobulin  antibody  used  in  HIV  enzyme  immunoassays;  the  NHS  ester  is 
reacted with the enzyme to give 30 and then the sulfhydryl-containing antibody is 
added.  This  two-step  reaction  scheme  results  in  the  formation  of  the  specific 
antibody-enzyme conjugates 31. 
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Scheme 11. Use of heterobifunctional reagent SMCC 20 in antibody-enzyme conjugate formation.  
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1.3.4 The use of maleimides in surface immobilisation 
Today the immobilisation of biomolecules to solid phase materials is a frequently 
used procedure to confer a specific affinity or enzymatic activity on the surface. The 
development  of  biosensor  devices  typically  requires  the  encapsulation  or  surface 
immobilisation of a molecular recognition element onto a surface for interfacing with 
a signal detector.
44 This has led to an explosion in the use of microarray technology 
(biochip)  as  a  promising  tool  for  gene  discovery,  genome  analysis,  medical 
diagnostics  for  genetic  diseases,  detection  of  single  nucleotide  polymorphism, 
nucleic  acid-ligand  interactions,  DNA  sequencing  by  hybridisation  and  DNA 
coupling,
45 as well as the discovery and mapping of novel protein-protein, protein-
DNA, protein-drug, and protein-lipid function.
46-48 
In performing these immobilisation reactions, the aim is generally to attach the often 
fragile ligands in such a way as to leave them structurally intact with their active sites 
easily accessible to specifically binding reactants present in the surrounding fluid 
phase.  Many  of  the  applications  demonstrated  thus  far  have  relied  on  protein 
attachment methods that result in non site-specific immobilisation, either covalently 
through  amine,  aldehyde,  and  epoxy-derivatised  surfaces
5,49,50  or  through  non-
covalent adsorption on nitrocellulose, hydrogel, or polylysine coated slides
51-54 by 
way  of  passive  adsorption  onto  hydrophobic  surfaces  or  electrostatic  interactions 
with  charged  surfaces.
8  A  number  of  more  selective  approaches  have  been 
demonstrated and employ affinity reagents that bind specific markers on proteins and 
render them in a correctly orientated manner such as (strept)avidin (figure 8).
55-57 
(Strept)avidin is a tetrameric protein able to bind biotin, a small naturally occurring 
vitamin, up to four times. The interaction has been shown to be stable in vivo and is 
essentially irreversible (Kd ~ 10
-15 M).
55,56 This has allowed the (strept)avidin-biotin 
system to emerge as an extremely powerful and versatile tool in biomedical science 
and clinical diagnostics.
58  
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Figure 8. (Strept)avidin. 
The  (strept)avidin-biotin  system  has  found  considerable  usage  in  affinity 
chromatography,  affinity  cytochemistry,  cell  cytometry,  blotting  technology, 
immunoassay,  histopathology  staining,  gene  probes,  bioaffinity  sensors  and 
biomarker  detection,
59  as  well  as  for  the  targeted  delivery  of  diagnostic  and 
therapeutic agents.
60 For this latter purpose, a ligand is modified either with avidin or 
with  biotin  and  is  then  allowed  to  accumulate  in  a  target  area.  Then  the 
pharmaceutical  agent  is  administered  as  a  conjugate  of  either  biotin  or  avidin 
(depending on the corresponding subunit) and concentrates locally in the desired area 
due to the fast formation of the avidin-biotin complex where it can take affect. Figure 
9 shows two typical sulfhydryl reactive biotinylation agents used today. Whilst one 
end contains the required biotin functional group, the other consists of the maleimide 
motif, thereby allowing specific targeting of sulfhydryl containing proteins. 
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Figure 9. Maleimide-PEG2-biotin 32 and N-biotinoyl-N′-(6-maleimidohexanoyl)hydrazide 33. 
Recently, these systems have been used for the visualisation of various pathological 
conditions such as tumours.
57 The approach is based on the observation that infected, 
inflamed, necrotic, and malignant areas are able to non-specifically accumulate large  
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protein molecules, such as immunoglobulin or albumin,
61,62 or even nanoparticles
63 
via  the  mechanism  of  impaired  filtration.  The  injection  of  (strept)avidin  or 
(strept)avidin-antibody conjugates into tumour containing rats has found it too will 
accumulate in malignant areas. The addition of  a biotin-associated label, such as 
radiolabel or dye, will then allow for visualisation of the infected area, due to the 
biotin-associated label seeking out and binding to the accumulated (strept)avidin in 
the rat (i.e. the tumour).  
1.4 Reversible maleimide reagents 
Despite  the  successful  utilisation  of  maleimide  as  a  reagent  for  the  chemical 
modification  of  proteins,  the  irreversible  nature  of  the  addition  prevents  any 
possibility for controlled disassembly of the conjugate regenerating the unmodified 
protein, a process desirable for in vitro or in vivo applications. Furthermore there are 
only two points of attachment, thus limiting the number of chemical or biological 
entities that could be attached to a system of interest. 
In 2009 Baker et al.
25 reported the use of monobromomaleimide, the first of a new 
class of reagent for the selective and reversible modification of cysteine. Previously, 
reversible cysteine modification could only be carried out using reagents that would 
form  a  disulfide  bond,  such  as  methanethiosulfonates,
64  and  these  reagents  were 
unstable and often resulted in scrambling with respect to the disulfide bond.
65 Instead 
Baker incorporated a bromine onto the maleimide double bond, allowing an addition-
elimination sequence to occur on reaction with N-Boc-Cys-OMe 34, a model for the 
single amino acid cysteine in peptides (scheme 12). The product was a thiomaleimide 
35,  which  had  retained  the  double  bond  in  contrast  to  the  succinimide  product 
usually obtained from  addition  of sulfhydryl  to  maleimide. Addition of a second 
nucleophile, TCEP, yielded cysteine again plus tentatively postulated by-product 36, 
thus  creating  a  very  powerful  pathway  for  cysteine  protection/deprotection  and 
general modification.  
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Scheme 12. Reversible addition of monobromomaleimide 3 to N-Boc-Cys-OMe 34. R = H, Me. 
Publication of the above results led to a collaboration between the Baker, Caddick 
and  Waksman  groups  to  investigate  further  the  applicability  of  this  reversible 
chemical modification on larger systems.
66 A single point mutant (L111C) of the 
SH2 domain of the Grb2 adaptor protein 37 was chosen as an ideal model protein for 
study, as it contained no disulfides and had only a single cysteine residue present.
67 
Treatment of 37 with monobromomaleimide reagent 3 led to complete addition to 
give 38 in 1 h as observed my LCMS (scheme 13). Furthermore, 100 equivalents of 
TCEP (tris(2-carboxyethyl)phosphine) resulted in 85% conversion back to protein 
37,  demonstrating  the  potential  for  reversible  covalent  modification  of  cysteine 
residues in proteins by the monobromomaleimide reagents. 
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Scheme 13. Modification of the Grb2 SH2 domain (L111C) with monobromomaleimide. R = H, Me, Nuc = TCEP, BME. 
Replacement of 100 eq of TCEP with 1 eq of a second nucleophilic thiol, namely 
glutathione  or  β-mercaptoethanol,  led  again  to  a  second  thiol  conjugate  addition  
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reaction. The resulting bis-thioether adducts  40 and 41 (figure 10) were the first 
examples of monobromomaleimide reagents containing three different groups and 
thus show the potential for three different points of attachment. 
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Figure 10. Examples of the first tri-substituted monobromomaleimide reagents. R = Me.  
Whilst the use of monobromomaleimide as a reagent for reversible cysteine labelling 
and as a linker with three points of attachment is potentially very interesting, the 
corresponding dibromomaleimide 42 means the retention of the double bond in the 
maleimide moiety of bis-thioether adducts 44 and 45, thus offering reversibility and 
the attachment of three different functional groups (scheme 14). 
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Scheme 14. Reversible modification of the Grb2 SH2 domain (L111C)  37 with 1 eq dibromomaleimide, followed by the 
glutathione or thioglucose, pH 8, 0 °C. R = H, Me. Nuc = 100 eq glutathione or BME, TCEP found to be unsuitable. 
In order to compare the relative reactivity of the bromomaleimides with Grb2 SH2 
domain 37, Baker and Caddick et al. treated 37 with traditional cysteine modifying  
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reagents (NEM and iodoacetamide) and monitored the reaction between 5 and 30 
min using LCMS (scheme 15).  By comparing the percentage conversion of Grb2 
SH2 37 into Grb2-cysteine modifying reagent conjugate, the order of reactivity was 
found  to  be  N-methylbromomaleimide  ≈  NEM  >  dibromomaleimide  >> 
iodoacetamide (figure 11).  
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Scheme 15. Additional of different cysteine modifying reagents to cysteine; Cys Mod Reag = NEM, N-methylbromomaleimde, 
dibromomaleimde and iodoacetamide. 
 
Figure 11. Relative reactivity of Grb2 SH2 domain (L111C) 37 with N-methylbromomaleimide, dibromomaleimide and N-
ethylmaleimide. Iodoacetamide is not shown as < 5% reaction had taken place after 30 min.   
Further work by Baker and Caddick focused on the insertion of bromomaleimide 
reagents  into the disulfide bonds  present  in  peptides  and proteins,  leading to  the 
formation of stable bridged disulfide adducts which still retained the native proteins 
structure and function. Thus somatostatin 47, a peptide consisting of 14 amino acids 
with a single disulfide bridge, was reduced with 1 eq of TCEP and treated with 1.1 
eq of dibromomaleimide (scheme 16). The resultant product was the stable bridged 
SST adduct 48 which could be reduced back to unbridged SST upon addition of 100 
eq  of  BME  in  1  h  at  room  temperature.  This  result  demonstated  that  the 
bromomaleimides offered the first effective reagent for controlled reversible bridging  
20 
 
of  disulfides  and  thus  the  potential  offered  to  the  world  of  bioconjugate  and 
biomedicinal chemistry. 
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Scheme  16.  Reversible  modification  of  the  disulfide  bond  of  somatostatin  47  (SST)  by  dibromomaleimide.  (a) 
dibromommaleimide, (b) TCEP. 
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2  The  use  of  functionalised  bromomaleimides  in  cysteine 
labelling 
2.1 Aim of project 
The addition of biotin maleimide reagents to proteins can be considered irreversible 
50  (scheme  17).  In  order  to  detach  the  constituent  parts,  strongly  denaturing 
conditions, such as high detergent concentration, are required to separate the avidin-
biotin  complexes.
68  The  development  of  reagents  based  on  mono-  and  di- 
bromomaleimides make this process reversible, offering a powerful method for the 
isolation of complete proteins, antigens and other biological molecules of interest, 
without the problems of denaturation associated with existing methods (scheme 18). 
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Scheme 17. Protocol for the isolation and purification of irreversibly bound biotin maleimide reagents. 
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Scheme 18. Potential protocol for the isolation and purification of reversibly bound bromomaleimide reagents.  
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Mono- and di- bromomaleimide reagents also offer the opportunity for three points 
of attachment, allowing the incorporation of more functionality into the system of 
interest  (scheme  19).  For  instance,  the  addition  of  a  cell  penetrating  peptide  56, 
sulfhydryl containing drug molecule 58 and fluorescent tag, to dibromomaleimide 
would  offer  the  potential  for  a  directed,  biologically  active  and  easily  traceable 
molecule  of  therapeutic  interest  59.  The  presence  of  a  fluorescent  tag  onto  the 
bromomaleimide motif would also offer an alternative to the currently irreversible 
fluorescein-maleimide reagents available today. 
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Scheme 19. Potential protocol demonstrating bromomaleimide reagents three points of attachment. 
With these potential applications in mind, figure 12 shows the intended targets for 
this project, namely biotinylated bromomaleimide reagents 60 and 61 and fluorescein 
tagged  bromomaleimide  reagents  62  and  63.  Whilst  these  are  similar  to  current 
reagents available today, the presence of the bromide substituents on the maleimide 
motif  introduces  some  complexities  for  the  proposed  synthetic  route.  Current 
methods of maleimide synthesis (discussed in section 2.2) may not be applicable for 
use in the development of their bromomaleimide counterparts. 
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Figure 12. Bromomaleimide reagents targeted for study in this project.  
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The  aims  of  this  project  are  thus  (1)  the  synthesis  of  elaborated  mono-  and  di- 
bromomaleimide  reagents;
25  (2)  the  incorporation  of  functionality  useful  for 
biomedical  research  applications,  particularly  fluorescent  tagging  and  biotin  pull-
down experiments. 
2.2 Previous routes to maleimide reagents 
Numerous synthetic strategies have been reported for the synthesis of N-substituted 
maleimides  66.  The  most  commonly  employed  method  involves  the  reaction  of 
maleic anhydride 64 with primary amines leading to maleimic acid intermediates 65, 
which  are  subsequently  dehydrated  into  the  corresponding  cyclic  maleimides 
(scheme 20).
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(a)  RNH2, AcOH, 21 °C, then heating with (or without) acetic anhydride and sodium acetate, X, X1 = H; X = 
H, X1 = Br. 
Scheme 20. General conditions for maleimide synthesis. 
Several variations using milder reagents have been described; reaction of the amine 
with maleic anhydride followed by dehydration with TMS-Cl/triethylamine;
6 HMDS 
and ZnBr2 in refluxing benzene.
71,72 However, the yields when converting maleimic 
acid to maleimide under acidic or dehydrating conditions are generally modest and 
the scope of the amine is limited. Additionally the reactions preclude the use of acid 
labile or other sensitive functionality which limits the scope of this strategy.
73 
A variation of this approach makes use of the initial ring closure described in scheme 
20  using  β-alanine,  or  other  similar  simple  amino  acids,  in  order  to  generate 
maleimide intermediates to which further functionality can be incorporated by amide 
coupling  reaction  (scheme  21).
74  This  circumvents  the  requirement  for  non-acid 
sensitive substrates and allows synthesis of reagents of considerable complexity.  
24 
 
O
O
O
X1
X
N
H
O
O
X1
X
OH
N
O
O
X1
X
64 67
68
OH
O
OH
O
N
O
O
X1
X
69
HN
O
R
a b
c
 
(a) AcOH, β-alanine, RT; (b) acetic anhydride, AcOH, 160 °C; (c) HBTU, NH2R, N-methylmorpholine, DMF; X, X1 
= H; X = H, X1 = Br. 
Scheme 21. Alternative synthesis of maleimide motif using a ring closure approach 
A number of other fairly conventional routes have been utilised. For example, one  
convenient method involves the direct reaction of primary amine derivatives with N-
methoxycarbonyl  maleimide.
75  Alternatively,  an  elegant  Mitsunobu  approach  has 
been reported by Walker
73 in which alcohol derivatives are reacted with maleimides 
in  the  presence  of  triphenylphosphine  and  a  dialkyl  azodicarboxylate  (scheme 
22).
6,73,76 The Mitsunobu reaction is more general since it can be carried out under 
essentially neutral conditions and at room temperature. The starting material is also 
an alcohol rather than an amine which allows an alternative synthetic entry into this 
class of maleimide. 
NH
O
O
X1
X
N
O
O
X1
X
R
70 66
a
 
(a)  PPh3, DIAD, -78 
oC, ROH, 15 h. X, X1 = H 
Scheme 22. Mitsunobu reaction.  
The method employed to synthesis the reagent will need to fulfil certain criteria; (1) 
be simple, cost effective and straightforward methodology; (2) need for the reagent 
to be chemically stable and sufficiently robust for general use;
77,78 (3) need for the 
reagent to be hydrophilic so as to ensure complete aqueous medium solubility.
79 
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2.3  Retrosynthetic  analysis  of  biotinylated  and  fluoresceinylated 
bromomaleimide reagents 
In order to develop a concise and divergent synthesis which could be used for the 
synthesis of a variety of bromomaleimide containing reagents, a route was conceived  
that would allow easy access to 71 (scheme 23), an intermediate which could then be 
manipulated to incorporate whichever functionality was desired. 
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Scheme 23. Target for synthetic route; X, X1 = Br, X = H, X1 = Br.  
The use of the TFA salt could be of importance in limiting potential degradation over 
time. The incorporation of an oligoethyleneglycol (OEG) spacer would be important 
for the biotin bromomaleimide reagents 60 and 61, to allow access to the active site 
of (strept)avidin, maintaining the strong interaction upon binding. OEGylation would 
also give increased solubility in aqueous solution. Scheme 24 shows the possible 
retrosynthetic strategies for such an intermediate.  
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Scheme 24. Retosynthetic analysis for species 71, the key intermediate in the synthesis of bromomaleimide reagents. 
Route  1  consists  of  the  reaction  of  mono-Boc  protected  diamine  75  with  γ-
butyrolactone  (GBL)  76,
80  Mitsunobu  coupling
73  with  either  mono-  or  di- 
bromomaleimides, followed by deprotection to afford 71. Route 2, despite requiring 
the reaction of an activated acid 77 with an amine rather than Mitsunobu coupling, 
also leads to the formation of intermediate 71. With this amine in hand, it would then 
be possible to attach a diverse range of functionality, including biotinylation, via the 
many amine reactive reagents commercially available.  
Where there is no requirement for the incorporation of a spacer, as in the case of 
fluorescent  bromomaleimides,  the  synthetic  scheme  can  be  simplified.  In  such 
instances, the retrosynthesis consists of one simple step (scheme 25), the forward 
synthesis  of  which  entails  acid  catalysed  ring-opening  and  closing  of  maleimic 
anhydride analogues 64 with fluoresceinamine 78 at elevated temperatures.   
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Scheme 25. Retrosynthetic analysis for fluorescein bromomaleimide reagents. 62 X, X1 = Br; 63 X = H, X1 = Br. 
2.4 Synthesis of biotinylated bromomaleimide reagents 60 and 61 
2.4.1 Route 1 to biotin bromomaleimide reagents 
The  investigation  was  initiated  with  an  evaluation  of  route  1  (scheme  26). 
Desymmetrisation of diamine 79 with γ-butyrolactone 76 in the presence of H2O led 
efficiently to amino alcohol 80 in 74% yield. However, Mitsunobu reaction of 80 
with mono- and di- bromomaleimide failed to produce the desired amines. Rather, a 
complex reaction mixture resulted, from which it was not possible to determine any 
discrete molecular structures. As an alternative, the free amine of amino alcohol 80 
was Boc-protected to give 73 and then subjected to Mitsunobu conditions, again to 
no avail. Replacement of the OEG-chain with a benzyl group to give 82 also failed to 
give the desired product under Mitsonobu conditions, suggesting that the presence of 
the amide group caused the reactions to fail. A possible explanation for this is the 
potential  ring  cyclisation  upon  ejection  of  triphenylphosphine  oxide  from  the 
Mitsunobu intermediates 83, although the expected lactam by-products 84 were not 
isolated (scheme 27). 
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(a) γ-butyrlactone 76, H2O, 90 
oC, 74% yield; (b) DIAD, PPh3, -78 
oC, mono- or di- bromomaleimide. 
Scheme 26. Route 1 to key intermediate 71.  
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Scheme 27. Formation of lactam by-product via ring cyclisation. R = (CH2CH2O)2NHBoc, (CH2CH2O)2NH2, Bn. 
Despite the fact that the lactam by-product was not detected, it seems reasonable to 
assume that the presence of the amide five carbons away from the O-P bond  was 
affecting the outcome of the Mitsunobu reaction. With this in mind, an alternative 
strategy was investigated which would preclude this potential cyclisation by removal 
of the amide bond in 73 (scheme 28). Therefore amino alcohol 85 was synthesised 
according  the  method  of  Lebeau,
81  and  reacted  with  dibromomaleimide  under 
Mitsunobu  conditions,  which  pleasingly  furnished  OEG-dibromomaleimide  86. 
However, this could not be isolated pure. Instead 86 was treated directly with TFA to 
yield amine-TFA salt 87, a derivative of the initial key intermediate 71. 
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(a)  Methane sulfonyl chloride, NEt3, 21 °C, 24 h, 33% yield; (b) NaN3, MeCN, 90 °C, 36 h, 84% yield; (c) 
PPh3, H2O, 21 °C, 4 h, 78% yield; (d) KOH, di-tert-butyl-di-carbonate, 21 °C, 4 h, 100% yield; (e) DIAD, PPh3, -78 
°C, 1 h, dibromomaleimide, then 21 °C, 15 h; (f) TFA/CH2Cl2, 21 °C, 24 h, 94% yield. 
Scheme 28. Synthesis of 87. 
With  the  synthesis  of  this  intermediate  completed,  the  first  of  several  coupling 
reactions was carried out with the biotin acid 88 (scheme 29). Disappointingly the 
coupling  conditions  of  EDC.HCl,  DMAP and  N-methylmorpholine (2  and 5  eq); 
EDC.HCl, HOBt and N-methylmorpholine (2 and 5 eq); EDC.HCl, HOBt and NEt3 
(2 and 5 eq); HBTU and DIEA (2 and 5 eq); SOCl2 and DIEA (2 and 5 eq) all led to 
eventual decomposition over time. Although trace amounts of product were observed 
spectroscopically  by 
1H  and 
13C  NMR  and  mass  spectrometry,  none  could  be 
isolated.  
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Scheme 29. Attempted amide coupling of biotin acid 88 with amine-TFA salt 87. 
It was postulated that the bromomaleimide motif could react with the amine base, 
leading to degradation of both 87 and 60. Therefore to investigate whether this was 
the case, a 
1H NMR reaction of 87 with NEt3 (two and five eq) was performed. 
Unfortunately  the  disappearance  of  the  maleimide  double  bond  was  observed, 
indicating degradation of the maleimide was taking place (scheme 30). 
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Scheme 30. Reaction of amine-TFA salt with NEt3. 
2.4.2 Route 2 to biotin bromomaleimide reagents 
Despite the requirement of another amide coupling reaction in this approach, it was 
considered useful to determine whether the problems encountered in route 1 would 
still be present in route 2. Therefore in order to test whether the acid 77 (scheme 24) 
would suffer the same problems of degradation as encountered with amine-TFA salt 
87  (scheme  30),  a  pilot  reaction  using  91  was  carried  out  (scheme  31). 
Dibromomaleic anhydride 90 was synthesised using the procedure of Dubernet
69 and 
condensed with β-alanine in refluxing acetic acid. Unfortunately the required amide 
coupling reaction again led to failure with significant decomposition taking place.  
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(a)  Br2, AlCl3, 160 
oC, 24 h, 78% yield; (b) β-alanine, AcOH, 150 
oC, 3 h, 70% yield. 
Scheme 31. Amide coupling reaction used in route 2. 
2.4.3 Route 3 to biotin bromomaleimide reagents 
Thus a third route was sought to circumvent the troublesome amide coupling reaction 
(scheme 32). No reaction involving the use of amine with bromomaleimide could be 
carried out. However, the reaction of β-alanine with bromomaleic anhydride has been 
shown to be a feasible alternative and high yielding (scheme 31 – formation of 91). 
The third synthetic route began with the coupling of mono-Boc protected amine 75
82 
with activated biotin,
83 followed by Boc-deprotection to give 93 in excellent yield. 
Addition of mono- and di- bromomaleimic anhydride in acid then gave ring opened 
maleimic acids, which underwent ring closure by heating to 170 °C for 2 h to yield 
compounds 60 and 61 (figure 13 and 14). 
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(a)  HBTU,  DIEA,  75,  2  h,  RT,  80%  yield;  (b)  TFA/DCM,  RT,  15  h,  100%  yield;  (c)  mono-  or  di- 
bromomaleimic anhydride, AcOH, 170 
oC, 2 h, 60 48% and 61 52%. 
Scheme 32. Route 3 to biotin bromomaleimides 60 and 61.  
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Figure 13. 
1H NMR of 60 in CD3OD. 
Figure 14. 
1H NMR of 61 in CD3OD.  
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Thus  we  have  successfully  developed  an  efficient  three  step  synthesis  of  biotin 
mono- and di- bromomaleimide reagents. Crucially this synthesis avoids the addition 
of free amine to the bromomaleimide moiety. By carrying out the reaction under 
strongly acidic conditions, we can ensure the amine remains protonated and therefore 
unable to react with the double bond of the bromomaleimide motif. Additionally, the 
acidic conditions do not impede formation of the maleimic acid intermediates or the 
ring closure to afford the biotin bromomaleimide reagents. 
2.5 Synthesis of fluorescein bromomaleimide reagents 62 and 63 
The attachment of biotin to bromomaleimides in section 2.4 required the use of a 
linker. However, in the case of the fluorescent tag a linker is not necessary. Therefore 
a simple acid catalysed condensation reaction was used to give fluorescein reagents 
62 and 63 (scheme 33, figures 15 and 16). 
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(a)  Mono- or di- bromomaleimic anhydride, AcOH, 170 
oC, 62 84% yield and 63 65% yield.  
Scheme 33. Synthesis of fluorescein bromomaleimides.  
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Figure 15. 
1H NMR of 62 in CD3OD. 
Figure 16. 
1H NMR of 63 in DMSO-d6. 
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2.6 Studies on the chemical modification of Grb2 SH2 domain 37 
With  the  biotinylated  and  fluoresceinylated  bromomaleimide  reagents  in  hand,  a 
series of experiments were carried out to investigate how well they would react with 
the single point mutant (L111C) of the SH2 domain of the Grb2 adaptor protein 37, a 
model protein chosen due to the presence of a single cysteine residue and absence of 
any disulfide bonds,
67 with the reactions monitored by Liquid Chromatography Mass 
Spectrometry (LCMS or HPLC MS). 
LCMS combines the physical separation capabilities of liquid chromatography with 
the mass analysis capabilities of mass spectrometry  (MS) and is therefore a very 
powerful technique, exhibiting high sensitivity and specificity. By running samples 
through a column prior to MS analysis, chemically different species can be separated 
and then analysed by MS individually, providing sufficient separation is achieved. 
This  separation  is  monitored  using  a  chromatogram  which  produces  absorbance 
peaks corresponding to all the different species present in solution and how long it 
takes each species to pass through the LC column (figure 17). 
 
Figure 17. LCMS chromatogram showing a single molecular species. 
By  MS  analysis  of  these  peaks  individually,  the  specific  species  present  can  be 
studied. In cases where separation is not good enough for accurate MS analysis of the 
individual peaks, the peaks can instead be analysed collectively (figure 18). This 
allows  for  the  MS  analysis  of  more  than  one  species  present  in  solution,  and 
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providing they are of similar sensitivity to MS, a ratio of their abundance can be 
determined. Whilst the presence of an amine in one species and an aromatic group in 
another will result in different degrees of sensitivity towards MS analysis, in proteins 
of similar size and chemical space this is not the case. 
 
Figure 18. LCMS chromatogram showing two inseparable molecular species. 
The addition of small molecules, such as bromomaleimides, to proteins can be shown 
not to significantly affect their chemical space, providing the modification is specific 
and  not  denaturing.  For  instance,  the  addition  of  bromomaleimide  to  the  single 
cysteine of Grb2 SH2 domain  37 does not significantly affect its interaction and 
movement through the LC column or its sensitivity to MS.
66 Therefore LCMS can be 
used as a way of monitoring the modification of proteins with small molecules, such 
as bromomaleimides, via the collective MS analysis of the peaks observed in the LC 
chromatogram  (e.g. figures  19 and 20),  and has become an  established and  well 
accepted method of analysis.
84-86 
By  taking  the  ratio  of  the  abundances  of  unmodified  and  modified  protein,  a 
percentage  conversion  can  be  obtained,  assuming  that  no  decomposition  of  the 
protein has taken place. However, even if this were the case, decomposition of such a 
large molecule would be observed by LCMS, and has been found to small extent in 
the  following  sections  (section  2.6.1  to  2.6.4,  tables  1  to  8,  column  7;  loss  of 
OEGbiotin, unidentifiable species, -23 m/z). 
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Figure 19. LCMS spectrum obtained from the addition of 60 to Grb2 SH2 domain 37. 
 
Figure 20. LCMS spectrum obtained from the addition of 100 eq of BME to Grb2-biotin dibromomaleimide conjugate. 
In this way, no internal standard is used. Rather, by analysing the overlapping peaks 
in the chromatogram collectively (figure 18), it is assumed that all protein species 
present  in  solution  are  accounted  for.  Additionally,  the  presence  of  an  internal 
standard of sufficient size to be of use (e.g. another protein) could be detrimental to 
the outcome of the reaction, by itself reacting with the other reagents present.
84 This 
also  applies  for  an  external  standard.  Studies  using  an  external  standard  usually 
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require the addition of a known amount of a reaction mixture to a second solution 
containing the  external  standard. MS analysis can then be used to  determine the 
percentage conversion by comparing the amount of starting material and product 
against  the  known  amount  of  external  standard.  However,  again  this  external 
standard would need to be of sufficient size and sensitivity towards MS analysis to 
be of use, and of a chemical nature that would not interact with the reagents and 
reactive species present in the solution. 
The error associated with not having an internal and external standard will be the 
same throughout this study. As the reaction conditions will be set for all experiments, 
a  comparison  can  be  made  as  to  the  trends  on  changing  from  the  biotin 
bromomaleimides  to  the  fluorescein  bromomaleimides,  as  well  as  changing  from 
mono to di bromomaleimide, and changes in pH and temperature, all of which will 
then be used to determine the best reagent and conditions for protein modification 
with bromomaleimides. 
If the assumption is made that the unmodified and modified Grb2 SH2 domain 37 
can  be  used  to  determine  the  percentage  conversion,  an  excess  of  the  protein 
modifying  reagent  (bromomaleimides)  would  be  needed  to  ensure  that  complete 
conversion  can  occur.  In  the  vast  majority  of  PTM  procedures  found  in  the 
literature,
26 a 100-fold excess of protein modifying reagent is the minimum that is 
used. However, in this study to demonstrate the specificity and reactivity of the new 
bromomaleimide reagents, only 2 equivalents will be used.  
Three temperatures have been chosen for this study of reactivity; 0 °C, 21 °C and 37 
°C. A standard time interval for each reaction is also required, in order to properly 
compare the results; 2 h was chosen for the addition of bromomaleimide reagent (2 
eq) to Grb2 SH2 domain 37, and 4 h for its elimination using BME (100 eq). These 
reactions were carried out at pH 7 and 8. It should be noted that whilst many MS 
studies in the literature only record species present in solution which are greater than 
5 % in abundance,
87 in this study all species present in solution will be taken into 
account. 
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2.6.1 Reactivity of biotin dibromomaleimide with 37 
Scheme 34 shows the protection reaction of Grb2 SH2 domain 37 with 60 and the 
possible intermediates formed, whilst table 1 shows the mean percentage conversion 
for this protection at pH 7 and 8. The standard error (i.e. standard deviation of the 
mean)
88 is shown in parenthesis. Note – all data is rounded to the nearest whole 
number. 
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Scheme 34. Reaction of Grb2 SH2 domain 37 with dibromomaleimide reagent 60 (2 eq) for 2 h. 
Entry  Temp  pH  37  94  95  Other 
1  0 °C  8  4 (±1) %  80 (±2) %  2 (±1) %  14 (±2) % 
2  0 °C
ω  8  3 (±1) %  82 (±1) %  3 (±3) %  12 (±1) % 
3  21 °C  8  3 (±2) %  43 (±2) %  41 (±1) %  14 (±3) % 
4  37 °C  8  0 (±0) %  1 (±1) %  66 (±3) %  34 (±2) % 
5  0 °C  7  3 (±2) %  83 (±2) %  0 (±0) %  14 (±2) % 
6  21 °C  7  1 (±1) %  72 (±12) %  10 (±10) %  17 (±5) % 
7  37 °C  7  2 (±1) %  0 (±0) %  80 (±5) %  18 (±4) % 
Table 1. Protection of Grb2 SH2 domain with biotin dibromomaleimide 60. Hyd = hydrolysis product 95; other = loss of 
OEGbiotin section of reagent, -23 m/z; 
ω 10eq of biotin dibromomaleimide reagent 60 used. 
The best results at pH 8 were that obtained for the protection of Grb2 SH2 domain 37 
with 60 at 0 °C (table 1, entries 1 and 2). At this temperature degradation was found 
to  be  minimal  but  became  more  pronounced  as  the  reaction  temperature  was 
increased (table 1, entry 4). At the higher temperatures (table 1 entries 3 and 4)  
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increased amounts of hydrolysis were also observed. This is a significant result, as 
the hydrolysed product 95 is inactive towards reduction with BME and thus creates a 
‘sink’ of irreversibly bound Grb2-bromomaleimide-species (scheme 35). The same 
observations were made when the reactions are carried out at pH 7. At 0 °C (table 1 
entry  5)  protection  is  optimal  with  no  hydrolysis  taking  place.  However,  as  the 
temperature is increased, both degradation and hydrolysis are again observed (table 1 
entries 6 and 7). 
Scheme  35  shows  the  conditions  used  for  the  deprotection  of  Grb2-biotin 
dibromomaleimide conjugate and table 2 the mean percentage conversions from the 
deprotection of Grb2-biotindibromomaleimide conjugate 94 with BME (100 eq) at 
pH 7 or 8 at 0 °C, 21 °C and 37 °C. The standard error is again shown in parenthesis. 
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Scheme 35. Deprotection of Grb2-biotin dibromomaleimide conjugate 94 with BME (100 eq) for 4 h. 
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Entry  Temperature  pH  94  37  95  Other 
1  0 °C  8  8 (±8) %  80 (±0) %  3 (±3) %  8 (±8) % 
2  21 °C  8  2 (±2) %  26 (±2) %  47 (±1) %  25 (±1) % 
3  37 °C  8  0 (±0) %  5 (±5) %  61 (±4) %  34 (±8) % 
4  0 °C(p)/21 °C  8  10 (±3) %  85 (±5) %  2 (±2) %  4 (±4) % 
5  0 °C(p)/37 °C  8  0 (±0) %  84 (±12) %  8 (±4) %  6 (±6) % 
6  0 °C  7  25 (±3) %  69 (±5) %  0 (±0) %  6 (±4) % 
7  21 °C  7  3 (±3) %  43 (±2) %  39 (±2) %  15 (±5) % 
8  37 °C  7  0 (±) %  10 (±2) %  65 (±2) %  25 (±1) % 
Table 2. Deprotection of Grb2-biotindibromomaleimide conjugate 94. Other = loss of OEGbiotin section of reagent. 
These  results  were  obtained  from  taking  the  reaction  mixture  of  the  original 
protection reactions and subjecting them to the conditions required for deprotection 
(BME 100 eq). For instance, the product from the protection at 0 °C (table 1 entry 1) 
was used directly in the deprotection reaction with BME at 0 °C (table 2 entry 1). 
However, this means that the composition of the reaction mixture obtained from the 
protection reactions will directly influence the latter deprotections. To illustrate this 
point,  let  us  compare  table  1  entry  4  and  table  2  entry  3.  66%  hydrolysis  was 
observed for the protection reaction at 37 °C (table 1 entry 4), whilst 61% hydrolysis 
was observed during the deprotection step at 37 °C (table 2 entry 3). These two 
values are very similar, suggesting that whatever was hydrolysed in the protection 
step remained hydrolysed and inactive during deprotection, thus demonstrating the 
irreversible nature of the hydrolysed products 95. To avoid this troublesome result, 
the protection conditions which produced the smallest amount of hydrolysis were 
used (table 1 entry 1), followed by deprotection at 21 °C and 37 °C (table 2 entries 4 
and 5), which pleasingly furnished the greatest yield in product 37.  
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The results also differed depending on the pH, with those reactions carried out at pH 
8 generally leading to poorer yields than those carried out at pH 7 (with the exception 
at 0 °C). This could be attributed to the increase in side reactions at  higher pH, 
leading to decomposition rather than the return of deprotected protein 37. 
2.6.2 Reactivity of biotin monobromomaleimide with 37 
The second biotin bromomaleimide reagent to be investigated was 61, using the same 
conditions to those employed for the reaction of 60 with Grb2 SH2 37 (scheme 36). 
Table 3 presents the mean percentage conversions for the protection of the Grb2 SH2 
domain 37 with 61 (2 eq) at 0 °C, 21 °C and 37 °C, and at pH 7 and 8, with the 
standard error again shown in parenthesis. 
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Scheme 36. Reaction of Grb2 SH2 domain protein 37 with biotin monobromomaleimide reagent 61 (2 eq) for 2 h. 
 
Entry  Temp  pH  37  97  98  Other 
1  0 °C  8  2 (±2) %  90 (±3) %  0 (±0) %  8 (±1) % 
2  21 °C  8  0 (±0) %  90 (±2) %  3 (±3) %  7 (±4) % 
3  37 °C  8  24 (±9) %  71 (±4) %  5 (±5) %  0 (±0) % 
4  0 °C  7  0 (±0) %  86 (±6) %  0 (±0) %  14 (±6) % 
5  21 °C  7  0 (±0) %  79 (±10) %  0 (±0) %  21 (±10) % 
6  37 °C  7  0 (±0) %  76 (±5) %  11 (±11) %  13 (±6) % 
Table  3.  Protection  of  Grb2  SH2  domain  with  biotin  monobromomaleimide.  Hyd  =  hydrolysis  product 98; other = loss of 
pegbiotin section of reagent, -23 m/z.  
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From the entries above it can be seen that addition of 61 does react with much less 
hydrolysis  (as  determined  by  the  mean  percentage  conversion  of  97  and  98), 
particularly at 0 °C and 21 °C (table 3 entries 1, 2, 4 and 5). Further, a comparison of 
reaction rates at different pH’s suggests that the reaction at pH 7 is slower than the 
corresponding reaction at pH 8. This is due to the increased formation of the anion of 
37 at higher pH, and thus faster reaction. At pH 7 degradation is also found to be 
slightly more pronounced, whereas at pH 8 it is minor. 
Table 4 shows the mean percentage conversion for the deprotection of Grb2 SH2 
domain – biotin monobromomaleimide conjugate with BME at 0 °C, 21 °C and 37 
°C (scheme 37), with standard errors shown in parenthesis. 
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Scheme 37. Deprotection of Grb2-biotin monobromomaleimide conjugate 61 with BME (100 eq) for 4 h. 
Entry  Temp  pH  97  37  98  Other 99 
1  0 °C  8  0 (±0) %  12 (±8) %  0 (±0) %  88 (±8) % 
2  21 °C  8  2 (±2) %  30 (±1) %  0 (±0) %  65 (±3)
 %
ξ 
3  37 °C  8  2 (±2) %  75 (±9) %  16 (±8) %  5 (±1)
 %
 ξ 
4  0 °C  7  0 (±0) %  5 (±5) %  0 (±) %  77 (±6) %
ξ 
5  21 °C  7  5 (±5) %  21 (±5) %  0 (±0) %  61 (±5) %
ξ 
6  37 °C  7  17 (±7) %  66 (±1) %  0 (±0) %  18 (±5) %
ξ 
Table 4. Deprotection of Grb2-biotin monobromomaleimide. Hyd = hydrolysis product 98; other = BME addition product 99; 
ξ 
remaining unaccounted mean percentage conversion is a combination of unidentifiable species.  
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It  can  be  seen  from  table  4  that  the  addition  of  BME  to  Grb2-biotin 
monobromomaleimide conjugate 97 at pH 7 and 8 resulted in little hydrolysis (16 % 
conversion - table 4 entry 3). However, rather than isolating the expected product 37, 
a BME-Grb2-biotin-monobromomaleimide adduct  99 was formed, whereby  BME 
had added across the maleimide double bond. 
Species 99 is a maleimide unit with three different groups attached and demonstrates 
that monobromomaleimide reagents offer an opportunity for the attachment of three 
functional groups. Interestingly, formation of species 99 was found to be reversible, 
thus when the temperature was increased to 37
 °C (table 4 entries 3 and 6), 37 was 
obtained. 
In conclusion it has been shown that biotin mono- and di- bromomaleimide can be 
used for the protection of the Grb2 SH2 domain, a single cysteine containing model 
protein. The optimum temperature for protection using biotin dibromomaleimide 60 
was 0 °C. At higher temperature hydrolysis became an issue, leading to the formation 
of irreversibly bound Grb2-biotin dibromomaleimic acid conjugate 95. The optimum 
temperatue  for  deprotection  was  37  °C,  although  even  at  this  temperature  the 
hydrolysed species 95 was still found to be inactive towards deprotection. 
Hydrolysis  was  shown  to  be  markedly  reduced  by  using  biotin 
monobromomaleimide  61,  allowing  higher  temperatures  to  be  used  throughout. 
However,  when  using  monobromomaleimide  61,  the  Grb2-biotin 
monobromomaleimic acid intermediate 99 was observed at low temperature but was 
shown to react at 21 and 37 °C to yield Grb2 model protein 37 in high yield. 
2.6.3 Reactivity of fluorescein dibromomaleimide with 37 
With the results for the protection and deprotection of the Grb2 SH2 domain using 
biotin mono- and di- bromomaleimide reagents complete, attention was turned to the 
fluorescein bromomaleimide equivalents 62 and 63. Scheme 38 shows the product 
formed from the protection of Grb2 37 with fluorescein dibromomaleimide 62 and 
table 5 the mean percentage conversion for the protection reaction at 0 °C, 21 °C and 
37 °C at pH 7 and 8. The standard error is shown in parenthesis.  
44 
 
SH
mass 14170
37
N
Br
Br
Fluorescein
O
O S
mass 14675
100
N
Br
Fluorescein
O
O HYDROLYSIS
S
H
N
Br
Fluorescein
O
O
OH
62
101
mass 14693  
Scheme 38. Reaction of Grb2 SH2 domain 37 with fluorescein dibromomaleimide reagent 62 (2eq) for 2 h. 
 
 
Entry  Temp  pH  37  100  101  Other 
1  0 °C  8  1 (±1) %  61 (±3) %  32 (±3) %  6 (±0) % 
2  21 °C  8  0 (±0) %  2 (±1) %  61 (±9) %  37 (±8) % 
3  21 °C dark
κ  8  0 %  12 %  80 %  8 %
 
4  37 °C  8  0 (±0) %  0 (±0) %  75 (±4) %  25 (±4) % 
5  0 °C  7  0 (±0) %  57 (±4) %  43 (±4) %  0 (±0) % 
6  21 °C  7  1 (±1) %  9 (±1) %  81 (±1) %  10 (±0) % 
7  37 °C  7  0 (±0) %  7 (±7) %  71 (±1) %  22 (±8) % 
Table 5. Protection of Grb2 SH2 domain with fluorescein dibromomaleimide. Hyd = hydrolysis product 101; other = -23 m/z, 
κ 
= reaction carried out once. 
The protection of Grb2 SH2 domain 37 using fluorescein dibromomalemide 62 at pH 
7 and 8 was found to be most efficient at 0 °C (table 5 entries 1 and 5), with higher 
temperatures resulting in degradation and hydrolysis (table 5 entries 2, 4, 6 and 7). 
The  failure  of  the  reaction  at  21  °C  was  also  of  note,  due  to  the  substantial 
degradation observed (37% conversion, table 5 entry 2). To investigate whether light 
was contributing to this degradation; the 21 °C reaction was repeated in the dark 
(table 5 entry 3). However, whilst this did alleviate degradation considerably, the 
amount of hydrolysis was seen to increase to a level comparable with that at 37 °C 
(table 5 entry 4). At this temperature, little product was observed, predominantly 
being hydrolysed species 101.  
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Thus  at  temperatures  above  0  °C  and  in  the  presence  of  light,  hydrolysis  was 
observed to be the major process taking place. In comparison with the biotinylated 
dibromomaleimide  reagent  60  discussed  in  section  2.6.1,  the  fluoresceinylated 
analogue  was  found  to  be  considerably  more  reactive  to  hydrolysis,  which  is  in 
agreement with observations of N-aryl maleimides reported in the literature.
26 
Table  6  presents  the  mean  percentage  conversions  for  the  deprotection  of  Grb2-
fluorescein dibromomaleimide conjugate 100 with BME, at pH 7 and 8, and at 0 °C, 
21 °C and 37 °C (scheme 39), with the standard error shown in parenthesis. 
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Scheme 39. Deprotection of Grb2-fluorescein dibromomaleimide 100 with BME (100 eq) for 4 h. 
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Entry  Temp  pH  100  37  101  Other 
1  0 °C  8  3 (±3) %  52 (±7) %  41 (±7) %  4 (±4) % 
2  21 °C
η  8  0 %  0 %  0 %  0 % 
3  37 °C  8  0 (±0) %  0 (±) %  93 (±2) %  7 (±2) % 
4  0 °C(P)/21 °C
η  8  0 %  0 %  0 %  0 % 
5  0 °C(P)/37 °C  8  0 (±0) %  58 (±2) %  39 (±5) %  3 (±3) % 
6  0 °C  7  0 (±0) %  58 (±2) %  42 (±2) %  0 (±0) % 
7  21 °C
η  7  0 %  0 %  0 %  0 % 
8  37 °C  7  6 (±1) %  0 (±0) %  93 (±2) %  1 (±1) % 
Table 6. Deprotection of Grb2-fluorescein dibromomaleimide. Hyd = hydrolysis product 101; other =  -23 m/z. η complete 
reaction failure. 
The highest mean percentage conversion for the deprotection of Grb2-fluorescein 
dibromomaleimide conjugate 100 at pH 7 and 8 were both obtained at 0 °C (table 6 
entries 1 and 6). At this temperature hydrolysis was also found to be of a comparable 
value  (41%  entry  1;  42%  entry  6).  In  order  to  avoid  this  hydrolysis  and  hence 
determine an accurate mean percentage conversion for the deprotection of 100 at 
elevated temperature, Grb2 was first protected with fluorescein dibromomaleimide 
62 at 0 °C and subsequently deprotected at 21 °C and 37 °C (table 6, entries 4 and 5). 
Despite this, no change in yield was observed, suggesting that the limiting factor in 
these reactions is the relative rates of protection and hydrolysis, and that deprotection 
is faster than hydrolysis. 
2.6.4 Reactivity of fluorescein monobromomaleimide with 37 
The major product from the protection of the Grb2 SH2 domain 37 with fluorescein 
dibromomaleimide 62 at elevated temperature was hydrolysed species 101. However, 
as shown in section 2.6.2, hydrolysis of the maleimide motif could be subdued by 
replacing  the  dibromomaleimide  motif  with  monobromomaleimide.  Therefore,  in  
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order to investigate whether a similar result could be achieved with the fluorescein 
analogues, the fluorescein dibromomaleimide was in turn replaced with fluorescein 
monobromomaleimide (scheme 40). 
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Scheme 40. Reaction of Grb2 SH2 domain 37 with fluorescein monobromomaleimide reagent 63 (2eq) for 2 h. 
The  results  for  the  protection  of  Grb2  SH2  domain  37  with  fluorescein 
monobromomaleimide  63,  at  0  °C,  21  °C  and  37  °C  and  at  pH’s  7  and  8,  are 
presented in table 7 as mean percentage conversions with standard errors shown in 
parenthesis. 
Entry  Temp  pH  37  103  104  Other 
1  0 °C  8  0 (±0) %  82 (±4) %  2 (±2) %  16 (±4) % 
2  21 °C  8  0 (±0) %  78 (±5) %  9 (±9) %  13 (±13) % 
3  37 °C  8  0 (±0) %  31 (±3) %  67 (±1) %  2 (±2) % 
4  0 °C  7  0 (±0) %  89 (±2) %  9 (±1) %  2 (±2) % 
Table 7. Protection of Grb2 SH2 domain with fluorescein monobromomaleimide. Hyd = hydrolysis product 104; other = -23 
m/z. 
The protection of the Grb2 SH2 domain 37 with fluorescein monobromomaleimide 
63 at 0 °C and 21 °C for pH’s 7 and 8 (table 7 entries 1, 2  and 4) was shown to 
proceed with the desired increase in product, demonstrating the beneficial effect of 
using a single bromine on the maleimide motif. Unfortunately at 37 °C significant 
hydrolysis was observed (table 7 entry 3), but was modest by comparison with the 
extent of hydrolysis observed with the fluorescein dibromomaleimide derivative 62, 
and so this approach is considered an improvement.    
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The mean percentage conversions for the deprotection of 103 using BME (scheme 
41) are presented in table 8, with the standard error shown in parenthesis. 
mass 14597
103
104
mass 14615
SH
HO S
N Fluorescein
O
O
S
H
N Fluorescein
O
O
OH
HYDROLYSIS SH
HO
NO REACTION
N
S
Fluorescein
O
O
HO
S
mass 14675
105
SH
mass 14170
37
21oC or 37 oC
 
Scheme 41. Deprotection of Grb2-fluorescein monobromomaleimide conjugate with BME (100 eq) for 4 h. 
Entry  Temp  pH  103  37  104  Other 105 
1  0 °C  8  0 (±0) %  27 (±3) %  0 (±0) %  65 (±0) %
κ 
2  21 °C  8  12 (±3) %  51 (±2) %  8 (±8) %  27 (±6) %
κ 
3  37 °C  8  7 (±7) %  23 (±9) %  70 (±2) %  0 (±0) % 
4  37 °C  7  1 (±1) %  87 (±1) %  11 (±1) %  1 (±1) % 
Table 8. Deprotection of Grb2-fluorescein monobromomaleimide. Other = yield corresponds to BME addition product 105, 
κ 
= remaining unaccounted mean percentage conversion is a combination of unidentifiable species. 
It  is  notable  that  at  pH  8  there  is  modest  product  formation,  irrespective  of  the 
temperature.  It  was  also  observed  that  the  BME  again  reacts  with  the 
bromomaleimide double bond leading to the maleimide complex 105. Heating of 105 
at pH 8 was observed to reverse the conjugate addition, although hydrolysis of the 
less stable aromatic maleimide group gave the hydrolysis product 104 (table 8 entry 
3), which was unreactive towards BME deprotection. However, at pH 7 a different 
mode of reactivity was observed with the reduced Grb2 SH2 37 being predominantly 
formed, with only a minor amount of hydrolysis (11 % conversion - table 8 entry 4).  
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This is a result of the decreasing concentration of hydroxide ion present in solution 
as the pH is decreased from 8 to 7.  
2.6.5 Comments and conclusions on the reactivity of mono - and di- 
bromomaleimides with 37 
It  has  been  shown  that  the  reaction  of  Grb2  SH2  domain  37  with  modified 
dibromomaleimides (biotin / fluorescein) occurs in high  percentage conversion at 
low temperature (0 °C), whilst at higher temperatures (21 °C and 37 °C) hydrolysis 
to form the inactive hydrolysed dibromomaleimide adducts is observed. However, 
the rate of hydrolysis appears slower than the protection of Grb2 SH2 domain with 
the dibromomaleimide reagents. Optimisation studies have indicated that at pH 7 and 
8, addition of the Grb2 SH2 domain to the dibromomaleimide reagents is complete 
within 35 min. It has previously been reported and found in this study that thiolates 
are unable to react with hydrolysed maleimides due to the electrostatic repulsion with 
the carboxylate.
26 This literature precedent along with the results from the present 
studies, indicate that addition of Grb2 SH2 domain to the bromomaleimide is the first 
step which is then followed by hydrolysis.  
The monobromomaleimides appear to be a useful alternative reagent, which can be 
used to avoid hydrolysis of the maleimide ring. The rate of hydrolysis is increased by 
the presence of two bromines on the maleimide motif, but the incorporation of only 
one  bromine  leads  to  greater  stability.  Although  the  resistance  to  hydrolysis  is 
desirable, the monobromomaleimide reagents do encounter another problem; at low 
temperature the intermediate from the cleavage reaction appears stable (scheme 42). 
Whilst this process can be reversed by heating at pH 7 or 8, this reverse reaction can 
also be complicated by further problems of hydrolysis, particularly at pH 8. At pH 7 
reversibility  is  ensured,  returning  the  Grb2  SH2  domain  unprotected  and  in  its 
original form (as characterised by LCMS), without undesired hydrolysis.  
50 
 
SH
HO S
106
N R
O
O
N
S
R
O
O
HO
S
107
SH
37
0 oC
H
OH
N
S
R
O
O
HO
108
37 oC
SH
HO S
109
N R
O
O
N
S
R
O
O
HO
S
110
SH
37
0 oC
N
S
R
O
O
HO
111
Br
0 / 21 / 37 oC
SH
HO
S HO
 
Scheme 42. Mechanism of cleavage for mono- and di- bromomaleimide reagents. 
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2.7 Studies on the chemical modification of Somatostatin 112 
It has previously been shown that treatment of Somatostatin, a peptide containing a 
single  disulfide  bridge,  with  1  eq  of  TCEP  at  pH  6.2  followed  by  1.1  eq  of 
dibromomaleimide  results  in  the  insertion  of  the  bromomaleimide  unit  into  the 
disulfide bond.
66 This modification can be reversed with the addition of 100 eq of 
BME.
25  Prior  work  had  demonstrated  the  proof  of  this  concept  using  a  simple 
dibromomaleimide  compound  (N  =  H)  and  hence  it  is  desirable  to  investigate 
whether this reaction can be accomplished with  more complex dibromomaleimide 
compounds,  particularly  those  containing  useful  functionality  such  as  biotin  or 
fluoroscein. 
2.7.1 Reactivity of fluorescein dibromomaleimide with 112 
Somatostatin 112 was first reduced with 1 eq of TCEP at pH 6.2 and 21 °C in 10 
min. To the reduced adduct was then added 1.1 eq of fluorescein dibromomaleimide 
63, which led to the conversion into the fluorescent bridged adduct 113 in 100% 
percentage conversion after 1 min, as determined by LCMS (scheme 43 and figure 
21). Subsequent addition of 100 eq of BME to 113 then led to the regeneration of the 
reduced somatostatin in 1 h. 
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Scheme 43. Reversible modification of the disulfide bond of SST by fluorescein dibromomaleimide reagent  63. Reactions 
carried out at 21 °C. 
It  is  notable  that  there  is  a  complete  lack  of  maleimide  hydrolysis  under  these 
reaction conditions; perhaps because (1) the dibromomaleimide motif is more stable  
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at pH 6.2 or (2) hydrolysis would result in an unfavourable conformation of the 
maleimide in the region of the initial disulfide bridge  115 (figure 22). 
 
 
Figure 21. LCMS spectrums for reaction of fluorescein dibromomaleimide reagent 50 plus SST peptide. 
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Figure 22. Potential hydrolysis product of SST bound fluorescein maleimide. 
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2.7.2 Reactivity of biotin dibromomaleimide with 112 
Reduction  of  the  Somatostatin  112  with  1  eq  TCEP    (pH  6.2,  21  °C,  10  min), 
followed by treatment with 1.1 eq of biotinylated dibromomaleimide  61 led to a 
biotinylated, bridged construct 116 in 65% percentage conversion after 1 min and 87 
% after 1 h (scheme 44). Addition of 100 eq of BME reversed the modification and 
regenerated the reduced SST in 92% percentage conversion after 1 h, again with 
complete absence of hydrolysis. 
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Scheme 44. Reversible modification of the disulfide bond of SST by biotin dibromomaleimide reagent 61. Reactions carried out 
at 21 °C. 
2.7.3 Comments and conclusions on the reactivity of fluorescein and 
biotin dibromomaleimides with 112 
From this study it appears that functionalized dibromomaleimide reagents 63 and 60 
can  be  used  for  the  rapid,  reversible  chemical  modification  of  the  peptide 
Somatostatin. These compounds were found to be stable at pH 6.2 and at 21 °C and 
did not undergo hydrolysis in the way that was observed in the Grb2 studies. This 
may  be  due  to  differences  in  the  peptide  structure,  but  could  be  more  likely 
attributable to an increased stability at pH 6.2. 
Significant differences in reactivity were observed between the biotin and fluorescein 
dibromomaleimide  reagents,  with  the  latter  being  considerably  more  reactive 
(addition of fluorescein to Somatostatin complete in 1 min, as opposed to 1 h for 
biotin  dibromomaleimide).  This  is  most  likely  due  to  the  fluorescein 
dibromomaleimide N-nitrogen’s lone pair being conjugated into the fluorescein π- 
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system, resulting in less electron density in the amide bond and thus favouring 1,4-
addition of somatostatin. 
2.8 General conclusions 
Previous work by Baker and Caddick et al. investigated the ability of simple mono- 
and di- bromomaleimide reagents to modify single sulfhydryl containing proteins, 
and found such modifications to be mild, selective, reversible and thus useful to the 
wider scientific community. However, other than acting as either protecting groups 
or blocking agents for sulfhydryl containing proteins, these reagents were limited in 
use. It has been shown in section 2 of this thesis that the reversible modification of 
sulfhydryl  containing  proteins  can  be  extended  to  include  mono-  and  di- 
bromomaleimide  reagents  more  functionally  diverse  than  the  simple  maleimides 
previously reported, such as the biotin and fluorescein bromomaleimides used here. 
Whilst the synthesis of fluorescein mono- and di- bromomaleimide was found to be 
straightforward, this was not the case for the biotin analogues; the presence of the 
bromine  on  the  maleimide  motif  leads  to  decomposition  under  basic  conditions. 
Therefore  a  synthetic  route  was  employed  that  kept  to  either  neutral  or  acidic 
conditions, enabling the formation of biotin mono- and di- bromomaleimide in three 
efficient steps. 
With the biotin and fluorescein bromomaleimide reagents complete,  a number of 
LCMS experiments were carried out to investigate how well they would react with 
the single point mutant (L111C) of the SH2 domain of the Grb2 adaptor protein and 
with Somatostatin, a peptide containing a single disulfide bridge. In both cases it was 
found that the biotin and fluorescein mono- and di-bromomaleimide reagents reacted 
selectively  and  efficiently.  However,  a  complicating  factor  not  observed  with 
bromomaleimide  and  N-methyl-bromomaleimide  by  Baker  and  Caddick  was  the 
issue of hydrolysis. Whilst  protection of the protein and peptide  with  biotin  and 
fluorescein  dibromomaleimide  occurred  in  high  yield,  hydrolysis  of  the  protein-
bromomaleimide conjugate yielded protein-bromomaleimic acid, a species inactive 
towards deprotection with BME. Hydrolysis was also found to be more pronounced 
for  the  aromatic  fluorescein  mono-  and  di-bromomaleimides,  in  line  with  the  
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literature, yet could be overcome at higher temperatures or by lowering the pH (as 
observed for reaction with Somatostatin at pH 6.2).Hydrolysis could additionally be 
overcome  by  switching  to  the  monobromomaleimide  reagents,  although  higher 
temperatures were needed to deprotect with BME in order to overcome the formation 
of intermediates stable at low temperature. 
Further research into the reversible modification of sulfhydryl containing proteins 
will need to take both the potential hydrolysis and formation of stable intermediates 
into account. Whilst the extension of the linker between the bromomaleimide motif 
and biotin/fluorescein functionality could feasible reduce hydrolysis, the formation 
of stable reaction intermediates will need to be more carefully considered. Further 
investigations are thus needed to ascertain what factors are involved and how they 
can  overcome  the  formation  of  these  stable  intermediates,  without  affecting  the 
efficiency and selectivity of reversible bromomaleimide modification. 
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3 Pd catalysis and DFT 
3.1 Palladium catalysed reactions 
Carbon-carbon and carbon-nitrogen bond forming reactions are the key steps in the 
synthesis of many organic substances.
89,90 The use of palladium in catalysing these 
types of reactions is very well documented and has become an extremely important 
tool  in  modern  day  synthesis.  Suzuki,
91-93  Negishi,
94,95  Heck,
96  Kumada
97-99  and 
Buchwald–Hartwig amination reactions
99-101 are just a few examples of the many 
powerful transformations possible using palladium catalysis (scheme 45). 
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Scheme 45. Palladium catalysed reactions. Ha = Halide, R = Alkyl, Ar = Aryl. 
An  example  of  a  palladium(0)-catalysed  reaction  is  shown  in  scheme  46.
102  The 
catalytic  cycle  is  initiated  by  formation  of  the  Pd(0)  active  catalyst,  either  by 
reducing  the  Pd(II)  precatalyst  with  phosphine  or  amine,  or  in  the  case  shown, 
dissociation of NHC from the pre-catalyst Pd(NHC)2 117, to give the catalytically 
active Pd(NHC) 118. From this point onwards there are 4 stages to the catalytic 
cycle. The first is the oxidative addition of a palladium(0) active species to an sp
 or 
sp
2 carbon-halide bond, yielding a ζ-aryl or ζ-alkenylpalladium(II) complex 119. 
This is the single most important reaction of palladium(0) complexes and involves 
oxidation of the metal from palladium(0) to palladium(II).
103 The resulting ζ-aryl or  
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ζ-alkenylpalladium(II) complexes formed can then participate in a wide variety of 
chemistry:  alkene  and  CO  insertion;  hydrogenolysis;  transmetallation  with  main 
group  organometallics;  addition  of  nucleophilic  carbon,  oxygen,  sulfur  or  amine 
(latter shown in scheme 46) to form a four coordinate species 120. Deprotonisation 
(if required) followed by cis-rearrangement then affords a three coordinate species 
primed for reductive elimination 121, allowing formation of the coupled product 122 
and regeneration of the palladium(0) catalyst 118 in the process. 
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Scheme 46. Example of the possible mechanism for a Pd catalysed reaction, Aryl amination reaction shown. 
The choice of aryl halide is important to the success of these reactions. It has been 
found  that  aryl  halides  containing  a  vacant  low  energy  orbital  (e.g.  iodides, 
bromides) are, in general, more reactive than aryl halides containing a vacant high 
energy orbital (fluorides). This is a result of the vacant low energy orbital ((sp/sp
2) 
carbon–halide  antibonding  orbital)  being  closer  in  energy  to  the  occupied  high 
energy orbital of the Pd(0) nucleophile, allowing an efficient interaction between the 
two sets of orbitals, and therefore oxidative addition to take place. However, the 
difference in energy for aryl halides containing a vacant high energy orbital is too 
great for an efficient interaction and no reaction occurs. Additionally, carbon-halide 
bond strength is known to decrease as you descend group 7, resulting in the weaker 
bonds  of  carbon-iodides/bromides  being  more  reactive  than  their  fluoride 
counterpart.  
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3.1.1 Control of stereochemistry 
Not only does palladium(0) catalysis allow for a vast array of different reactions, but 
also the potential control of the stereochemistry in the product. Whilst only readily 
available at sp and sp
2 centres, the extension of palladium chemistry to use a sp
3 
centre would offer a powerful methodology for producing complex chiral molecules, 
provided  the  reactions  proceeded  with  an  absolute  control  of  stereochemistry.  A 
comparison of the oxidation addition of an active Pd(0) species into either a (sp/sp
2) 
carbon-halide bond or (sp
3) carbon-halide bond, finds that whilst the former occurs 
by  a  concerted  process,  the  latter  is  stepwise  (scheme  47).  This  is  due  to  the 
inaccessibility  of  the  (sp/sp
2)carbon-halide  anti-bonding  orbital  for  direct 
nucleophilic attack by Pd(0). However, in the case of the (sp
3)carbon-halide bond, 
the antibonding orbital is available for nucleophilic attack by Pd(0), which will result 
in  an  inversion  of  the  stereochemistry  of  the  product  in  relation  to  the  starting 
material. Therefore in an analogous fashion with the use of the Mitsunobu reaction to 
invert the stereochemistry of alcohols, synthetic schemes can be designed which give 
both useful products, and also take advantage of the inversion of stereochemistry 
associated  with  Pd  catalysed  reactions  using  alkyl  halides  to  give  products  of  a 
desired stereochemistry.  
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Scheme 47. Inversion of stereochemistry upon oxidative addition of Pd(0) into sp
3 carbon halide bond. 
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3.1.2  Choice of catalyst ligand 
The choice of ligand bound to the metal in catalysis plays a very important role. 
Studies have shown that adjusting the properties of these ligands results in changes to 
the activity of the catalyst. Selectivity has found to be controlled by electronic and 
steric factors.
104 Therefore a proper choice of supporting ligand can affect both the 
oxidative addition and the reductive elimination steps, via preferential stabilisation of 
the  metal  complex  at  different  stages  of  the  catalytic  cycle.
105  For  instance, 
monodentate,  bulky,  electron-donating  tertiary  phosphines  have  generally  been 
employed as ancillary ligands in coupling systems.
106 The increased steric bulk of the 
phosphine  ligand  favours  the  dissociation  of  excess  phosphine  and  therefore 
formation  of  the  catalytically  active  monodentate  Pd(0)  phosphine  complex. 
Additionally,  the  electron-donating  nature  of  the  tertiary  phosphine  increases  the 
electron density on the Pd centre, which raises the energy of its occupied high energy 
orbital. In doing so, this will decrease the difference in energy between the Pd(0)’s 
occupied high energy orbital and the aryl halides vacant low energy orbital (carbon–
halide antibonding orbital), in turn increasing the orbitals ability to interact and form 
a bond. 
Therefore bulky and electron-donating tertiary phosphines increase the reactivity of 
the Pd centre towards oxidative addition. However, whilst oxidative addition requires 
an occupied high energy orbital on the Pd centre, reductive elimination requires a 
vacant low energy orbital into which electron density can be donated. This means 
that reductive elimination will be increased by using ancillary ligands which remove 
electron density from the Pd centre, thus lowering the energy of this vacant orbital. 
By  using  bulky  tertiary  phosphine  ligands  which  favour  the  formation  of  mono-
ligated Pd(PR3) over di-ligated Pd(PR3)2, reductive elimination is favoured. This is 
due to lowering of the energy of the vacant orbital on the Pd centre via the donation 
of  electron  density  from  only  one  PR3  ligand  as  opposed  to  two.  Additionally, 
phosphine ligands allow back-donation of electron density from the Pd centre, which 
again lowers the energy of the Pd’s vacant orbital. 
Catalytic activity is therefore a balance between the opposing factors contributing to 
oxidative  addition  and  reductive  elimination.  Oxidative  addition  requires  bulky,  
60 
 
electron-donating  ligands,  whilst  reductive  elimination  requires  bulky,  electron-
withdrawing ligands, and it is the use of ligands which give balance between these 
two processes which is important. 
3.1.3 N-Heterocyclic carbene ligands 
Although  tertiary  phosphine  ligands  are  useful  in  controlling  the  reactivity  in 
organometallic chemistry and homogeneous catalysis, they often undergo significant 
phosphorus-carbon bond degradation at higher temperatures. Unfortunately, this can 
result in deactivation of the catalyst; there is no longer control of oxidative addition 
and  reductive  elimination,  or  stabilisation  of  the  metal  centre  by  association  of 
ligand. As a result, there is a need for strongly nucleophilic, electron rich ligands 
which can form stable bonds to the metal centre. N-Heterocyclic carbenes (NHCs) 
have been shown to be such ligands and combined with their behaviour as phosphine 
mimics, has enabled them to fulfil the role of alternative ligand.
107 
First reported by Wanzlick and Schonher
108 and by Olefe et al. in 1968, then isolated 
and characterised by Arduengo in  1991,
109 NHCs  (figure 23) have since become 
ubiquitous ligands in both organometallic and inorganic coordination chemistry.
110 
Their  similarity  to  electron-rich  organophosphines,
111  in  terms  of  their  metal 
coordination chemistry, ligand properties and in their metal complex synthesis was 
noted as early as 1993. NHCs were shown to bind to transition metals, in either high 
or low oxidation state, as well as to many main group elements such as beryllium, 
sulfur and iodine. 
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Figure 23. Basic structure of NHCs (R = 
tBu, 
iPr, Ms, Ad, Me, Bz). 
NHCs are found to stabilise and activate diverse metal centres in many different key 
catalytic steps of organic synthesis.
110 Being strong ζ-donors, they activate metal 
centres towards oxidative addition by donation of electron density onto the metal 
centre  and  thus  raising  the  energy  of  the  metals  occupied  high  energy  orbital. 
Additionally, NHCs such as IAd, IPr and IBu are found to be of sufficient steric bulk  
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to allow the formation of mono-ligated metal complexes, the active species in the 
oxidative addition step of many catalytic reactions. 
Comparison of bond dissociation energies (BDEs) of metal bound NHCs and other 
ligands  indicated  that  the  NHCs  were  generally  more  coordinating  than  amines 
(NR3), phosphines (PR3) and CO (scheme 48). The finding that the BDEs calculated 
for the NHCs were considerably higher than for PR3 (by almost 30 kJ mol
-1 in some 
cases)  was  in  agreement  with  the  assumption  that  NHCs  bind  more  tightly  than 
phosphines to transition metals. 
TiCl4.2PR3
VCl2.4NR3
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2 NHC
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Scheme 48. Comparisons of NHCs binding with tertiary amines and phosphines. 
It was initially thought that NHCs behaved like typical ζ-donor ligands
112,113 such as 
amines,  ethers  and  phosphines,  which  would  classically  donate  two  electrons. 
However, structural and thermodynamic studies led Nolan et al. to conclude that, 
with  the  exception  of  the  most  sterically  bulky  NHCs  (e.g.  adamantyl  carbene), 
NHCs  generally  behave  as  better  donors  than  the  best  of  the  phosphine  donor 
ligands.
114,115 
This simplified picture is beginning to change and recent studies have suggested that 
NHC ligands are not simple ζ-donors. Since there are filled π and empty π* orbitals 
on the NHC ring, these could contribute to the NHC-metal bond.
116,117 Meyer et al. 
found that NHC ligands could accept electron density from electron-rich group 11 
metal atoms, via d → π* back bonding, and could thus stabilise an electron-rich 
metal centre containing high energy orbitals. They could also stabilise an electron-
deficient metal centre, containing low energy orbitals, through a π → d bonding 
scheme back onto the metal. However, current opinion is divided, and it appears 
most likely that, depending on the metal centre in question, they can act as both π 
donors and acceptors.
118,119 
Reactions  using  saturated  NHCs  were  found  to  give  higher  yields  than  for  the 
corresponding  unsaturated  variants  (table  9).
100  Theoretical  studies  using  electron  
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density analysis has indicated that more electron density is back-donated from the 
metal  centre  to  saturated  NHCs  than  to  unsaturated  ones.  Therefore  unsaturated 
NHCs  are  both  less  ζ-donating  and  less  efficient  π-acceptors,  and  hence  weaker 
ligands  than  their  saturated  counterparts.  In  the  case  of  the  Pd-catalysed  aryl 
amination reaction in table 9,
100 the strongly ζ-donating saturated NHCs will impart 
more electron density onto the Pd centre, thus raising the energy of the Pd’s occupied 
high energy orbital. This will close the gap in energy between the Pd(sat-NHC) high 
energy  orbital  and  the  aryl  halides  vacant  low  energy  orbital  (carbon–halide 
antibonding orbital), lowering the energy for oxidative addition, the rate determining 
step  of  the  reaction.  However,  for  the  less  ζ-donating  unsaturated  NHCs,  the 
opposite will happen. The occupied orbital of the Pd(unsat-NHC) will be lowered in 
energy and therefore there will be a bigger difference in energy to the vacant low 
energy orbital of the aryl halide. 
Additionally, as already stated, sterically demanding NHCs such as IPr favour the 
formation  of  the  mono-ligated  Pd(NHC)  complex,  the  active  species  in  these 
reactions.
120 Shorter metal-carbon distances (0.01-0.02 Å) are predicted for saturated 
complexes,  which  enhances  any  steric  effect  already  observed,  again  favouring 
formation of mono-ligated Pd(NHC). Additionally the more sterically encumbersome 
saturated  NHCs  favour  formation  of  three  coordinate  Pd  complexes,  the  species 
believed to be more react towards reductive elimination (see section 3.2.2). 
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Cl + H2N
H
N
Pd(NHC)2 (2 mol %)
KOtBu (1.5 eq.)
Dioxane
100 oC, 5 h  
NHC  Yield (%) 
SIPr  91 
IPr  52 
SIBu  30 
IBu  19 
 
Table 9. Comparison of the effect on yield of various NHCs after 5 h.
100 
Therefore  it  is  emerging  that  for  the  Pd-catalysed  aryl  amination  reaction  to  be 
carried  out  in  high  yield  and  in  an  efficient  time  frame;  the  catalytic  system 
employed must be able to form to the active mono-ligated Pd(NHC) quickly and in 
sufficient concentration, and contain NHC ligands both large in size and strongly ζ-
donating in nature. To increase the concentration and formation of the mono-ligated 
Pd(NHC)  species,  Caddick  and  Cloke  et  al.
121  and  Organ  et  al.
95  have  used 
precatalysts containing easily dissociable ‘throw away’ ligands and only one NHC 
(figure 24 – 123 and 124). These pre-catalysts lead more quickly to the active mono-
ligated  Pd(NHC),  and  containing  only  one  NHC,  avoid  the  potential  problem  of 
excess NHC inhibiting the reaction. 
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Figure 24. Pre-catalysts containing a single NHC. 
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3.2  Transition  metal  catalysed  carbon(sp
3)-nucleophile  bond 
formation 
Whilst the literature contains an enormous number of examples of carbon(sp or sp
2)-
nucleophile bond formation,  for carbon(sp
3), in comparison, this is not the case. The 
presence of β-hydrogens on any carbon(sp
3) species usually results in fast β-hydride 
elimination to give an alkene product, rather than the slower transmetallation and 
reductive elimination (scheme 49). This alkene is then able to take part in a variety of 
side reactions: including insertion reactions into Pd(II) complexes, analogous to the 
Heck reaction. 
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Scheme 49. Carbon(sp
3)-nucleophile bond formation. 
Initial  work  carried  out  on  carbon(sp
3)-nucleophile  bond  formation  focused  on 
substrates  which  did  not  contain  any  β-hydrogens  (e.g.  benzyl  halides),  so  as  to 
reduce  the  potential  for  β-hydride  elimination.  However,  this  severely  limits  the 
scope of the reaction. More recent research has instead focused on control of the 
selectivity  of  reductive  elimination  to  β-hydride  elimination  by  careful  choice  of 
catalyst and ligand system.  Fu and Zhou,
122-124 for instance, discovered a Pd/PR3 
protocol (PR3 = PCy3 or P(
tBu)2Me) which served as an effective catalyst for Suzuki 
reactions  of  primary  and  secondary  alkyl  bromides,  chlorides  and  tosylates  with 
trialkylboranes. 
Fu found that the choice of ancillary ligand has a substantial impact on the success of 
these  reactions;  only  trialkylphosphines  of  an  appropriate  size  could  produce 
catalysts  active  in  Negishi  couplings  (table  10  entries  1  and  2),
124,125  whilst  
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triarylphosphines (entry 3), chelating electron-rich phosphines, NHCs (entry 5) and 
phosphites (entry 4) gave none of the desired coupled product. 
BnO Br
nBu ZnBr +
2% Pd2(dba)3
8% ligand, NMI (0.2 eq.)
BnO nBu
2:1 THF/NME
80 oC, 14 h  
Entry  Ligand  Yield (%) 
1  PCyp3  70 
2  P(
tBu)2Me  55 
3  PPh3  5 
4  P(o-tol)3  1 
5  IMe  4 
 
Table 10. An investigation of the effects of ancillary ligands on the yield of the Negishi reaction after 14 h.
125 
The  trialkyl  phosphine  ligands,  being  strongly  ζ-donating,  lower  the  energy  for 
oxidative energy (by raising the energy of the Pd(0) occupied high energy orbital). 
However, the key to efficient selectivity is the inhibition of β-hydride elimination, 
due to the large size of the trialkyl phosphine ligand. β-hydride elimination requires a 
free  coordination  site  on  the  metal  centre.  Therefore  the  use  of  large  trialkyl 
phosphines which block this site will inhibit β-hydride elimination and instead favour 
reductive elimination. 
Further work using excess diene has built on these principles, again by blocking the 
free coordination site on the metal centre. Knochel demonstated this using nickel 
complexes to catalyse Negishi reactions of both primary alkyl bromides and iodides 
with a range of organozinc reagents,
126 whilst Kambe reported a nickel complex that 
could catalyse the coupling of unfunctionalised Grignard reagents with primary alkyl 
bromides  and  tosylates  (scheme  50).
127,128  Beller  later  went  on  to  extend  these 
reactions to include the use of alkyl chlorides with aryl Grignards.
129 Not only does  
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the added diene block the free coordination site on the metal, it also removes electron 
density from the metal centre, lowering the energy of the metals vacant orbital, thus 
favouring reduction of the metal. As β-hydride elimination is no longer available, the 
major reaction pathway becomes reductive elimination. 
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Scheme 50. Use of diene to block metal centres free coordination site and inhibit β-hydride elimination.
126-128 
Despite  the  considerable  progress  made  towards  alkyl-alkyl  bond  formation  by 
control of β-hydride elimination, little success has been achieved concerning C(sp
3)-
N bond formation 
3.2.1  C(sp
3)-N bond formation; alkyl amination reaction 
The Pd-catalysed alkyl amination cross-coupling has not previously been reported to 
any great extent, with only limited theoretical studies undertaken.
119,130 These have 
implied that in the corresponding sp
2 reaction (i.e. formation of an enamine), the 
participation  of  the  π-system  creates  a  lower-energy  pathway  for  the  reductive 
elimination step, which leads to the formation of the C-N bond. The lack of a π-
system in the alkyl C-N bond formation might therefore be expected to inhibit such 
reactions. 
A computational study of the oxidative addition of alkyl chlorides (chloromethane) 
to  bis-carbene  palladium  complexes  has  been  reported  by  Green  et  al.
119  The 
transition state for the oxidative addition of an alkyl chloride was found to be higher 
in energy than for the oxidative addition of the aryl chloride, indicating that this 
process would be significantly less favourable. This is consistent with the findings of 
Caddick and Cloke et al., who observed difficulties in carrying out the oxidative  
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addition of neopentyl chloride to the Pd(IBu)2 complex, forcing an alternative route 
to be devised.
131,132 
Research  by  Macgregor
130  described  the  use  of  DFT  calculations  to  study  the 
possibility  of  carbon-heteroatom  bond  formation  via  the  reductive  elimination 
reactions  of  cis-Pd(PH3)n(CH3)(X),  where  X  =  CH3,  OH  and  NH2  and  n  =  1,  2 
(scheme  51).  This  study  led  to  a  number  of  differences  to  Green’s  earlier  work 
(although the ligand ancillary system in Macgregor’s work was PH3 as opposed to an 
NHC); the computed structures of the  cis-Pd(PH3)2(CH3)(NH2) reactants were all 
found to display slightly distorted square planar geometries. Reductive elimination 
appeared to be feasible from either of two isomers, a TCH3 or a TNH2 form in which 
the CH3 or NH2 was trans to the vacant site. Yet the TCH3 isomer 125 (isomer shown 
in scheme 51) was found to be ~13.8 kcal mol
-1 more stable most probably due to the 
greater trans effect of CH3 over NH2 and the preference of CH3 to be trans to the 
vacant site. The formation of the alkyl amine was also found to be an endothermic 
process (9.3 kcal mol
-1), as had been found by Green, Caddick and Cloke. 
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Scheme  51.  Computed  reaction  profiles  (kcal  mol
-1)  for  C-N  reductive  elimination  from  the  TCH3  isomer  of 
Pd(PH3)2(CH3)(NH2).
130  
68 
 
In  order  to  bring  about  the  desired  C(sp
3)-N  bond  formation  experimentally, 
researchers have instead sought to oxidise the Pd(II) centre to Pd(IV), which would 
lower the energy of the vacant low energy orbital on Pd (scheme 52). However, upon 
investigation of the stereochemical course of this C-N bond formation in reactions of 
Pd(IV),  Backvall,
133,134  Muniz
135,136  and  Gaunt
137  all  noted  a  clean  inversion  of 
configuration.  This  is  indicative  of  a  SN2  type  reaction,  requiring  first  the 
dissociation of the amide from the Pd coordination sphere 126, a process considered 
not to be a true coupling reaction. 
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Scheme 52. Example of a Pd(IV) coupling reaction. 
Caddick  and  Cloke  have  previously  reported  efforts  towards  developing  a  new 
protocol for catalytic alkyl amination reactions employing (NHC)–Pd complexes as 
catalysts.
131,132  These  studies  were  undertaken  using  neopentyl  chloride,  an  alkyl 
halide  that  does  not  contain  β-hydrogens,  so  that  oxidative  addition  could  be 
thoroughly examined. The reaction investigated was the coupling of morpholine 127 
to neopentyl chloride 128 using the palladium biscarbene complex Pd(IBu)2 to give 
neopentyl morpholine 129 (scheme 53). Morpholine was chosen as it had exhibited 
the  greatest  reactivity  in  other  coupling  systems  and  as  a  result  had  become  a 
standard  choice  in  such  reactions.  Uncatalysed  reaction  conditions  required  the 
heating of morpholine (1 eq) and neopentyl chloride (1 eq) in a sealed bomb at 160 
°C  for  three  days  to  produce  the  neopentyl  morpholine  product,
138  conditions 
considerably more extreme than those employed with the palladium catalyst. 
O
H
N
Cl +
O
N Pd(IBu)2
127 128 129  
Scheme 53. Neopentyl chloride plus morpholine with Pd(IBu)2 and base.  
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In order to maximise C–N bond formation, Caddick and Cloke employed IBu as 
ligand.  McGuinness  and  Cavell  et  al.
139  had  shown  that  sterically  demanding 
substituents on metal-bound NHC ligands would hinder the close approach of the 
alkyl groups to the NHC, so the 
tBu groups on the NHC should inhibit unwanted 
side-reactions of NHC with the neopentyl unit. It was also reasoned that the steric 
bulk of the neopentyl would prevent direct SN2 attack by the amine on the initially 
formed insertion complex, and hence the only reaction able to occur would be the 
(sp
3)C–N reductive elimination from the metal-bound alkyl and amide. 
Caddick and Cloke first investigated the oxidative addition of neopentyl halide to 
Pd(IBu)2 by monitoring the reaction via 
1H NMR at room temperature. However, the 
formation of 2,5-dimethylhexane and Pd(IBu)2I2 as the major products implied an 
intermolecular  exchange  mechanism,  as  described  by  Cavell  and  McGuinness.
140 
Additionally, at higher temperatures (75 °C) C-H activation of the tert-butyl group of 
IBu  was  observed;  a  process  known  to  occur  at  iridium,
141  ruthenium
142,143  and 
nickel
144  centres,  for  both  sp
2  and  sp
3  C-H  bonds.  For  Caddick  and  Cloke,  C-H 
activation  was  followed  by  reductive  elimination  to  yield  neopentane.  It  was 
rationalised that this was a consequence of the concentration of NHC (2 eq) and if 
this  was  reduced  (to  1  eq),  both  of  these  undesired  processes  could  be  reduced. 
Therefore an alternative route was devised to form an alkylpalladium halide NHC 
complex  with  only  a  single  NHC  attached  130,  which  could  then  be  used  to 
investigate  the  reductive  elimination  step  in  an  alkyl  amination  catalytic  cycle 
(scheme 54). 
Cl Li Pd
Cl
Pd
Cl
Cl
Pd
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IBu
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Cl
NH
IBu
O
a b
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Li, 65 °C, 4 d; (b) Pd(COD)Cl2, -78 °C to 21 °C, 5 h; (c) IBu, 0 °C, 30 min; (d) morpholine, 0 °C, 30 min. 
Scheme 54. Route employed for the synthesis of alkyl palladium halide NHC complex. 
Complex  130  was  the  first  alkyl  transmetallation  product  to  be  isolated  and 
characterised.
131,132  It  proved  remarkably  stable  and  did  not  undergo  reductive  
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elimination despite having the required cis geometry. Furthermore, no evidence was 
found  to  suggest  that  deprotonation  of  the  coordinated  amine  occurred  when  a 
variety of bases were added (KO
tBu, LHMDS, NaH, NaOCEt3). Instead morpholine 
was liberated with additional formation of Pd(IBu)2 and neopentane. Caddick and 
Cloke proposed that the electron donating effect of the alkyl group, combined with 
the strong ζ-donation of IBu, led to an increase of the electron density on the metal 
centre.    As  a  result,  the  nitrogen  was  more  electron-rich,  requiring  less  electron 
density  from  the  bound  hydrogen,  which  becomes  less  electropositive  and  thus 
harder to remove. 
The aim of this project is to investigate the factors affecting the C(sp
3)-N coupling 
reaction,  with  an  emphasis  on  gaining  a  greater  understanding  of  the  reductive 
elimination  stage,  using  a  combination  of  computational  (DFT)  and  mass 
spectrometry analytical techniques. Before the theory behind these two methods is 
introduced,  however,  it  is  appropriate  to  discuss  the  factors  affecting  reductive 
elimination. 
3.2.2  Reductive elimination reaction 
The reductive elimination reaction is responsible for the formation of the new ζ-bond 
in the product of the catalytic coupling process. The reaction involves the coupling of 
two covalent ligands and a formal reduction of the metal.
105 Reductive elimination 
reactions to form carbon-carbon and carbon-heteroatom bonds from aryl and vinyl 
complexes  are  typically  more  favourable  than  with  alkyl  complexes.  In  fact, 
examples of C-O and C-C bond formation involving alkyl carbons are very rare.
145 
Theoretical and early experimental studies have suggested that reductive elimination 
from  metal  complexes  with  more  weakly  electron-donating  ligands  is  more 
favourable  than  from  metal  complexes  with  more  strongly  electron-donating 
ligands.
146-148 This is a result of the electron-withdrawing ligands removing electron 
density from the metal centre, lowering the energy of the metals vacant low energy 
orbital required for reductive elimination.  
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Reductive elimination is also more favourable for compounds in high and/or unstable 
oxidation states. In fact, oxidizing a stable complex to an unstable oxidation state can 
induce  reductive  elimination,  a  process  called  oxidatively  induced  reductive 
elimination (scheme 55).
149 
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Scheme 55. Oxidatively induced reductive elimination. 
It  is  generally  true  that  reductive  elimination  from  metal  complexes  with  more 
hindered  ancillary  ligands  is  more  favourable  than  from  complexes  with  less 
hindered ancillary ligands. This effect arises from a relief of steric congestion upon 
generation of the coupled product and the reduced coordination number of the metal 
centre.
146 Additionally, hindered ancillary ligands force the two reacting groups (i.e. 
aryl and amide) into closer proximity, increasing the orbital overlap between the two 
groups, enabling reductive elimination to take place (figure 25 131<<132,133). As 
reductive  elimination  decreases  the  coordination  number  of  the  complex,  steric 
hindrance will also affect the energy of the reactant more than the energies of the 
transition state and product.  
P Pd N
O
P Pd N
O
P Pd N
O
131 133 132
 
Figure  25.  The  use  of  hindered  ancillary  ligands  to  increase  the  orbital  overlap  between  groups  taking  part  in  reductive 
elimination; Tolman’s cone angle increases from left to right. 
The  use  of  hindered  ancillary  ligands  will  also  favour  the  formation  of  three-
coordinate organometallic complexes over four coordinate ones. This is important  
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because Yamamoto
150 and Stille
151 have shown that the reductive elimination to form 
C-C  bonds  from  complexes  containing  mono-  and  bis-  phosphines  occurred 
considerably faster from three-coordinate monophosphine complexes than from the 
corresponding four-coordinate bisphosphines. Whilst it is believed that mono-ligated 
organometallic complexes are the active species from which oxidative addition takes 
place,
119,120 three-coordinate organometallic complexes are believed to be the species 
that  from  which  reductive  eliminations  takes  place.  As  already  stated,  reductive 
elimination is favoured for organometallic complexes containing a vacant low energy 
orbital,  and  disfavoured  for  complexes  containing  a  vacant  high  energy  orbital 
(figure 26). Therefore if only three ligands are bound to the metal 134, less electron 
density  will  reside  on  the  metal  centre,  the  energy  of  the  vacant  orbital  will  be 
lowered, favouring reductive elimination. However, if four ligands are bound to the 
metal 135, more electron density will be directed towards the metal centre, raising 
the energy of the vacant orbital, disfavouring reductive elimination. Additionally, 
ancillary ligands containing an empty orbital, such as trialkyl phosphine’s, will be 
able to accept electron density back from the metal centre, lowering the energy of the 
metals vacant orbital further.  
L Pd N
O L
L Pd N
O
Vacant high energy orbital
Vacant low energy orbital
Occupied high energy orbital
E (kJ mol -1)
134
135
 
Figure 26. Differences in electron density of three and four-coordinate organometallic complexes; L = electron-donating ligand. 
Arylpalladium halide complexes with a single phosphine have in fact been isolated 
but  each  complex  contains  an  agostic  interaction  at  the  open  site  of  a  T-shaped 
geometry (figure 27).
152 Heating these three-coordinate species have been found to  
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cause reductive elimination, leading to the formation of aryl amines in reasonable 
yields. Hartwig et al. found that kinetic studies for this thermolysis were consistent 
with irreversible reductive elimination directly from the three-coordinate species.
153 
It  was  even  found  that  complexes  with  highly  deactivating  groups  on  both  the 
palladium bound aryl ring and the nitrogen underwent such a reductive elimination.  
 
Figure 27. Ortep diagram of three coordinate Pd(Ph)(Br)(P(
tBu)2Ad).
152 
Thus  an  idea  of  the  factors  involved  in  reductive  elimination  has  come  to  light. 
Organometallic complexes containing ancillary ligands both sterically cumbersome 
and electron-withdrawing in nature will favour reductive elimination; due to forcing 
the two reacting groups together, favouring formation of three coordinate over four 
coordinate complexes, and removing electron density from the metal centre, the latter 
two of which lower the energy of the vacant orbitals on the metal. 
3.3  An introduction to computational chemistry 
Computational  chemistry  uses  the  mathematical  results  of  quantum  mechanics 
incorporated  into  powerful  computer  programs  to  calculate  the  structures  and 
properties of molecules and solids, which can then be applied to real world problems. 
The programs  used are  based on many different  quantum chemical  methods  that 
solve the molecular Schrödinger equation (1). In quantum mechanics the Schrödinger 
equation describes the quantum state of a physical system, dependent or independent 
of time.  
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(1)          
Here   is the electronic energy,   the wavefunction and   the Hamiltonian energy 
operator, given by 
(2)                   
ET  is  the  kinetic  energy,  EV  the  nuclear-electron  attraction  energy 
(incorporating       the  extential potential acting on  electron  i, dependent  on the 
nuclei of charges Zα), and EU the electron-electron repulsion energy. 
(3)           
 
   
     
   
(4)                
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(6)            
  
   
   
However, the major difficulty with the solution of this equation and the calculation 
of properties of chemical systems containing many electrons is how to accurately 
incorporate  the  numerous  electron-electron  interactions,  which  statistical  methods 
model insufficiently accurately. This is no new problem. Understanding the planetary 
motion  of  the  celestial  bodies  had  troubled  and  attracted  the  best  mathematical 
physicists, e.g. Newton and Laplace, for centuries. 
Rather  than  dealing  with  these  electron-electron  interactions  individually,  or 
removing them from equations altogether, an approximate interaction energy can be 
assumed. Therefore whilst it is clear that a given electron moves under the influence 
of the nucleus, it can also be justifiable to suppose that it moves under the average 
influence of all the other electrons. This greatly simplifies the problem. The explicit 
electron-electron  interactions  are  replaced  by  a  mean  field,  v,  in  which  all  the 
electrons move. The solutions  to  the new form of this  equation  yield  a set  of  n 
electronic orbitals ψi(r). However, since the field v depends on the electronic orbitals 
ψi(r), a chicken or egg paradox has been created. This is solved by stipulating that the 
field v generated from the orbitals ψi(r) must also be able to generate those orbitals.  
75 
 
Thus we have arrived at the Self–Consistent Field (SCF) or Hartree method,
154 which 
can be used iteratively to provide more accurate solutions of E. 
If a molecule has n electrons with coordinates ri, the total energy is found by solving 
the Schrodinger equation,        , where the Hamiltonian is, 
(7)      
 
     
             
 
 
         
 
          
   
 
   
with v(ri) the classical electrostatic potential due to the nuclei, which are assumed to 
be fixed on the basis of the Born-Oppenheimer approximation. The complicating 
factor is the third term, which couples the motion of the electrons. Assuming that 
each electron moves in an average field due to all the others, the problem can be 
simplified  to  one  whose  solution  yields  n  one-electron  orbitals  ψi(r)  using  a 
simplified Hamiltonian, 
(8)      
 
     
             
 
 
              
   
One of the difficulties arising from this analysis is the determination of a reasonable 
value for the average field υ1. Since the 1920s much effort has gone into describing 
such a potential; Hohenberg and Kohn
155 proved an extraordinary result in which the 
unique potential (given by the variational principle), could be obtained from a unique 
density (vide infra). Firstly, the energy expression used in quantum chemistry will be 
discussed. 
It is convenient to separate the total electronic energy E of a chemical system into its 
components, 
(9)                             
From left to right we have ET, the kinetic energy of the electrons, EV the coulomb 
energy of the electrons due to the attraction from the nucleus, EJ the coulomb energy 
the electrons have if moving in an average field, and EX + EC which contains all the 
corrections due to the assumptions made. EX is known as the exchange energy and is 
the larger correction. It accounts for the non-independent motion of the electrons due 
to their spin, the consequent stabilisation and a correction for self repulsion (the latter  
76 
 
being only a true correction in Hartree Fock theory). EC, the correlation energy, is by 
far smaller and accounts for the correlated motion of all electrons. Although much 
smaller than EX, EC can be of the order of a chemical bond strength, and is thus of 
obvious chemical importance. 
3.3.1  Density functional theory (DFT) 
DFT has in the recent past emerged as an important computational method to predict 
chemical properties accurately and to analyse and interpret these in convenient and 
simple chemical terms. Examples of its use include the rational design of palladium 
NHC  catalysts,
95  study  of  the  chemical  bonding  in  transition  metal  carbene 
complexes, and oxidative addition and reductive elimination reactions.
156 
The origins of the DFT analysis date back to the 1920s with Hartree,
154 who in 1928 
first introduced the idea of an SCF and proposed a model in which the i
th electron in 
an atom moved completely independently of the others in an orbital ψi(r). Therefore, 
in this completely uncorrelated model, the coulumbic electron-electron repulsion was 
taken to be only an average value. As a result, the total kinetic energy was simply the 
sum of all the kinetic energies of the electrons. Then in 1930 Fock
157 showed that the 
Hartree  wavefunction  violated  the  Pauli  Exclusion  Principle  because  it  was  not 
antisymmetric. By antisymmetrising the wavefunction he was able to describe how 
electrons with the same spin avoided one another. 
In 1964 Hohenberg and Kohn
155 proved that there existed a universal functional of 
charge density, F[ρ(r)], such that the expression 
(10)                            
has at its minimum value the correct ground-state energy associated with a given 
potential  υ(r).  They  did  this  by  first  beginning  with  a  collection  of  an  arbitrary 
number of electrons, enclosed in a large box and moving under the influence of an 
external potential υ(r) and a mutual coulombic repulsion. The Hamiltonian would 
thus have the form, 
(11)                    
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Since the density ρ(r) is a function of the wavefunction Ψ, so are the kinetic (ET) and 
interaction energy (EU), 
(12)                           
where F[ρ] is a universal function, valid for any number of particles and any external 
potential. With its aid and for a given potential υ(r), the energy functional Eυ[ρ] can 
be defined as, 
(13)                             
And so for the correct charge density ρ(r), the energy functional Eυ[ρ] equals the 
correct ground-state energy E as long as the admissible functions are restricted by the 
condition, 
(14)                     
With N = the number of electrons in the system. Therefore if F[ρ] were a known and 
sufficiently simple functional of the charge density ρ(r), the problem of determining 
the ground-state energy and density for a given potential would be rather easy since 
it required the minimisation of a functional of the three-dimensional density. The 
major  complexity  of  the  many-electron  problem  would  be  associated  with  the 
determination of the universal function F[ρ]. It was Kohn and Sham
158 who in 1965 
discovered the correct form of this function. 
Separating from F[ρ] the classical coulomb energy EJ (where ET has now become the 
kinetic energy in a system of non-interacting electrons ET-non) gives, 
(15)                   
(16)              
 
   
         
                     
And so substituting into equation 13 the energy functional becomes 
(17)                       
 
   
         
                     
(18)                               
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(19)                                        
where EJ is the classic coulomb potential. ET-non is the kinetic energy of a system of 
non-interacting electrons of density  ρ(r) and  EXC  is the exchange and correlation 
energy of an interacting system with density ρ(r). It contains everything that cannot 
be evaluated, such ET–ET-non and the electron-electron interaction not included in EJ. 
This expression is a minimum for the correct density functional ρ(r). 
An approximation for G[ρ] can be proposed, which leads to a scheme analogous to 
Hartree’s  method  but  contains  the  major  part  of  the  effects  of  exchange  and 
correlation. Firstly it can be stated that, 
(20)                            
For a sufficiently slow varying ρ(r), it can be shown that  
(21)                            
With the exchange correlation potential being 
(22)          
          
    
And for simplicity a modified external potential υeff can be stated as, 
(23)                 
     
            
          
    
(24)                           
with   (r)  and  μXC(ρ)  the  exchange  and  correlation  contribution  to  the  chemical 
potential  of  the  uniform  gas  of  density,  ρ.  Therefore  for  a  given  exchange  and 
correlation functional, where μXC is the exchange-correlation potential, the correct 
charge density ρ(r) which satisfies these equations is obtained by solving the series 
of one-particle Schrodinger-like equations, 
(25)    
 
                                         
therefore  
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(26)    
 
                        
with  
(27)                     
     
where N is the number of electrons.  As in the Hartree Fock (HF) scheme, the Kohn 
Sham (KS) equations are a pseudo-eigenvalue problem and equations 23 and 26 have 
to be solved iteratively through an SCF procedure. Beginning with an estimated set 
of one-electron orbitals ψi, a charge density ρ(r) can be constructed from equation 27. 
This is then used to find the Kohn-Sham effective potential υeff and a new charge 
density  ρ(r)  is  then  calculated.    Once  a  self-consistent  charge  density  ρ(r)  is 
established, the total energy can then be computed from, 
         
 
 
  
         
        
                                       
 
 
 
Or from equation 19, 
                              
Still,  it  should  be  kept  in  mind  that  the  Kohn  Sham  orbitals  have  no  physical 
significance other than in allowing one to construct the charge density.   
Thus all density functional theory is based upon two powerful theorems proposed by 
Hohenberg  and  Kohn.  First,  the  ground  state  charge  density  (ρ)  is  sufficient  to 
describe all of the ground state properties of a system. Second, for any trial density, 
the energy is always greater than the true value, (known as the variational theorem).  
However, they left two unanswered questions, what was the form of F[ρ] and how 
exactly could the charge density ρ(r) be determined? The answers came courtesy of 
the derivation of Kohn and Sham. This one-electron orbital treatment is rigorously 
correct and, provided that the correct exchange-correlation potential EXC is used, the 
exact charge distribution ρ(r) any electronic system of interest can be determined 
exactly. However, this is the drawback in DFT. No one knows the precise form of 
the correct functional EXC for atoms and molecules. Instead, approximations have to  
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be made to provide an expression for EXC and depending on the system of interest, 
many are now available today. 
3.3.2  The form of Exchange-Correlation energy EXC 
The reason for the problem of not knowing the exact explicit form of EXC can be 
traced  back  to  the  non-homogeneity  of  the  charge  density  in  molecular  systems. 
Neglecting this altogether gives one of the simplest forms of the functional which 
assumes that the charge density is constant or very slowly changing. Being only a 
local function of the charge density, EX[ ], it is therefore known as a Local Density 
functional Approximation (LDA).  
The LDA, however, does not take into consideration systems in an external magnetic 
field. To include these allows for the incorporation of additional physics into the 
equations and is in turn known as the Local Spin Density Approximations (LSDA). 
Further  corrections  over  the  years  have  enhanced  the  accuracy  of  these  EXC 
functionals.  One  particularly  important  correction  was  the  addition  of  a  gradient 
correction for the non-uniformity of the atomic and molecular densities, known as a 
Generalised-Gradient Approximation (GGA). Although many generalisations of the 
LDA were proposed, this was the first really practical one. In this method, EXC[ρ] 
and  so  EXC[ρ
ʱ,  ρ
β]  were  evaluated  not  only  from  the  local  value  of  the  electron 
density but also from the gradient of electron density at position r. This allowed not 
only an improvement of the EX but also EC. The recommended nonempirical GGA of 
Perdew, Burke and Ernzerhof (PBE)
159,160 will be the EXC of choice employed in this 
study. 
3.3.3  The Amsterdam density functional code 
The DFT computational package used in this investigation is the Amsterdam Density 
Functional  Package  (ADF).
161  This  is  a  particularly  popular  programme  in  the 
research areas of homogeneous and non-homogeneous catalysis, inorganic chemistry 
and heavy element chemistry. It has been used to deal with molecules on surfaces, in 
solvents and in protein environments, as well as periodic systems.  
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ADF works by a fragment oriented approach, with the poly-atomic system to be 
computed  conceptually  built  up from  fragments.
161 For a calculation, the volume 
around an atomic fragment, the atomic cell, is thus divided into different regions 
depending on the character of the region and these are then evaluated accordingly. 
3.3.4  Basis sets 
Atomic  orbitals  are  mathematical  functions  which  describe  the  behaviour  of  the 
electron density of the different orbitals. They consist of functions, a basis set, which 
combine to give an accurate representation of the way electrons behave in space. 
ADF takes advantage of Slater type functions (STOs) as basis functions, as these 
resemble  the  true  atomic  orbitals  more  closely  than  certain  other  basis  functions 
(Gaussian Type Orbitals, GTOs). Although computationally expensive compared to 
GTOs, STOs are used to construct the total wavefunction of the molecule. 
3.3.5  Relativistic effects 
From calculations it is clear that the heavier the nucleus, Z, the larger the relativistic 
correction to the wavefunction, ψ. This is due to two effects. First, orbitals close to 
the nucleus (mainly s-orbitals) contract. Second, as the electron density close to the 
nucleus increases, more of the nuclear charge is shielded from the outer electrons, 
meaning that the effective charge experienced by these electrons is smaller. The d 
and f electrons are less attracted to the nucleus and the orbitals thus expand. Due to 
the fact that palladium is a relatively heavy transition metal, relativistic effects need 
to be included. Fortunately this is easy with ADF, which incorporates relativistic 
effects  by  a  quasi-relativistic  method  based  on  the  Zero-Order  Regular 
Approximation (ZORA) to give accurate results. The calculation employed is very 
similar in structure to the non-relativistic one, having only a few additional terms in 
the Hamiltonian.
162 
3.3.6  Solvent effects 
The computational description of molecules in a vacuum or in the gas phase has 
progressed remarkably over the past fifty years.
163 It has now reached a state which 
allows the calculation of the most interesting features of isolated systems or small  
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clusters by more or less sophisticated molecular orbital calculations. However, many 
biological and catalytic processes occur in solution where the chemical properties 
and  processes  are often very different  from the gas  phase. Due to  the  enormous 
importance of obtaining such information much effort has gone into the creation of 
solvent models able to carry out such tasks.
 
Chemistry in solution can be studied in ADF
164 via the Conductor like Screening 
Model (COSMO) of salvation.
163,165,166 The COSMO is a dielectric model in which 
the  solute  molecule  is  embedded  in  a  molecule-shaped  cavity  surrounded  by  a 
dielectric medium with given dielectric constant ε. 
3.3.7  Catalytic cycles 
An investigation of the energies of active intermediates involved in a catalytic cycle 
is  very  desirable.  It  allows  the  calculation  of  enthalpy,  entropy  and  free  energy, 
which can then be used to determine the likelihood of a reaction taking place. ADF 
can be employed to help produce a catalytic cycle of the major steps involved the 
alkyl amination reaction and in particular the reductive elimination step. The key 
question is how we go about obtaining such information and a literature study of 
such catalytic cycles offers valuable insight. 
A recent DFT report by Green described a study in which the key intermediates in 
the  oxidative  addition  of  aryl  chlorides  to  palladium  NHC  complexes  and  the 
subsequent reductive elimination reaction was modelled.
119 Reaction energetics were 
calculated for various levels, zero point energy corrections were used to estimate the 
internal energy change at 0 K and frequency calculations used to obtain these zero 
point energies.  Solvent corrections were then made to give an accurate Gibbs free 
energy. The major problem encountered was that the entropy term referred to that 
obtained in the gas phase and as a result did not take into account molecular tumbling 
in solution. This entropy term is usually found to consist of 30-60 % translational and 
rotational contributions, which would be reduced in solution due to the effect of 
solvent-solute interactions. This meant that depending on whether the reaction was 
by an associative or dissociative mechanism, the free energies would be either an 
overestimation or underestimation respectively. Similar problems were encountered  
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by Zhu and Ziegler whilst using DFT calculations to study the influence of different 
ligands  on  the  rate  and  mechanism  of  methane  activation  by  PtCl2X2.
167  They 
reported  all  free  energies  neglecting  the  electronic  entropy  energy  term.  Instead 
standard expressions were used to calculate the remaining gas-phase enthalpic and 
entropic contributions at non zero temperature, including the zero-point vibrational 
contribution. 
TS structures are characterised using vibrational frequency analysis which should 
show one imaginary frequency corresponding to the mode of decomposition to the 
adjacent  true  minima  (reactants  and  products).  The  creation  of  displacement 
structures along the reaction coordinate by adding +/- 5% to the TS geometry should 
then lead back to the starting material or forward to the product.  
Therefore in the preparation of a theoretical catalytic cycle, a number of key steps are 
required. The structures of reactants, intermediates, transition states, and products all 
need  to  be  fully  optimised  in  the  gas  phase.  Frequency  calculations  are  then 
performed on all optimised structures to characterise the stationary points as minima 
or transition states, as well as for the calculation of gas phase Gibbs energies at 
298.15 K. For all optimised structures, the Gibbs energies of solvation would then be 
computed  in  solvent  (THF  in  the  present  study)  at  the  gas-phase  optimised 
geometries. The zero-point energy and internal  energy corrections would then be 
added to the gas-phase energy to obtain the overall free energy, including entropic 
effects. 
3.4 Mass spectrometry 
Mass spectrometry (MS) is a scientific technique used to measure the mass of ions. 
As  a  tool  it  allows  for  the  potential  interception  and  characterisation  of  key 
intermediates,  either  as  transient  species  or  as  protonated/deprotonated  forms  of 
neutral species. The process by which the mass spectrometer works begins with the 
ionisation of the molecule of interest. These ions are then accelerated to a beam of 
constant speed, and in the case of ESI and API (section 3.4.1), passed through a 
quadrupole mass analyser, which filters the ions according to their mass to charge 
ratio (m/z). Only ions of a certain m/z reach the detector for a given ratio of voltages:  
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other  ions  would  have  unstable  trajectories  and  collide  with  the  walls  of  the 
instrument. This process permits selection of an ion with a particular m/z and also 
allows the scanning of a range of m/z values by continuously varying the applied 
voltage. 
3.4.1 Atmospheric pressure ionisation and electrospray ionisation 
Two powerful and hence widely used ionisation methods are Atmospheric Pressure 
Ionisation  (API)  and  Electrospray  Ionisation  (ESI),  both  of  which  enable  the 
investigation of solutions by mass spectrometry. In principle, they allow the potential 
detection  and  study  of  reaction  substrates  and  products  and  short-lived  reaction 
intermediates.
87 
ESI protocol works by passing a solution of the analyte through a capillary held at 
high potential. The high voltage generates a cloud of highly charged droplets which 
passes through a potential and pressure gradient toward the analyser portion of the 
mass spectrometer. As the ions travel, the solvent evaporates which reduces the size 
of the droplets. This leads to an increasing charge-density on the shrinking solvent 
evaporate which then causes the droplets to subdivide. Eventually the ions become 
completely desolvated,
168,169 and it is these ions which are observed by the mass 
spectrometer. API, on the other hand, works by a different mechanism. Chemical 
ionisation of the solution takes place at atmospheric rather than high pressure, and is 
thus a soft process, inducing little or no fragmentation of the analyte. Rather than 
employing high voltages as in ESI, no voltages are applied in the spray formation in 
API  and  hence  the  neutral  molecules  are  carried  to  the  gas  phase  by  a  thermic 
process. Desolvation is achieved by heating the solution within the API assembly, 
normally maintained between 150 and 550 
oC. Finally a corona discharge needle 
with an applied voltage between 300 and 5000 V then provides electrons that ionise 
the gaseous analyte via a series of gas phase ion/molecule reactions at atmospheric 
pressure. 
The intensity of the detected gas-phase ions and the corresponding concentrations of 
these  ions  in  the  ESI  and  API  are  related.  In  cases  where  the  solution  contains 
compounds able to react with these ions, the intensities could change significantly  
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and much more complex relationships could prevail. Therefore there is a requirement 
to prove unambiguously that the species detected by ESI are those predominating in 
solution and more importantly, to confirm that they are indeed intermediates in the 
reaction  path.
87  However,  in  practice  this  is  not  possible  to  do.  MS  is  a  violent 
technique,  employing  harsh  conditions  not  experienced by molecules in  solution. 
Care needs to be taken when proposing a structure for any species observed by MS; 
taking into account the fact that the species could have been formed as a result of the 
harsh conditions employed and not a result of any catalytic or reaction pathway. 
Research groups using MS as a tool for monitoring reactions additionally employ 
MS/MS  as  a  method  to  tentatively  propose  a  possible  structure  for  any  species 
observed. In MS/MS ions of specific molecular weight are first filtered and then 
bombarded with Argon zero, a gas of high energy and purity, in order to induce 
collisions with the ions and cause them to fragment. The resulting fragmentation 
pattern can then be used to help determine, with higher accuracy than ESI alone, a 
potential structure for the species observed. 
3.4.2 Offline and online screening 
Currently there are two general methods to study reaction mechanisms: (1) Offline 
Screening and (2) Online Screening. In the offline screening method the reagents are 
mixed to produce the different intermediates and the solution composition is then 
determined over time as the reagents are progressively turned into products. This is 
accomplished by  direct  MS screening of the reaction mixtures  during  predefined 
intervals  and  then  characterising  the  ions  observed  by  MS/MS.  This  is  only 
achievable if there is a reasonable concentration of intermediates in solution and if 
these species are not degraded within a few minutes. It is key that the time resolution 
matches  the  rate  of  the  process  to  yield  the  desired  information.  Otherwise  an 
inherent limitation is approached: it may not be possible to analyse the transient 
species  due  to  their  short  lifetime  in  solution.  The  second  method,  although  not 
available  in  this  study,  is  Online  Screening.  Here  the  kinetic  and  mechanistic 
information for the reactants in solution is studied by coupling a reactor containing 
the reagents directly to the ion source. This allows screening of the reaction in real- 
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time and the trapping of any transient species, and is thus superior to the offline 
method. 
3.4.3 Examples of MS use in monitoring reactions 
There are many literature examples of the use of API and ESI online and offline 
methods as their many benefits have come to light.
170,171 Non-palladium containing 
reactions  such  as  the  Baylis-Hillman  reaction,  ring  contractions,  nucleophilic 
substitutions  and  ʱ-methylenolation  of  keto  esters,  have  all  been  studied 
extensively.
87 Those examples which study palladium chemistry or organometallics 
have all been published in the last eight or so years.  One such study by Santos et al. 
looked at the active intermediates and reaction pathway of the Stille reaction.
172 They 
used  online  ESI(+)-MS(/MS)  monitoring  to  intercept  and  characterise  the 
catalytically active species Pd
0(PPh3)2, including the potential oxidative addition 136, 
transmetallation 137 and reductive elimination products 138 (scheme 56).  
87 
 
[Pd(PPh3)2]+
m/z 630
[Pd(OAc)2]
+ 2 PPh3
I
Cl
Pd
Cl
Ph3P I
Ph3P
Pd
Cl
Ph3P
Ph3P
I
m/z 777
m/z 127 Pd
Cl
I
Ph3P
SnBu3
SnBu3
PPh3
Pd
Cl
Ph3P
Ph3P
Cl
Pd
Ph3P
Ph3P
m/z 657
PPh3
Bu3SnI
m/z 291
Bu3Sn+
I
m/z 127
Pd
Cl
Bu3Sn
m/z 569
m/z 958
Cl
Cl Cl
Cl
.+
Cl
Cl
136
137
138
 
Scheme 56. Study of ESI-MS in the Stille reaction. 
Using similar methods Santos  et al. were further able to investigate the catalytic 
cycle proposed for the alkynylation of tellurides mediated by a PdCl2 catalyst.
173 
They were able to conclude from their study that the coupling of vinyl tellurides with 
alkynes via PdCl2 greatly depended on the amount of Pd catalyst used and, more 
interestingly, on the presence of CuCl2, which was used to reconvert Pd
0 back into 
Pd
II. 
Eberlin and co-workers took the idea of using ESI-MS tandem mass spectrometry to 
study  the  Heck  arylation  using  arenediazonium  salts:
174  proposing  the  cationic 
intermediates 139, 140, 141 and 142 for the catalytic cycle (scheme 57). From these 
results a detailed catalytic cycle for the Heck reaction was proposed.  
88 
 
[Pd2(dba)3]
[Pd(CH3CN)4]
N2
+
OMe
[ArN2Pd(CH3CN)3]+
CH3CN
N2
(CH3CN)2Pd
OMe
dba CH3CN
Pd+
OMe
CH3CN
dba O
OMe
O
Pd+ CH3CN
dba
O
OMe
Pd+
H
dba
CH3CN
Base
Base-H
139
m/z 295 MH+
140
m/z 488
141
m/z 558
142
m/z 382
 
 Scheme 57. Use of ESI-MS in the Heck reaction. 
Aliprantis  and  Canary  studied  the  Suzuki  coupling  of  pyridyl  halides  with 
phenylboronic  acids  using  offline  ESI-MS  techniques
175  and  Markent  and  Pfaltz 
applied  the  Online  principles  for  the  parallel  screening  of  the  Pd-catalysed 
enantioselective allylation reaction of diethyl ethyl malonate with allylic esters, to 
further illustrate the scope of this method.
176 
The  ability  to  isolate  ionic  species  directly  from  crude  reaction  mixtures  is  an 
interesting  feature  of  API-MS  and  ESI-MS.  These  new  applications  in  the 
mechanistic chemistry of transient species undoubtedly appear an important tool in 
the future study of labile and sensitive intermediates in solution, especially since 
there is no need for the previous purifications, or isolation for further characterisation 
of active species, intermediates of reactions and products. However, the assumption 
is made that the species observed by MS are the same as those present in solution, 
which in reality can not be guaranteed.  
Despite the literature precedent above, no MS studies have been carried out using Pd 
in conjunction with NHC ligands to the best of our knowledge. Thus not only would 
this work be useful in proposing the intermediates present in the Pd-catalysed alkyl  
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amination reaction but would also be the first ESI(+)-MS offline study employing the 
use of Pd bound NHCs. The presence of six naturally occurring Pd isotopes means 
that a very distinct and easily identifiable isotopic pattern would be available to ‘fish’ 
for ions of interest. The additional incorporation of an ionisable MS tag, such as a 
tertiary amine, to either of the reagents would allow further ease of identification. 
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4 An investigation of the potential energy surfaces available 
to Pd(L)(alkyl)(morpholide) 
4.1  Studies  on  the  reductive  elimination  of  neopentyl  morpholine 
from Pd(IBu)(neopentyl)(morpholide) complex 
As  noted  in  the  introduction,  previous  attempts  to  deprotonate 
Pd(IBu)(neopentyl)(morpholine)(Cl)  130  (figure  28)  had  been  unsuccessful.
131,132 
One  possible  explanation  is  that  the  combined  effects  of  the  electron  donating 
character of the alkyl  substituent  and the strong ζ-donation of  IBu increases  the 
electron density at the metal centre, hence weakening the interaction with the amine 
lone pair. Assuming the proton abstraction is rate limiting, the pKa of the amino-
proton would therefore increase making reductive elimination less likely to occur. 
Pd IBu
130
Cl
HN
O  
Figure 28. Pd(IBu)(neopentyl)(morpholine)(Cl) 130. 
4.1.1 Replacement of morpholine with lithium morpholide 
Although  the  addition  of  base  to  130  does  not  result  in  reductive  elimination,  a 
colour change from dark green to bright red was observed by Caddick and Cloke.
177 
As this colour change occurred on addition of base, two possibilities arise; either the 
base does deprotonate the amine but reductive elimination doesn’t take place; or the 
base itself binds to the Pd, both of which change the electronics of the Pd centre and 
hence the colour of the solution. To test both hypotheses, morpholine was replaced 
with lithium morpholide. Removal of the proton to give the pre-formed amide would 
overcome  the  problem  of  the  deprotonation  step  and,  upon  addition  of  lithium 
morpholide to Pd(IBu)(neopentyl)(chloride) dimer 143, synthesised using the method 
of  Esposito,
132  would  give  direct  access  to  tricoordinate 
Pd(IBu)(neopentyl)(morpholide) complex 144 which should be capable of reductive 
elimination (scheme 58). Alternatively if the base does indeed bind to the Pd centre,  
91 
 
then the addition of lithium morpholide to Pd(IBu)(neopentyl)(chloride) dimer 143, 
would eliminate this problem because the addition of base (lithium morpholide in 
this  case)  would  still  give  Pd(IBu)(neopentyl)(morpholide)  144,  the  complex 
required for reductive elimination. 
Pd
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143 144  
Scheme 58. Addition of lithium morpholide to Pd(IBu)(neopentyl)(chloride) dimer. 
Interestingly,  the  addition  of  lithium  morpholide  to  Pd(IBu)(neopentyl)(chloride) 
dimer 143 did result in a colour change from green to bright red, which was the same 
result  as  that  obtained  for  the  addition  of  base  to 
Pd(IBu)(neopentyl)(morpholine)(Cl) 130.  Therefore if either hypotheses hold for the 
outcome of adding base to Pd(IBu)(neopentyl)(morpholine)(Cl) 130 (page 90), then 
these  should  also  apply  to  the  reaction  of  lithium  morpholide  and 
Pd(IBu)(neopentyl)(chloride) dimer 143; either deprotonation can take place without 
leading to reductive elimination, or the base can bind to the Pd centre. In both cases 
this  will lead to  the formation  of  Pd(IBu)(neopentyl)(morpholide)  144. However, 
reductive elimination was still found not to take place, either at room temperature or 
elevated temperature (60 °C, 90 °C, 120 °C). Instead Pd(IBu)2 and morpholine was 
observed, followed by decomposition, after 2 h. 
Upon  addition  of  lithium  morpholide  to  Pd(IBu)(neopentyl)(chloride)  dimer  143 
(figure 29), it was observed by 
1H NMR that the resultant reaction mixture contained 
more than one species (>1 NHC backbone and tert-butyl environment) (figure 30). 
However, the morpholide signal had split from two signals into four, possibly due to 
the morpholide protons residing in four different environments, indicative of binding 
to the Pd centre.
132 A comparison of figures 29 and 30  also finds that the NHC 
backbone has shifted 0.4 ppm upfield, the CH2 of neopentyl 0.1 ppm upfield, whilst 
all tert-butyl groups have stayed approximately the same. This suggests the species 
present in figure 30 is different from that in figure 29.  
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Figure 29. 
1H NMR of 143 in THF-d8. 
Figure 30. 
1H NMR of 144 in THF-d8 (THF-d8 solvent peaks at 3.62 and 1.90 ppm, Si(Si(CH3)3)4 at 0.27 ppm).  
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It cannot be ruled out that the morpholide was not bound to two different species. A 
possible structure for these different species could be the cis and trans isomers of the 
three-coordinate  Pd(IBu)(neopentyl)(morpholide)  complex  144,  or  the  four 
coordinate Pd(IBu)2(neopentyl)(morpholide) complex 145 (figure 31). If this were 
the  case,  all  species  could  potentially  give  reductive  elimination,  upon  cis-
rearrangement and dissociation respectively. 
Pd N IBu
144
O Pd IBu
N
O
144a
Pd IBu
145
IBu
N
O  
Figure 31. cis and trans isomers of 144 and four-coordinate Pd(IBu)2(neopentyl)(morpholide) 145. 
Proposed complex 144 was found to decompose within 10 minutes at a temperature 
of  60  °C  and  above.  However,  below  this  temperature  (21  °C  and  40  °C) 
decomposition  was  found  to  occur  after  2  h,  meaning  complex  144  was  not  a 
transient species but in fact present in significant concentration. This implies 144 is 
indeed stable towards reductive elimination. Whereas heating these three coordinate 
Pd complexes has been shown to induce reductive elimination,
153 this was found not 
to be the case. In order to promote reductive elimination, attention was focused on 
the ancillary ligand bound to the Pd. 
4.1.2 Replacement of IBu with a range of ancillary ligand 
IBu  was  replaced  with  a  range  of  different  ligands;  PPh3,  DMPM  (1,1-
bis(dimethylphosphino)methane),    PCyp3  (tricyclopentylphosphine),  PCy3 
(tricyclohexylphosphine), DPPM (1,1-bis(diphenylphosphino)methane), DPPP (1,3-
bis(diphenylphosphino)propane), P
tBuMe2 and IPr, in order to determine the effect it 
would have on the reaction. Previous work by Caddick and Cloke has found that, 
contrary to theory, the addition of an excess of ancillary ligand could help to drive 
the desired reductive elimination. For instance, the formation of neopentyl chloride 
and  Pd(IBu)2  from  Pd(COD)(neopentyl)Cl  and  two  equivalents  of  IBu  has  been 
reported (scheme 59).
132 This result is most certainly due to sterics, as two strongly 
ζ-donating ligands would presumably raise the energy of the vacant orbital on the Pd  
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to too high a level for reductive elimination to take place. However, the two hindered 
IBu  ligands  would  also  force  the  neopentyl  and  chloride  groups  into  very  close 
proximity, forcing a reaction to take place. 
(COD)Pd
Cl
2 eq IBu
Cl Pd(IBu)2  
Scheme 59. Formation of neopentyl chloride with Pd(IBu)2.
132 
Therefore to the reaction mixture obtained from the addition of lithium morpholide 
to  Pd(IBu)(neopentyl)(chloride)  dimer  143,  presuming  to  contain 
Pd(IBu)(neopentyl)(morpholide) 144, was added one, two and four equivalents of 
alternative ancillary ligand. Whereas one equivalent would be expected to decrease 
electron density on the Pd centre (upon exchange with IBu, phosphine would remove 
electron density from the Pd via backbonding), two and four equivalents would be 
expected to impart more electron density onto the Pd centre. However, as shown by 
Caddick and Cloke,
132 the use of excess ancillary ligand could force the neopentyl 
and morpholide groups into closer proximity to react. 
Upon  addition  of  one,  two  and  four  equivalents  of  ancillary  ligand  to  proposed 
species  Pd(IBu)(neopentyl)(morpholide)  144,  the  desired  reductive  elimination 
reaction was still not observed. Rather, a complex reaction mixture resulted, along 
with the formation of free morpholine and Pd(IBu)2. Additionally in the case of PPh3 
and DPPP, crystals of Pd(PPh3)4 and Pd(DPPP)2 were isolated.  
In order to gain a greater understanding of the factors important for the reductive 
elimination of neopentyl morpholine from Pd(IBu)(neopentyl)(morpholide) 144, and 
to  investigate  whether  possible  alternative  reaction  pathways  existed,  a  DFT 
investigation was carried out. The aim of this investigation was to develop a series of 
potential energy surfaces for the possible reaction pathways available to 144, which 
would allow the identification of key determinants for reductive elimination, as well 
as any other potential reaction pathway, and the selectivity issues involved.  
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4.2 A DFT investigation of the Pd catalysed reductive elimination of 
neopentyl morpholine from Pd(IBu)(neopentyl)(morpholide) 
4.2.1 Geometry optimisation and analytical frequency calculations 
In  order  to  develop  a  potential  energy  surface  for  the  reductive  elimination  of 
neopentyl morpholine from Pd(IBu)(neopentyl)(morpholide) 144, the ground state 
energy  of  each  proposed  intermediate  in  the  reductive  elimination  pathway  was 
required, along with the energy of the transition state for reductive elimination. To 
find these energies, the geometries of all intermediates were first optimised to give 
the minimum energy ground state and transition state structures. Two types of ADF 
calculation  enabled  this  to  happen;  a  ground  state  energy  geometry  optimisation 
calculation  optimised  (corresponding  to  n0  is  figure  32)  and  a  transition  state 
geometry optimisation calculation (corresponding to the saddle point in figure 32).  
 
Figure 32. General reaction pathway for the conversion of reactants into products. 
Strictly  speaking,  true  ground  state  energies  have  all  positive  eigenvalues  in  the 
Hessian  (the  matrix  of  second  derivatives  of  the  total  energy  with  respect  to 
displacement  of  the  nuclei)  and  hence  all  real  vibrational  frequencies.  Transition  
96 
 
states, on the other hand, have a single negative eigenvalue in the Hessian, giving a 
single imaginary vibrational mode (associated with motion through the TS). 
If  a  ground  state  geometry  optimisation  calculation  was  carried  out  on  an 
intermediate  with  a  geometry  corresponding  to  the  transition  state,  the  geometry 
would  try  to  rearrange  to  give  the  lowest  energy  structure  (with  only  positive 
eigenvalues), corresponding to the structure of the starting material or the product 
(figure 33). 
 
Figure 33. Geometry optimisation calculation carried out on a transition state structure. 
If  a  transition  state  geometry  optimisation  calculation  was  carried  out  on  an 
intermediate  whose  structure  was  that  of  the  starting  material  or  product,  the 
transition  state  geometry  would  not  be  able  to  optimise;  the  energy  of  the 
intermediate  would  be  at  the  bottom  of  the  well  (corresponding  to  only  positive 
eigenvalues) and any rearrangement of the structure would be too small to reach the 
transition state structure (with a single negative eigenvalue in the Hessian) (figure 
34). However, if the transition state geometry optimisation calculation was carried 
out on an intermediate whose energy corresponded to the saddle point in figure 34, 
the geometry would be able to converge to give a stable transition state structure 
(with a single negative eigenvalue in the Hessian).  
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Figure 34. Transition state optimisation calculation carried out on a ground state energy structure. 
4.2.1.1 Procedure for the development of potential energy surfaces 
A comparison of the optimised geometries of Pd(IBu)(neopentyl)(morpholine)(Cl) 
130 and Pd(IBu)2 with that obtained experimentally
119,132 found that all bond lengths 
involving the Pd atom deviated by no more than 0.05 Å from their experimental 
values.  With  this  information  in  hand,  it  was  presumed  that  the  geometry 
optimisations of the other intermediates would also be accurate to this degree. 
Having optimised the geometry of all intermediates to obtain the minimum energy 
structures,  n0,  an  analytical  frequency  calculation  was  then  carried  out  on  these 
structures to obtain the zero-point energy correction for the ground state energy (zpe 
= n1-n0), as well as the enthalpic and entropic contributions to the energy. This was 
repeated using the cosmo solvent model, with THF chosen as the solvent, to give the 
minimum energies in solvent. However, analytical frequency calculations could not 
be carried out using the cosmo model for the transition state structure. Instead, the 
zero point energy, enthalpic and entropic corrections were taken from the gas phase 
optimised transition state structure, and applied to the solvent optimised transition 
state structure. Whilst not ideal, the fact that the geometries, energies and corrections 
for other intermediates were found to vary little, suggested that this would not affect 
the overall trend to changes in energy.  
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4.2.2  Reductive  elimination  of  neopentyl  morpholine  from 
Pd(IBu)(neopentyl)(morpholine) 
The study began with the attempted geometry optimisation of both cis and trans 
isomers of Pd(IBu)(neopentyl)(morpholine) 144 and 144a (section 4.1.1, scheme 31), 
the  species  from  which  reductive  elimination  takes  place.
119,130  However,  it  was 
found that both structures converged to the same geometry 144, with IBu trans to the 
morpholide,  a  result  of  the  greater  trans  influence  of  the  strongly  ζ-donating 
neopentyl group. This species was found to have a distorted T-shaped geometry, due 
to the steric bulk of the neopentyl group (figure 35). 
 
Figure 35. Geometry of Pd(IBu)(neopentyl)(morpholine) 144. 
The proposed steps involved in the reductive elimination of neopentyl morpholine 
are  examined  in  scheme  60.  It  can  be  seen  that  elimination  would  first  require 
rotation of the neopentyl group through ~ 90
o around the Pd–C bond to form 144b, a 
rotamer of 144 with a (neopentyl)Pd(morpholide) bond angle of 103° (figure 35), 
formed at a cost of 8.1 kJ mol
-1. Further movement of the neopentyl group towards 
the morpholide would then lead to a reduction in the neopentyl-Pd-morpholide bond 
angle, and hence to transition state TS-145, 131.0 kJ mol
-1 higher in energy than 144. 
The neopentyl group can then pass to the nitrogen of the morpholide, to give Pd(0) 
complex 146, 16.2 kJ mol
-1 more stable than 144. This increased stability is due to 
two reasons; the alleviation of strain associated with changing from a distorted T-
shaped Pd(II) complex 144 to a 2-coordinate Pd(0) complex 146; and the reduced 
electron density, and therefore lowering of the energy of the Pd orbitals, on having 
two formally neutral ligands bound to the Pd centre as opposed to the three ligands in 
144 (one formally neutral and two formally negative). Finally neopentyl morpholine  
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129 can dissociate to give complex 147, 35.6 kJ mol
-1 more stable than Pd complex 
144. 
4.2.3 Addition of THF to the free coordination site on Palladium 
Whilst the employment of the cosmo solvent model describes the average solvent 
field  observed by  the  complexes  under investigation, it does  not account  for the 
exclusive  binding  of  a  molecule  of  solvent  (in  this  case  THF)  to  any  free 
coordination sites on the Pd centre. An ideal calculation would combine an infinite 
field of solvent molecules, with additional free solvent molecules able to associate 
and dissociate from the Pd centre. However, this is very computationally expensive 
and not possible to do. Instead a single solvent molecule can be attached to the Pd 
centre and the energy of this complex calculated in an analogous fashion to those 
described previously.
119 
The attempted geometry optimisation of complex 146 to include a molecule of THF 
on the free coordination site of the  Pd led to  failure, with  the molecule of THF 
repeatedly  dissociating  (figure  36).  This  is  a  result  of  the  Pd  centre  being  too 
sterically congested and therefore unable to support the addition of another ligand to 
its centre. The geometry optimisation of complex 147 containing a molecule of THF 
was also unsuccessful,  with the molecule of THF again dissociating followed by 
calculation failure
178 (figure 36). In this case, however, steric congestion would not 
be the cause, as the Pd centre would only have two ligands attached. It is therefore 
believed that the strongly ζ-donating NHC ligand forces the dissociation of the THF 
molecule due to the greater trans influence of the NHC. 
 
Scheme 36. Dissociation of THF to complexes 146 and 147.  
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Scheme 60. Calculated relative energy level diagram (kJ mol
-1) of the stationary points on the potential energy surface for reductive elimination from 144. The energies quoted are gas phase, including zero point, 
thermal and entropic corrections (at 298.15 K). Values in parentheses are derived from electronic energies computed with the inclusion of solvent effects, with zero point energies, thermal and entropic corrections taken 
from the gas phase calculations.  
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4.2.4 Association and dissociation of IBu to Pd(IBu) 
The addition of IBu to Pd(IBu) 147 leads to the formation of Pd(IBu)2 148, with an 
energy  gain  of  102.9  kJ  mol
-1  (scheme  61).  The  reverse  of  this  process,  the 
dissociation of IBu from Pd(IBu)2 148, is known to occur at the beginning of many 
Pd(0) catalysed cycles with a similar energy to that calculated below (110 kJ mol
-
1).
120 Hence there is no obvious reason why, on the basis of scheme 61, the reductive 
elimination stage of the alkyl amination reaction (via TS-145) should not take place. 
 
Scheme 61. Association of  IBu to Pd(IBu). The energy quoted is calculated for the gas phase, and includes zero point, thermal 
and entropic corrections (at 298.15 K). The value in parenthesis is derived from the electronic energy computed with the 
inclusion of solvent effects, with zero point energy, thermal and entropic corrections taken from the gas phase calculation. 
Following these calculations it was decided that further DFT studies were warranted 
in which (i) the neopentyl group was replaced with phenyl (for which the reductive 
elimination is known to take place) and (ii) the strongly  donating IBu was replaced 
with a less donating trialkyl phosphine (PCyp3). It was intended that these studies 
would  offer  a  valuable  insight  into  the  differences  in  the  activation  energy  of 
reductive elimination on changing the ancillary ligand and R group bound to the Pd. 
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4.3  Differences  in  the  potential  energy  surfaces  of 
Pd(IBu)(neopentyl)(morpholide),  Pd(IBu)(phenyl)(morpholide)  and 
Pd(PCyp3)(neopentyl)(morpholide) 
Energy level diagrams with neopentyl replaced with phenyl and IBu with PCyp3 are 
shown in scheme 62. It can be seen that the replacement of IBu by PCyp3 gives an 
activation  energy  from  153  to  TS-154  still  well  in  excess  of  100  kJ  mol
–1.  By 
contrast, the activation energy from 149, the three-coordinate phenyl complex known 
to undergo reductive elimination easily, is only 60.1 kJ mol
–1 (to TS-150) in solution, 
substantially lower than the analogous steps on either the IBu or PCyp3 neopentyl 
surfaces. 
The much higher activation energy in the neopentyl systems may well result from 
steric factors. 144 is distorted by 40° from a typical T-shaped geometry on account of 
the steric bulk of the neopentyl group and hence, as discussed above, the neopentyl 
group  must  rotate  in  order  to  bring  the  neopentyl  and  morpholide  ligands  into 
sufficiently close proximity. This rotation is accompanied by the undesirable clash of 
the 
tBu groups of the NHC with those of the neopentyl, and the combination of this 
congestion and the initial rotation may well have a significant effect on the energy of 
TS-145.  Furthermore,  the  energy  released  on  forming  the  two-coordinate  species 
151, 146 and 155 from the preceding transition states is approximately 50% greater 
for the neopentyl  systems,  indicative of larger steric congestion in  the neopentyl 
transition states TS-145 and TS-154 relative to the phenyl TS-150. 
In  order  to  probe  the  role  of  sterics  in  these  reactions,  the  neopentyl  of  the 
Pd(IBu)(neopentyl)(morpholide)  complexes  was  replaced  with  methyl,  and  the 
potential energy surface recalculated as above. On doing so it was found that the 
activation energy was reduced, but only by 102.9 kJ mol
–1; thus sterics could not 
account  for  all  of  the  differences  observed  in  the  neopentyl/phenyl  system  and 
electronics must also play a role.  
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Scheme 62. Calculated energy level diagram (kJ mol
-1) of the stationary points on the potential energy surface for reductive 
elimination from 144, 149 and 153. The energies quoted are gas phase, including zero point, thermal and entropic corrections 
(at 298.15 K). Values in parentheses are derived from electronic energies computed with the inclusion of solvent effects, with 
zero point energies, thermal and entropic corrections taken from the gas phase calculations.  
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4.3.1  Differences  in  bond  length  between  
Pd(IBu)(neopentyl)(morpholide),  Pd(IBu)(phenyl)(morpholide)  and 
Pd(PCyp3)(neopentyl)(morpholide) 
Tables 11-13 present the calculated bond lengths for the structures discussed above. 
It is interesting to see how these bond lengths change as the reductive elimination 
progresses along the potential energy surface.   
Pd(IBu)(neopentyl)(morpholide) complexes 
Bond  130  144  TS-145  146 
Pd–N  2.170  2.004 (0.83)  2.026 (0.59)  2.250 (0.32) 
Pd–C(neo)  2.120  2.097 (0.78)  2.408 (0.45)  - 
C–N  -  (0.12)  (0.47)  (0.86) 
Pd–C(IBu)  2.000  2.037  2.036  1.985 
Table 11. Pd–ligand bond lengths (Å) and Mayer bond orders (in parentheses) for selected stationary points on the potential 
energy surfaces for Pd(IBu)(neopentyl)(morpholide) complexes. 
In the IBu/neopentyl system, the Pd–N distance shortens significantly from the four 
coordinate species 130 to the three-coordinate 144. This is in line with the idea that 
the amine is bound only datively to the Pd centre in 130, but much more strongly 
upon deprotonation in 144, with the latter being a traditional metal-amide bond. On 
progression to TS-145 there is a slight lengthening in the Pd-N bond and then more 
significantly in 145, as the amine becomes datively bound again before departing. 
There  is  little  difference  in  the  Pd–C(neopentyl)  distance  between  the  four-  and 
three-coordinate species, but a very significant lengthening in TS-145, due to the 
movement  of  the  neopentyl  group  towards  the  amine.  By  contrast,  there  is  little 
change in the Pd–C (IBu) distance from 130 to 146. 
The analogous bond lengths in the PCyp3 system behave similarly, with an increase 
in the Pd–N distance from 153 to 155, and a reduction in Pd–P. There is also a 
significant  lengthening  in  the  Pd–C(neopentyl)  distance  on  going  from  the  
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three-coordinate  153  to  the  transition  TS-154,  such  that  the  Pd–C(neopentyl) 
distances in TS-145 and TS-154 are quite alike, ~ 2.4 Å. The distances in the phenyl 
complexes are also similar to their equivalents in the neopentyl compounds, with the 
notable exception of the Pd–C(phenyl). Whereas the analogous bond in the neopentyl 
complexes is lengthened very significantly in TS-145 and TS-154 relative to the 
preceding three-coordinate minima, that in TS-150 is only 0.06 Å longer than in 151. 
Pd(PCyp3)(neopentyl)(morpholide) complexes 
Bond  -  153  TS-154  155 
Pd–N  -  2.007 (0.83)  2.037 (0.57)  2.294 (0.27) 
Pd–C(neo)  -  2.075 (0.80)  2.436 (0.39)  - 
C–N  -  (0.10)  (0.49)  (0.86) 
Pd–P  -  2.239  2.522  2.199 
Table 12. Pd–ligand bond lengths (Å) and Mayer bond orders (in parentheses) for selected stationary points on the potential 
energy surfaces for Pd(PCyp3)(neopentyl)(morpholide) complexes. 
 
Pd(IBu)(phenyl)(morpholide) complexes 
Bond    149  TS-150  151 
Pd–N  -  1.993 (0.87)  2.017 (0.55)  2.210 (0.31) 
Pd–C(phenyl)  -  2.011 (0.85)  2.071 (0.66)  - 
C–N  -  (0.11)  (0.49)  (0.95) 
Pd–C(IBu)  -  2.031  2.049  1.988 
Table 13. Pd–ligand bond lengths (Å) and Mayer bond orders (in parentheses) for selected stationary points on the potential 
energy surfaces for Pd(IBu)(phenyl)(morpholide) complexes.  
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4.3.2  Differences  in  Mayer  bond  order  of 
Pd(IBu)(neopentyl)(morpholide),  Pd(IBu)(phenyl)(morpholide)  and 
Pd(PCyp3)(neopentyl)(morpholide) 
In addition to the bond length data discussed above, tables 11, 12 and 13 also report 
the  intermediates’  Mayer  Bond  Orders  (MBOs).
179,180  MBOs  contain  all  of  the 
contributions to a bond between two atoms, i.e. they take account of all bonding and 
antibonding interactions in a single number and have been applied to a variety of 
systems by, for example, Bridgeman and co-workers.
181 In general, the greater the 
bond order, the higher the electron density and therefore the stronger the bond. 
The  MBOs  in  tables  11,  12  and  13  are,  in  general,  rather  similar  in  analogous 
complexes, with the exception of the Pd–C bond which weakens over the transition 
states.  Specifically,  the  MBO  for  the  weakening  Pd–C  bond  in  TS-150  is 
significantly larger than for TS-145 and TS-154, suggesting that the Pd–phenyl bond 
in TS-150 is stronger than the Pd–alkyl bonds in the analogous transition states (the 
MBO for the Pd–C(Me) bond in the IBu/methyl transition state is the same as the 
Pd–C(neopentyl)  MBO  in  TS-145).  The  stronger  Pd–C(phenyl)  bonding  in  the 
transition state, consistent with the shorter Pd–C bond in TS-150 vs TS-145 and 
TS-154,  contributes  significantly  to  the  reduced  activation  energy  on  the  phenyl 
potential energy surface.  
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4.4 A DFT investigation of the morpholide promoted C-H activation 
of neopentyl from Pd(IBu)(neopentyl)(morpholide) 
No other reaction pathway is available for Pd(IBu)(aryl)(morpholine) 149 other than 
the  reductive  elimination  of  the  aryl  substituent.  However,  if  another  reaction 
pathway was available for complex 144, then a selectivity issue would arise. 
Pd(IBu)(neopentyl)(morpholide) 144 has three 
tBu groups, two from the NHC and 
one from the neopentyl ligand. Although it has previously been reported that C–H 
activation of 
tBu in IBu readily occurs,
144 this was not observed in our study nor 
could a transition state for such a process be found computationally, leaving only the 
neopentyl  group  as  a  C–H  activation  candidate.  Several  studies  involving 
neopentyl-bound Ni and Pt have shown C–H activation to be a viable process,
182-184 
often  resulting  in  loss  of  1,1-bis-dimethylcyclopropane  from  a  metallocyclobutyl 
intermediate, a process which neighbouring group participation by the nitrogen of 
morpholide would facilitate. Therefore  further computational studies were carried 
out to identify a mechanism to support the transfer of a hydrogen from neopentyl to 
the  morpholide  of  Pd(IBu)(neopentyl)(morpholide)  144  resulting  in  subsequent 
dissociation  of  morpholine,  followed  by  the  loss  of  the  neopentyl  group  and 
formation of Pd(IBu)2 148. The results are shown in scheme 63. 
The pathway begins with the transfer of a hydrogen atom from one of the neopentyl 
tBu groups to the Pd centre, resulting in TS-157, a five coordinate transition state 
consisting of bound IBu, morpholide, hydride, and a metallocyclobutyl  ring. The 
hydrogen lies in the same plane as the morpholide nitrogen and the neopentyl carbon 
atom to which it was previously bonded. Attempts to locate analogous transition 
states which do not involve the morpholide nitrogen proved unsuccessful, strongly 
suggesting that for the current system the presence of the nitrogen as a hydrogen 
acceptor is required. TS-157 lies approximately 88 kJ mol
-1 higher in energy than 
144, some 43 kJ mol
-1 lower than the barrier  for reductive elimination (TS-145, 
scheme 60).  Furthermore,  144  is  appropriately  positioned for the C–H activation 
process whereas for reductive elimination, rotation of the bulky neopentyl group is 
first required. Additionally, the free rotation of the 
tBu group means that there are  
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nine possible sites for C–H activation, compared with the one C centre for reductive 
elimination (see following paragraphs). From TS-157, movement of the hydrogen 
towards the nitrogen of the morpholide results in 158, a four coordinate Pd species of 
similar energy to the starting complex 144. Rotation and dissociation of morpholine, 
followed by loss of 1,1-bis-dimethylcyclopropane, gives Pd(IBu) 147, 50.5 kJ mol
-1 
more stable than 144. 
Two factors need to be taken into account when discussing the selectivity  of the 
reductive  elimination  and  morpholide-promoted  C-H  activation  reactions;  the 
number of reaction sites available (1C versus 9H), and the activation energies of both 
processes,  the  latter  of  which  provides  the  biggest  contribution  to  reaction 
selectivity.
185 If the different carbon and hydrogen reaction sites could be considered 
equivalent,  which  in  this  case  they  cannot,  and  the  activation  energies  of  both 
processes were the same, which they aren’t, then the rate of reaction would increase 
in proportional to the number of reaction sites available (i.e. 9H > 1C). Therefore 
morpholide-promoted  C-H  activation  would  be  nines  times  faster  than  reductive 
elimination from the neopentyl carbon. However, the carbon and hydrogen reaction 
sites are not considered equivalent. 
Fortunately, the difference in activation energy provides the biggest contribution to 
the reaction selectivity, assuming that the collision frequency is the same (equation 
28, A1=A). However, as there are nine hydrogens to only one carbon reaction centre, 
assuming the collision frequency is equivalent will mean that any affect on the rate 
constant of the reaction will be an underestimate. Neverless, taking the ratio of the 
rate  constants  (k1/k)  of  morpholide-promoted  C-H  activation  against  reductive 
elimination finds morpholide-promoted C-H activation is favoured by 2.6 x 10
7.  
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Not only is there a larger rate constant and lower activation energy barrier for C-H 
activation compared with reductive elimination, but the reaction also results in the  
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liberation  of  morpholine  and  1,1-bis-dimethylcyclopropane,  which  is  entropically 
more  favourable  than  reductive  elimination.  The  reverse  of  this  process,  the 
association of morpholine and insertion of Pd(0) into the cyclopropane ring of 1,1-
bis-dimethylcyclopropane  is  highly  unfavourable,  both  entropically  and 
energetically. All of these factors therefore imply that the morpholide-promoted C-H 
activation of neopentyl would be selectively favoured over reductive elimination. 
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Scheme 63. Calculated relative energy level diagram (kJ mol
-1) of the stationary points on the potential energy surface for morpholide-promoted C-H activation of 
tBu in 144. The energies quoted are gas phase, 
including zero point, thermal and entropic corrections (at 298.15 K). Values in parentheses are derived from electronic energies computed with the inclusion of solvent effects, with zero point energies, thermal and 
entropic corrections taken from the gas phase calculations.  
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4.5 A DFT investigation of the Pd catalysed reductive elimination of 
2-methylpropyl  morpholine  from  Pd(IBu)(2-
methylpropyl)(morpholide) 
Schemes 60 and 63 suggest that reductive elimination is selectively less favourable 
in comparison with C–H activation; due to the lower activation energy barrier for C-
H activation, 9:1 ratio of H:C reaction centres and larger rate constant calculated for 
C-H activation. However, the neopentyl compound does not possess -hydrogens, 
and  therefore  it  was  decided  to  investigate  the  possible  reaction  pathways  for  a 
compound  analogous  to  144  which  contains  such  hydrogens,  Pd(IBu)(2-
methylpropyl)(morpholide) 161. This would allow the comparison of the potential 
surfaces  not  only  for  C–H  activation  and  reductive  elimination,  but  also  for  -
hydride elimination.
Scheme 64 shows the potential energy surface for the reductive elimination of 2-
methylpropylmorpholine from Pd(IBu)(2-methylpropyl)(morpholide) 161 and table 
14 the bond lengths and Mayer bond orders for the intermediates involved. 
Pd(IBu)(2-methylpropyl)(morpholide) complexes 
Bond  161  TS-162  163 
Pd–N  1.988 (0.87)  2.019 (0.56)  2.242 (0.32) 
Pd–C(2-methylpropyl)  2.091 (0.81)  2.346 (0.39)  - 
C–N  (0.10)  (0.51)  (0.85) 
Pd–C(IBu)  2.012  2.033  1.986 
Table 14. Pd–ligand bond lengths (Å) and Mayer bond orders (in parentheses) for selected stationary points on the potential 
energy surfaces for Pd(IBu)(2-methylpropyl)(morpholide) complexes.  
112 
 
 
Scheme  64.  Calculated  relative  energy  level  diagram  (kJ  mol
-1)  of  the  stationary  points  on  the  potential  energy  surface  for  the  reductive  elimination  of  2-methylpropyl  morpholine  from 
Pd(IBu)(2-methylpropyl)(morpholide) 161. The energies quoted are gas phase, including zero point, thermal and entropic corrections (at 298.15 K). Values in parentheses are derived from electronic energies computed 
with the inclusion of solvent effects, with zero point energies, thermal and entropic corrections taken from the gas phase calculations.  
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Comparison of schemes 60 and 64 shows that the reductive elimination pathways for 
144 and 161 are rather similar. 23 kJ mol
-1 less is required to reach the transition 
state  for  reductive  elimination  (TS-162),  than  on  the  equivalent  surface  for  the 
neopentyl  derivative,  possibly  because  there  is  one  methyl  group  fewer  in  the 
2-methylpropyl system and hence reduced steric congestion in the transition state. 
From TS-162 the transfer of 2-methylpropyl to the morpholide nitrogen can take 
place, reducing Pd(II) to Pd(0) and lengthening Pd–morpholine bond from 2.019 to 
2.242 Å (table 14). This is strongly exothermic (-133.6 kJ mol
–1 in THF solution) and 
results in the formation of Pd(0) complex 163, 26.6 kJ mol
-1 more stable than 161. 
The comparative process for the Pd neopentyl complex 144 was found to be 13.5 kJ 
mol
-1 more exothermic, again a result of the increased steric bulk associated with the 
neopentyl group. Subsequent loss of 2-methylpropylmorpholine 164 finally leads to 
the formation of Pd(IBu) complex 147, 35.4 kJ mol
-1 more stable than Pd(IBu)(2-
methylpropyl)(morpholide) 161. 
4.5.1 Morpholide promoted C-H activation of 2-methylpropyl from 
Pd(IBu)(2-methylpropyl)(morpholide) 
The second process considered for 144 was the morpholide-promoted C–H activation 
of 
tBu. To establish the effect of removing one of the three methyl groups from 
neopentyl, a potential surface for the 2-methylpropyl system 161 was developed, 
with  the  results  presented  in  scheme  65.  As  with  the  reductive  elimination, 
comparison  of  schemes  63  and  65  reveals  rather  similar  surfaces.  Indeed,  the 
activation energy from 161 to TS-165 is almost exactly the same as that between 144 
and TS-157 for the neopentyl system. That said, it might be expected that there is a 
rather larger dependence on the orientation of the alkyl group in 161 than in 144, in 
that C–H activation requires a 2-methylpropyl methyl group to be adjacent to the 
morpholide N atom. There are, of course, only six such C–H bonds in 161 compared 
to the nine in 144. Due to the activation barrier for the reaction being near identical, 
and  considering  the  hydrogen  reaction  centres  in  161  and  144  to  be  equivalent, 
means  that  the  rate  of  C-H  activation  is  directly  proportional  to  the  number  of 
hydrogen reaction centres. Therefore the rate of reaction for C-H activation is 1.5 
times faster for 144 than 161 (hydrogen ratio 3:2).   
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A comparison of the rate of reductive elimination against morpholide promoted C-H 
activation  is  less  straightforward  (see  section  4.4,  p108,  paragraphs  2  and  3). 
Assuming  in  161  that  the  single  carbon  reaction  centre  is  equivalent  to  the  six 
hydrogen  reaction  centres,  which  of  course  it  is  not,  implies  that  the  rate  of 
morpholide  promoted  C-H  activation  from  161  is  six  times  faster  than  reductive 
elimination. 
The larger factor determining the rate of reaction is the activation energy. Again 
assuming the collision frequency is the same for the carbon and hydrogen reaction 
centres  (A1=A),  finds  that  the  ratio  of  rate  constants  (k1/k)  is  334  in  favour  of 
morpholide-promoted  C-H  activation  (equation  29).  However,  as  there  are  six 
hydrogens as opposed to one carbon, and assuming that the formation of a transition 
state consisting of a five membered ring is easier to obtain than a three-membered 
ring,
186 means that the collision frequency of the hydrogen reaction centres (A1) will 
be  higher  than  for  the  carbon  reaction  centres  (A).  The  ratio  found  for  the  rate 
constants (k1/k) will therefore be an underestimate, as A1>A as opposed to A1=A. 
  (29) 
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Scheme 65. Calculated relative energy level diagram (kJ mol
-1) of the stationary points on the potential energy surface for morpholide-promoted C-H activation of 2-methylpropane in 161. The energies quoted are gas 
phase, including zero point, thermal and entropic corrections (at 298.15 K). Values in parentheses are derived from electronic energies computed with the inclusion of solvent effects, with zero point energies, thermal 
and entropic corrections taken from the gas phase calculations.  
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4.5.2  β-Hydride  elimination  of  isobutene  from  Pd(IBu)(2-
methylpropyl)(morpholide) 
A third possible reaction of 161 is -hydride elimination from 2-methylpropyl, and 
the potential surface for this process is shown in scheme 66. The activation energy to 
form TS-169 is only 70.8 kJ mol
-1 in solution, compared with 107.0 kJ mol
-1 for 
reductive  elimination  (scheme  64  TS-162)  and  92.6  kJ  mol
-1  for 
morpholide-promoted  C–H  activation  (scheme  65  TS-165).  Following  -hydride 
transfer, loss of either alkene or morpholine from complex 170 is possible. However, 
it was found that the most favourable reaction was loss of morpholine to form 171 
(-71.7  kJ  mol
-1),  a  result  of  the  stronger  bonding  between  Pd  and  the  alkene 
(confirmed by calculation of the metal-alkene interaction energy (-199.9 kJ mol
-1) 
compared with the metal-morpholine interaction energy (-32.3 kJ mol
-1)). This is 
consistent with our observation that a -hydride transition state could be located only 
for morpholide-assisted loss of hydride. 
As stated previously, the most likely reaction pathway is not only determined by the 
activation energy (although this provides the largest contribution) but also by the 
number  of  reaction  centres  available.  In  the  case  of  161  there  is  one  hydogren 
available for -hydride elimination, six for morpholide-promoted C-H activation and 
one carbon for reductive elimination. A comparison of -hydride elimination against 
morpholide-promoted  C-H  activation  therefore  finds  that  the  latter  process  is  six 
times more likely to occur,  whilst a comparison of -hydride elimination against 
reductive elimination finds the rate of reaction the same, providing the assumption is 
made that the hydrogen and carbon reaction centres are equivalent in all cases. 
Assuming the collision frequency is the same for all three processes, the difference in 
activation  energy  can  be  used  to  calculate  the  ratio  of  the  rate  constants  for  the 
respective reactions (equations 30, 31 and 32). Therefore, following this it was found 
that the ratio of the rate constants (k1/k) is 6627 in favour of -hydride elimination 
over  morpholide-promoted  C-H  activation,  and  2.2  x  10
6  in  favour  of  -hydride 
elimination over reductive elimination.  
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It  is  therefore  found  that  the  most  favourable  reaction  of  161  is  -hydride 
elimination, followed by morpholide promoted C-H activation and then reductive 
elimination. The bulky 2-methylpropyl group impedes the formation of the reductive 
elimination transition state resulting in a higher activation energy for the coupling of 
2-dimethylpropyl with morpholide. Whilst the energy for -hydride elimination is 
lower  than  for  morpholide-promoted  C–H  activation,  the  increased  number  of 
hydrogens  available  for  the  latter  process  does  offset  this  energy  difference. 
However, the largest contribution for determination the most likely reaction pathway 
is  the activation  energy, providing the difference in  collision frequency is  small. 
Therefore, despite the difference in number of reaction sites, -hydride elimination is 
more still more favourable than morpholide-promoted C-H activation. 
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
Scheme 66. Calculated relative energy level diagram (kJ mol
-1) of the stationary points on the potential energy surface for the -hydride elimination reaction from 2-methylpropyl in 161. The energies quoted are gas 
phase, including zero point, thermal and entropic corrections (at 298.15 K). Values in parentheses are derived from electronic energies computed with the inclusion of solvent effects, with zero point energies, thermal 
and entropic corrections taken from the gas phase calculations.  
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4.6  Comments  and  conclusions  on  the  proposed  potential  energy 
surfaces of Pd(L)(alkyl)(morpholide) 
By  development  of  energy  level  diagrams  for  the  stationary  points  on  potential 
energy surfaces of a series of Pd catalysed reactions, all starting from a common 
intermediate, we have been able to determine the most likely pathway for reactions 
of  Pd(IBu)(neopentyl)(morpholide)  144.  Unfortunately  it  seems  that  reductive 
elimination  of  neopentyl  morpholine  is  not  the  most  favoured  pathway.  In 
comparison, it was shown that the reductive elimination of phenyl morpholine was 
considerably lower in energy than the analogous neopentyl compound and was the 
only  possible  product  available  from  Pd(IBu)(phenyl)(morpholide).  Yet  for 
Pd(IBu)(neopentyl)(morpholide)  this  was  not  the  case;  whilst  searching  for 
alternative reaction profiles, morpholide promoted C-H activation was discovered as 
an  alternative  reaction  pathway,  although  experimentally  the  key  product  1,1-
dimethylcyclopropane could not be observed. 
To  compare  these  two  possible  reactions  with  the  possible  alternative,  β-hydride 
elimination,  a  final  series  of  potential  energy  pathways  were  developed  using 
Pd(IBu)(2-methylpropyl)(morpholide)  161.  From  this  it  was  found  that  the  most 
favourable  pathway  was  indeed  β-hydride  elimination,  followed  by  morpholide-
promoted  CH  activation  and  finally  reductive  elimination.  Therefore  whilst  the 
presence of β hydrogens has been known to be problematic when carrying out cross 
coupling  reactions,  the  additional  presence  of  hydrogens  able  to  undergo  C-H 
activation will also need to be considered. 
In  this  study  we  have  not  observed  any  key  Pd-bound  intermediates  other  than 
Pd(IBu)(neopentyl)(morpholide), yet it would be very desirable to be able to identify 
them  in  future  reactions.  One  technique  which  could  possibly  allow  the 
characterisation  of  key  intermediates  from  complex  reaction  mixtures  is  mass 
spectrometry (although not with 100% certainty - see section 3.4.1, p85), and is the 
final subject of this project.  
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5 The use of mass spectrometry in monitoring Pd catalysed 
reactions 
Santos has shown that online ESI(+)-MS(/MS) monitoring of the Stille reactions can 
be  used  to  intercept  and  characterise  key  reaction  intermediates.  These  methods 
allow the study of transient reactive intermediates by preserving the inert atmosphere 
in which the reaction takes place. This is achieved by coupling the reactor containing 
all the reagents directly to the ion source. However, Santos’ work did not extend to 
the use of offline ESI(+)-MS methods which require the transfer of a known amount 
of reaction mixture to the ion source by the experimentalist, a process that could 
possibly compromise the inert conditions under which the reaction takes place. A 
major concern of an offline method would thus be the neutralisation and degradation 
of key reactive intermediates upon transferring the reaction mixture to the ion source. 
5.1 Pd catalysed aryl amination of 4-chlorotoluene and morpholine 
The coupling of 4-chlorotoluene with morpholine was chosen as an ideal reaction to 
test the efficiencies of the offline ESI(+)-MS monitoring (scheme 67), as it is known 
to  be  a  reliable  high  yielding  process.
187  However,  upon  investigation  of  the 
intermediates present, the only potential palladium bound species observed was the 
pre-catalyst Pd(IBu)2 148 at 465 m/z. The reagents, 4-chlorotoluene and morpholine, 
and  the  product  4-p-tolyl-morpholine,  were  found  to  have  too  small  a  m/z  ratio 
(below 250 m/z) to be monitored accurately by ESI(+)-MS. Below ~250 m/z the high 
abundance of solvent and free IBu peaks had a pronounced effect. The presence of 
free IBu at 180 m/z also ‘swamped’ the presence of any other signal, however, above 
250 m/z the spectrum appeared cleaner. Major peaks at 465 m/z could potentially be 
attributed to [Pd(IBu)2]
+ and at 558 m/z  as [Pd(IBu)2(C6H4Me)]
+
 173, the oxidative 
addition product (minus Cl
-) of chlorotoluene or C-H activation product from the 
solvent toluene. 
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Scheme 67. Offline ES(+)-MS monitoring of the palladium catalysed reaction of 4-chlorotoluene with morpholine.  
5.2 Synthesis of dansyl functionalised  aryl amination reagents for 
MS analysis 
Due  to  the  difficulty  in  identifying  the  MS  species  below  250  m/z,  alternative 
reagents were sought to allow the use of mass spectrometry to probe these coupling 
reactions. It was conceived that functionalisation of 4-chlorotoluene and morpholine 
in order to increase their mass above the 250 m/z threshold would in principle bring 
them in range to be observed by ESI(+)-MS. 
The  incorporation  of  functional  groups  that  contain  nitrogen,  oxygen  and  sulfur 
would  help  to  distinguish  the  transient  reagent  bound  intermediates,  due  the 
increasing  complexity  of  their  isotope  pattern.  The  additional  restriction  that  the 
functional groups should act as an easy ionisable MS tag, such as a tertiary amine, 
would allow further ease of identification. Finally, restricting the functional group to 
one that has a simple 
1H and 
13C NMR spectrum, as well as fluorescent properties,  
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would add to its universal appeal. One such functional group that fills all of the 
above criteria is the fluorescent dansyl piperazine.
188 
5.2.1  Synthesis  of  dansyl  piperazine  and  N-dansyl-4-
chlorobenzylamine 
Initial attempts to synthesise dansyl piperazine by reacting mono-Boc-piperazine 174 
directly with dansyl chloride proved unsuccessful due to instability of the Boc group 
under the reaction conditions.  Instead mono-Boc-piperazine 174 was protected to 
give  the  N-Boc-N-Cbz-piperazine  175  (scheme  68).
189  The  Boc  group  was  then 
removed and the mono-Cbz-protected-piperazine 176 reacted with dansyl chloride. 
Deprotection of the Cbz group by transfer-hydrogenation then furnished the required 
dansyl piperazine 178 in high yield.  
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(a)  Di-tert-dibutoxycarbonate, AcOH, 21 °C, 24 h, 82%; (b) benzyl chloroformate, NEt3, 0 °C, 1 h, 99%; (c) 
TFA/CH2Cl2, 21 °C, 1 h, 97%; (d) dansyl chloride, DMAP, 0 °C, 24 h, 80 %; (e) Pd-C (5%), formic acid, EtOH, 95 
°C, 3 h, 100%. 
Scheme 68. Synthesis of dansyl piperazine. 
The synthesis of N-dansyl-4-chloro-benzylamine 179 was accomplished by reaction 
of dansyl chloride with catalytic DMAP for 24 h (scheme 69). 
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(a)  Dansyl chloride, DMAP 0 °C, 24 h, 85%. 
Scheme 69. Synthesis of N-dansyl-4-chloro-piperazine.  
123 
 
5.3 Offline ESI(+)-MS monitoring of the Pd catalysed aryl amination 
of chlorotoluene and dansyl piperazine 
The initial palladium catalysed reaction of chlorotoluene and dansyl piperazine was 
found  to  occur  in  80%  isolated  yield  after  24  h  (scheme  70).  Using  the  same 
conditions, the reaction was repeated and monitored offline via ESI(+)-MS; 0.01 mL 
of reaction mixture was removed under a positive flow of argon, diluted with 0.99 
mL  of  MeCN  and  injected  directly  into  the  ESI(+)-MS  probe.  This  process  was 
carried out after 1, 2, 4, 8 and 24 h intervals, and repeated at least three times for 
each time interval. 
a HN N S
O
O
N 178
N N S
O
O
N 180  
(a)  4-chlorotoluene, Pd(IBu)2, KO
tBu, 60 °C, 24 h, 80%. 
Scheme 70. Palladium catalysed reaction of chlorotoluene with dansyl piperazine. 
A major limitation with this approach is that the transient Pd bound species could 
decompose or react further during removal and transferring to the probe. However, 
there is a second limitation; the starting material, Pd bound species and product are 
of  a  different  chemical  nature,  and  therefore  could  exhibit  different  sensitivities 
towards the ESI(+)-MS, despite being in equal equivalents. For instance, the dansyl 
piperazine reagent 178 was found to be extremely sensitive towards MS ionisation 
and could be observed at very low concentration, due to containing a primary amine, 
whereas the product and any Pd-bound species would only contain a tertiary amine, 
which is less sensitive towards MS ionisation. Therefore, even if the reaction is 90% 
complete,  the  ratio  of  starting  material:product  cannot  be  used  to  determine  an 
accurate percentage conversion. Unlike section 2.6, where the coupling of the small 
bromomaleimide  reagent  to  the  considerably  larger  Grb2  SH2  domain  does  not 
change the sensitivity of the Grb2 SH2 or the resultant protein-conjugate product 
towards MS ionisation, with dansyl piperazine 178 and the dimethyl-(5-(4-p-tolyl-
piperazine-1-sulfonyl)-naphthalen-1-yl)-amine coupled product 180, this is not the 
case.  Not  only  are  178  and  180  both  small  in  molecular  weight,  but  also  of  a  
124 
 
sufficiently  different  chemical  nature  to  affect  their  sensitivity  towards  MS 
ionisation. 
Whilst percentage conversion cannot be accurately used to monitor reaction progress, 
thin layer chromatography can be combined with MS offline analysis to provide real 
time updates as to reaction progress. However, it should be noted that the aim of 
these MS experiments is not to monitor percentage conversion or reaction progress, 
but  to  observe  and  characterise  any  Pd-bound  species  present.  Therefore  whilst 
differences in MS ionisation are a limitation in this study, they do not affect the aims 
set out. 
Scheme  71  shows  the  results  for  the  offline  ESI(+)-MS  monitoring  of  the  Pd-
catalysed reaction of dansyl piperazine and chlorotoluene, and the possible structures 
for the species present. 
HN N
Cl
Pd Cl
Pd Cl
HN
N
Pd
N
N
N
S
O
O N
[Pd(IBu)2]+
[Pd(IBu)]+
IBu
IBu
IBu
148
m/z 465
178
m/z 320 MH+
KOtBu
KCl + HOtBu
S O
O
N
S O
O
N
N
S
O
O
N
180
m/z 448 MK+
Pd+
IBu
Pd+
IBu
IBu
173
m/z 558
1 h (10%)
24 h (10%)
1 h (0%)
24 h (100%)
1 h (100%)
24 h  (0%)
1 h (14%)
24 h (24%)
 
Scheme  71.  Species  observed  in  the  offline  monitoring  of  the  palladium  catalysed  reaction  of  chlorotoluene  with  dansyl 
piperazine. Abundances shown in parenthesis.  
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A species, possible [Pd(IBu)2]
+ 148, was observed at 465 m/z along with the dansyl 
piperazine  starting  material  178  at  320  m/z.  Disappointingly  the  only  possible 
intermediate  visible  was  the  potential  oxidative  addition  product 
[Pd(IBu)2(C4H4Me)]
+ 173 at 558 m/z, whilst all intermediates containing the dansyl 
piperazine were absent. However, more positive was the observation of a peak for 
the dansyl piperazine 178 which decreased in abundance with time and was replaced 
by the aryl-amine coupled product 180 at 448 m/z (MK
+). 
5.3.1  MS/MS  analysis  of  the  ionic  species  observed  in  the  Pd 
catalysed  aryl  amination  reaction  of  4-chlorotoluene  and  dansyl 
piperazine 
Despite  the  lack  of  transient  palladium-bound  species  observed  by  ESI(+)-MS, 
further analysis using MS/MS was carried out on those species that were present, in 
order to investigate their fragmentation pattern and thus allow futher confirmation of 
their structure. However, the only species with a recognisable fragmentation pattern 
was the dansyl piperazine reagent 178 (figure 37). 
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Figure 37. MS/MS induced fragmentation pattern of dansyl piperazine. 
MS/MS fragmentation of dansyl piperazine proved remarkably successful. Loss of 
oxygen from sulfur was prevalent (181 and 182), as was loss of methyl(s) from the 
dimethylamino moiety of the dansyl group (181, 182, and 184). Fragmentation of the  
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piperazine  unit  was  also  observed  (184).  However,  by  far  the  most  abundant 
fragment was that which had lost both piperazine and SO2 functionality 185. 
5.4 Offline ESI(+)-MS monitoring of the Pd catalysed aryl amination 
of N-dansyl-4-chloro-benzylamine and morpholine 
The palladium catalysed reaction of N-dansyl-4-chloro-benzylamine and morpholine 
was found to give a yield of only a 15% after 24 h, although the product could not be 
obtained  pure  (scheme  72).  This  lower  yield  could  be  a  result  of  the  reaction 
requiring a longer time to go to completion. 
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(a)  Morpholine, Pd(IBu)2, KO
tBu, 60 °C, 24 h. 
Scheme 72. Pd-catalysed coupling of morpholine and and N-dansyl-4-chloro-benzylamine. 
Pleasingly the introduction of N-dansyl-4-chloro-benzylamine 179 as reagent led to 
the  observation  of  considerably  more  palladium-bound  intermediates  by  offline 
ESI(+)-MS (scheme 73). Again a species with a m/z corresponding to [Pd(IBu)2]
+ 
148 was present at 465 m/z, along with the starting N-dansyl-4-chloro-benzylamine 
reagent 179 at 375 m/z, the latter of which was seen to disappear with time. The aryl-
amine  coupled  product  186  was  also  observed  464  m/z  (MK
+)  and  increased  in 
abundance as the reaction progressed. 
No oxidative addition product was observed for this reaction. However, palladium-
bound species  173  was observed at  558 m/z, analogous  to  the previous two MS 
experiments. Whilst in the previous two cases this was assigned to the oxidative 
addition  product,  [Pd(IBu)2(C4H4Me)]
+,  in  this  experiment  no  such  oxidative 
addition is available. Therefore this species could be the result of C-H activation of 
toluene by Pd(IBu), followed by addition of free IBu. 
Interestingly,  two  new  species  were  observed  at  789  and  753  m/z,  which  could 
correspond to the transmetallation intermediates 187 and 188 respectively. In order  
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to  investigate  this  further,  the  reaction  conditions  were  varied  and  the  effects 
monitored again by ESI(+)-MS. 
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Scheme  73.  Palladium  bound  species  observed  by  ESI(+)-MS  for  the  reaction  of  N-dansyl-4-chloro-benzylamine  and 
morpholine. Abundances shown in parenthesis. 
5.4.1  Effect  of  varying  the  conditions  of  the  Pd  catalysed  aryl 
amination of N-dansyl-4-chloro-benzylamine and morpholine 
Optimisation of the reaction conditions found a temperature of 60 °C was required 
for oxidative addition. Therefore the reaction was carried out at 21 °C and ESI(+)-
MS used to monitor the presence of Pd bound species. It was observed that the only 
potential  Pd  bound  species  present  were  the  pre-catalyst  148  and  species  173, 
indicating that the other  Pd bound species  could not  be formed before oxidative 
addition had taken place. When the temperature was raised to 60 °C, however, the  
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proposed  associated amine-intermediates  187 and  188 were observed,  along with 
formation of product. 
The  order  to  which  KO
tBu  was  added  to  the  reaction  was  varied.  Normal 
experimental procedures required addition of KO
tBu to a reaction mixture already 
containing  N-dansyl-4-chloro-benzylamine  179,  morpholine  and  Pd(IBu)2  148. 
However, the effect of adding KO
tBu before Pd(IBu)2 was found to be insignificant 
to  the  outcome  of  the  reaction  and  the  observance  of  any  transient  species.  The 
equivalents of KO
tBu were varied from 1 to 4 but showed no effect on species 187 
and 188. Finally, KO
tBu was omitted from the reaction altogether. In the absence of 
KO
tBu,  no  product  was  observed.  Instead  only  starting  material  and  proposed 
associated amine species 187 (789 m/z) was observed, due to lack of deprotonation 
taking place. When KO
tBu was added, the reaction began to proceed through to the 
formation of product 186 (464 m/z), with loss of starting material 179 (375 m/z) and 
amine species 187 (789 m/z), all of which was observed by MS. 
5.4.2  MS/MS  analysis  of  the  ionic  species  observed  in  the  Pd 
catalysed aryl amination reaction of N-dansyl-4-chloro-benzylamine 
and morpholine 
Whilst  the  MS/MS  analysis  of  the  dansyl  piperazine  reagent  178  produced 
fragmentation patterns that were useful for analytical purposes, N-dansyl-4-chloro-
benzylamine  179  failed  to  give  such  useful  fragments  under  similar  conditions 
(figure 38). The only potentially recognisable fragments observed resulted from loss 
of oxygen from sulfur or loss of methyl from the dimethylamino moiety, both of 
which were in line with previous MS/MS analysis in section 5.3.1. However, whilst 
the N-dansyl-4-chloro-benzylamine 179 reagent did not fragment well, the transient 
palladium-bound species faired better.  
129 
 
Parent ion Daughter ions
N
S
O
O HN
Cl
Pd Cl
NH
S O
O N
HN
O
N
S
O
O HN
N O
IBu
179
m/z 375 MH+
186
m/z 464 MK+
N
S HN
189
m/z 277
Pd Cl
NH
S O
O N
HN
O
190
m/z 568 MH+
N
S
O
O HN
N O
192
m/z 410
Pd
NH
S
N
191
m/z 413
+
+
+
187
m/z 789 MK+
 
Figure  38.  MS/MS  induced  fragmentation  pattern  of  N-dansyl-4-chloro-benzylamine  and  associated  intermediates  from 
palladium catalysed aryl amination reaction. 
The proposed amine-bound palladium species 187 produced two fragments; the first 
potentially corresponding to having lost IBu 190 and the second having potentially 
having  lost  morpholine,  IBu,  Cl  and  the  oxygens  from  sulfur  191.  The  coupled 
product 186 was also found to fragment, with loss of a single methyl group from the 
dimethylamino moiety 192. This was most probably due to its similarity with the 
starting material and thus inability to fragment in a conceivable way. 
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5.5 Offline ESI(+)-MS monitoring of the Pd catalysed aryl amination 
of N-dansyl-4-chloro-benzylamine and dansyl piperazine 
In  order  to  compare  the  ionisability  of  the  dansyl  functionalised  reagents,  an 
experiment was carried out using both reagents. The palladium-catalysed reaction of 
N-dansyl-4-chloro-benzylamine  and  dansyl  piperazine  is  shown  in  scheme  74. 
However, this combination of reagents resulted in a complex reaction mixture, of 
which only 10% product could be obtained and not pure. This was possibly a direct 
result of the large size of both dansyl functionalised reagents, inhibiting the approach 
and binding of the reagents to the palladium centre. Fortunately, ESI(+)-MS is an 
extremely  sensitive  process,  and  the  reaction  could  be  monitored  offline  to 
investigate if the reaction was actually taking place (scheme 75). 
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(a)  Pd(IBu)2, KO
tBu, 60 °C, 24 h. 
Scheme 74. Pd-catalysed coupling of N-dansyl-4-chloro-benzylamine with dansyl piperazine. 
The offline ESI(+)-MS analysis failed to find any transient Pd bound species from 
the  reaction.  Again,  both  starting  materials  178  and  179  were  present  at  the 
beginning,  only  to  decrease  in  abundance  as  the  reaction  progressed,  whilst  the 
opposite was found for the bisdansyl functionalised product 193. Interestingly the 
dansyl piperazine 178 starting material was found to decrease to 0% abundance after 
24 h, whilst the less sensitive chlorobenzylamine 179 did not, suggesting that either 
decomposition of 178 occurred or it was able to react further to an unknown and un-
observable species. 
The product 193 mass to charge ratio was found to be 657 m/z, indicative of the 
singly  charged  ion.  No  doubly  charged  ion  of  328  m/z,  or  for  any  reaction 
intermediates, was observed during this experiment, indicating that the tertiary amine  
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present in the dansyl functional group was not protonated. This could have been a 
result of the conjugation of the amine with the π-system of the dansyl unit, with the 
majority of the electron density channelled into the SO2NR moiety via the aromatic 
ring. 
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Scheme  75.  Palladium  catalysed  reaction  of  N-dansyl-4-chloro-benzylamine  and dansyl  piperazine.  Abundances  shown  in 
parenthesis. 
Whilst  the  reactions  of  (1)  dansyl  piperazine  and  chlorotoluene  and  (2)  dansyl 
piperazine and N-dansyl-4-chlorobenzylamine were unsuccessfully monitored using 
offline  ESI(+)-MS  techniques,  the  reaction  of    morpholine  with  N-dansyl-4-
chlorobenzylamine had shown some success. Therefore attention was turned to the 
troublesome  alkyl  amination  reaction.  It  was  hoped  that  the  observation  of  any 
intermediates present would shed light on the inability of the tricoordinate palladium 
complex, Pd(IBu)(neopentyl)(morpholide) 144, to undergo reductive elimination. It  
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would also be of interest to see whether any of the intermediates proposed in the 
DFT study would be visible and thus provide potential confirmation of the reaction 
pathway taken. 
5.6 Offline ESI(+)-MS monitoring of the reductive elimination stage 
of the Pd catalysed alkyl amination reaction 
Offline ESI(+)-MS analysis for the reaction of Pd(IBu)(neopentyl)(Cl) dimer with 
lithium morpholide, or morpholine and base, led in both cases to a complex reaction 
mixture  with  a  considerable  number  of  unidentifiable  Pd-bound  species  present 
(scheme 58, p 90). Further MS/MS analysis of these intermediates led in all cases to 
fragmentation to an unidentified ion, the m/z of which did not correspond with any 
proposed complex. The only potentially recognisable palladium-bound species was 
the corresponding monomer 194 of Pd(IBu)(neopentyl)(chloride) dimer (scheme 76). 
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Scheme 76. Palladium catalysed alkyl amination reaction. 
Following  this,  morpholine  was  replaced  with  the  previously  successful  dansyl 
piperazine  178  and  the  ESI(+)-MS  reactions  repeated.  The  increased  m/z  of  the 
amine reagent would provide additional information as to the amines fate, as would  
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its easily recognisable MS/MS fragmentation pattern. However, upon carrying out 
the  ESI(+)-MS  experiment,  the  only  notable  observation  was  that  of  free  dansyl 
piperazine reagent 178. No other information could be ascertained from this study. A 
1H  NMR  experiment  confirmed  that  no  reaction  had  taken  place,  returning  only 
starting material, most likely due to the sterical congestion created on binding dansyl 
piperazine to Pd(IBu)(neopentyl)(Cl) monomer 194 (scheme 77). 
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(a)  [Pd(IBu)(neopentyl)(Cl)]2, KO
tBu, 21 °C to 60 °C, 24 h.  
Scheme 77. Palladium catalysed alkyl amination reaction of Pd(IBu)(neopentyl)(morpholine) with dansyl piperazine. 
5.7 Comments and conclusions of the offline ESI(+)-MS and MS/MS 
analysis of Pd catalysed aryl and alkyl aminaton reactions 
Initially the study of the palladium catalysed aryl amination reaction was intended to 
assess the potential utility of offline ESI(+)-MS to screen for the presence of any 
transient palladium bound species in the reaction mixture. This process was then to 
be applied to the alkyl amination reaction in an attempt to observe any species that 
might offer insight into the reductive elimination step. However, during this initial 
study  many  factors  came  to  light  which  would  influence  the  observation  of  any 
potential species or catalytic process. 
Size of reagent and intermediate was found to be very important. Below a threshold 
of 250 m/z, solvent and free IBu ‘swamped’ the MS signal. Above this threshold, 
however,  the  complex  palladium  isotopic  pattern  enabled  the  observation  of  a 
number  of  palladium  bound  species.  By  variation  of  the  temperature  and  base 
(KO
tBu),  the  intensity  of  these  species  could  be  varied,  allowing  a  possible 
assignment of these species. With the completion of the initial offline experiments, 
the application of this method to the reductive elimination stage of the palladium 
catalysed alkyl amination reaction was investigated.  
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Unfortunately  no  useful  Pd-bound  species  could  be  seen  by  ESI(+)-MS.  The 
complex  reaction  mixture  resulted  in  a  considerable  number  of  species,  none  of 
which  could  be  assigned  with  confidence  by  ESI(+)-MS  or  MS/MS.  The  use  of 
dansyl piperazine also failed to produce any results, due to its inability to bind to the 
palladium  centre  of  Pd(IBu)(neopentyl)(Cl)  monomer  formed  in  situ  from 
Pd(IBu)(neopentyl)(Cl) dimer. 
In  order  to  investigate  the  potential  for  offline  ESI(+)-MS  reaction  monitoring 
further,  and  in  particular  its  use  in  the  alkyl  amination  reaction,  different  mass 
spectrometry tags would be required that would allow efficient reaction coupling. 
The dansyl linkers used in this study were found to be unsuitable, due to their large 
size. However, the reaction failure could also be due to the system in question, as 
reductive elimination was initially found not to take place. Therefore in future work, 
attention needs to be paid to the reagents in the alkyl amination reaction and the 
catalyst system used, in order to find success in both offline ESI(+)-MS reaction 
monitoring and in finding a system of general use. 
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6 Experimental section 
6.1 General methods and experimentation 
All the starting materials including solvents were used as received without further 
purification, unless otherwise stated. Where necessary, reactions were carried out 
under argon, unless otherwise stated. Specially dried (anhydrous) solvents were used 
when necessary. 
Reactions were monitored by TLC analysis carried out on SIL G/UV254 silica plates 
purchased from VWR, and were visualized under a UV lamp operating at short and 
long wavelength ranges. Visualisation was aided by dipping plates into an alkaline 
potassium  permanganate  solution.  Flash  column  chromatography  was  carried  out 
with Kieselgel 60M 0.04/0.063mm (230-400 mesh) silica gel. All yields quoted are 
isolated yields, unless otherwise stated, and when multiple products are obtained, 
data are presented in terms of order isolated.  
1H and 
13C NMR spectra were recorded at room temperature on a Bruker Avance 
400 instrument operating at a frequency of 400 MHz for 
1H and 100 MHz for 
13C, a 
Bruker Avance 500 instrument operating at a frequency of 500 MHz for 
1H and 125 
MHz for 
13C, and a Bruker Avance 600 instrument operating at a frequency of 600 
MHz for 
1H and 150 MHz for 
13C. CDCl3, CD3OD and DMSO-d6 were used as the 
deuterated solvents for all spectra run. Peaks are reported as singlet (s), doublet (d), 
triplet (t), quartet (q), quintet (quintet), broad (br) or multiplet (m). All chemical 
shifts are reported in parts per million (ppm) relative to residual protiated signals of 
the solvent, and coupling constants (J) are in Hertz (Hz). Infra-red spectra were run 
on a PerkinElmer Spectrum 100 FT-IR spectrometer operating in ATR mode with 
frequencies given in reciprocal centimeters (cm
-1). Mass spectra and high resolution 
mass data were recorded on a VG70-SE mass spectrometer (EI and ESI(+) mode). 
Melting  points  were  taken  on  a  Gallenkamp  heating  block  and  are  uncorrected. 
Lyophilised  somatostatin  was  purchased  from  Sigma-Aldrich  and  used  without 
further  purification.  Grb2  SH2  domain  model  protein  37  was  obtained  from  the 
Waxman group.
67  
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LC-MS was performed on protein samples using a Waters Acquity uPLC connected 
to Waters Acquity Single Quad Detector (SQD). Column: Acquity uPLC BEH C18 
1.7µm 2.1 x 50 mm. Wavelength: 254 nm. Mobile Phase: 95:5 Water (0.1% Formic 
Acid): MeCN (0.1% Formic Acid) Gradient over 4 min (to 5:95 Water (0.1% Formic 
Acid): MeCN (0.1% Formic Acid). Flow Rate: 0.6 mL/min. MS Mode: ES+. Scan 
Range: m/z = 85-2000. Scan time: 0.25 sec. Data obtained in continuum mode. The 
electrospray source of the MS was operated with a capillary voltage of 3.5 kV and a 
cone voltage of 50 V. Nitrogen was used as the nebulizer and desolvation gas at a 
total flow of 600 L/h.Total mass spectra for protein samples were reconstructed from 
the ion series using the MaxEnt 1 algorithm pre-installed on MassLynx software. 
Density Functional Theory (DFT) calculations were performed using the Amsterdam 
Density Functional (ADF) quantum chemistry package
161 with the PBE Generalized 
Gradient  Approximation  (GGA)  exchange  correlation  functional.
159,160  TZ2P 
Zero-Order Regular Approximation (ZORA) all electron basis sets were used on all 
atoms. Scalar relativistic effects were accounted for by the ZORA. The integration 
grid parameter was set to 6.0, and the geometry convergence was 10
–3 au Å
–1. All 
geometries  were  optimised  without  symmetry  constraints.  Analytical  harmonic 
frequency  calculations  were  used  to  characterise  stationary  points  as  either  true 
minima or transition states by the observation of 0 or 1 imaginary vibrational modes 
respectively. Solvent effects (tetrahydrofuran) were included by the COnductor-like 
Screening Model (COSMO)
163,190 with the following values for the atomic radii: Pd 
= 2.3 Å, O = 1.72 Å, Cl = 2.05 Å, N = 1.83 Å, P = 2.0 Å, C = 2.0 Å and H = 1.3 Å. 
The  solvent  radius  and  dielectric  constant  used  were  r  =  3.18  Å  and  ε  =  7.58. 
Entropic,  internal  and  zero-point  energy  corrections  were  taken  from  gas-phase 
calculations  and applied to  both  gas-phase  and  solvent  optimised geometries and 
transitions  states.  Schlenk  line  manipulations  involved  the  use  of  oven-dried 
glassware or  glassware  that had been  flame dried  under vacuum. Glassware  was 
repeatedly  evacuated  and  purged  with  dry  argon.  Glove  box  manipulations  were 
performed  in  a  Mbraun  or  a  Miller  Howe  glove  box  under  an  atmosphere  of 
dinitrogen.  Alkyl  halides,  PPh3,  DMPM  (1,1-bis(dimethylphosphino)methane), 
PCyp3  (tricyclopentylphosphine),  PCy3  (tricyclohexylphosphine),  DPPM  (1,1-
bis(diphenylphosphino)methane),  DPPP  (1,3-bis(diphenylphosphino)propane),  
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P
tBuMe2 were purchased from commercial sources (Aldrich). Amines were distilled 
at  reduced  pressure.  The  N-heterocyclic  carbenes  IBu  and  IPr  were  prepared 
according  to  literature  procedure.
191,192  Anhydrous  solvents  were  obtained  from 
Anhydrous Engineering (USA) solvent systems after drying on alumina granules or 
pellets. NMR solvents were purified by refluxing over a suitable drying agent, then 
vacuum transferred to an ampoule and stored under dinitrogen in a glove box. 
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6.2 Experimental data 
6.2.1 Route 1 to mono- and di- bromomaleimides 
N-(2-(2-(2-Amino-ethoxy)-ethoxy)-ethyl)-4-hydroxy-butyramide
80 80 
HO
H
N
O
O
O
NH2
 
Dihydro-furan-2-one (1.72 g, 20.0 mmol, 1 eq) was added to a solution of 2-(2-(2-
aminoethoxy)ethoxy)ethanamine (2.96 g, 20.0 mmol, 1 eq) and H2O (1 mL) and the 
reaction mixture heated at 90 °C for 15 h under argon.  The solvent was removed in 
vacuo  and  the  product  purified  by  column  chromatography  (5:2:2:1 
Et2O/MeOH/MeCN/Et3N) to yield 80 as a light yellow oil (3.47 g, 14.8 mmol, 74% 
yield). 
1H  NMR  (500  MHz,  CDCl3)  δ  6.99  (br,  1H,  NH),  3.61-3.57  (m,  4H, 
OCH2CH2O), 3.54-3.52 (m, 6H, CH2OCH2CH2OCH2 & CH2OH), 3.35 (t, J = 5.5 Hz, 
2H, C(O)NHCH2), 2.81 (t, J = 5.5 Hz, 2H, OCH2CH2NH2), 2.27 (t, J = 6.0 Hz, 2H, 
C(O)CH2CH2), 1.79 (quintet, J = 6.0 Hz, 2H, C(O)CH2CH2); 
13C NMR (125 MHz, 
CD3OD) δ 175.98 (s), 73.45 (t), 71.32 (t), 71.27 (t), 70.59 (t), 62.23 (t), 42.06 (t), 
40.33 (t), 33.58 (t), 29.79 (t); IR (neat) 3000, 1739, 1366, 1217 cm
-1; HRMS (CI) 
calcd for C10H23N2O4 [M+H]
+ 235.1658, observed 235.1661. 
(2-(2-(2-(4-Hydroxy-butyrylamino)-ethoxy)-ethoxy)-ethyl)-carbamic  acid  tert-
butyl ester 73 
HO
H
N
O
O
O
NHBoc
 
Di-tert-butyl-dicarbonate (93.0 mg, 0.43 mmol, 1 eq) in CH2Cl2 (5 mL) was added 
dropwise  to  solution  of  N-(2-(2-(2-amino-ethoxy)-ethoxy)-ethyl)-4-hydroxy-
butyramide 80 (100 mg, 0.43 mmol, 1 eq) and NEt3 (60.0 µL, 0.43 mmol, 1 eq) in 
CH2Cl2 (10 mL) and the reaction mixture stirred at 21 °C for 15 h. The solvent was 
then removed in vacuo and the product purified by column chromatography (5:2:2:1 
Et2O/MeOH/MeCN/Et3N) to yield 73 as a light yellow oil (140 mg, 42.1 mmol, 98% 
yield). 
1H NMR (600 MHz, CDCl3) δ 3.56 (t, J = 6.5 Hz, 2H, CH2OH), 3.53 (bs, 4H, 
OCH2CH2O), 3.47 (t, J = 5.0 Hz, 4H, CH2OCH2CH2OCH2), 3.35 (t, J = 5.0 Hz, 2H,  
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C(O)NHCH2),  3.23  (t,  J  =  5.0  Hz,  2H,  C(O)NHCH2),  2.27  (t,  J  =  6.5  Hz,  2H, 
C(O)CH2CH2), 1.78 (quintet, J = 6.5 Hz, 2H, C(O)CH2CH2), 1.35 (s, 9H, C(CH3)3); 
13C NMR (150 MHz, CDCl3) δ 173.92 (s), 156.13 (s), 79.44 (s), 71.32 (t), 70.24 (t), 
69.63 (t), 68.56 (t), 61.65 (t), 40.39 (t), 38.04 (t), 33.74 (t), 28.22 (q), 27.99 (t); IR 
(neat)  3324,  2932,  1690,  1640  cm
-1;  HRMS  (CI)  calcd  for  C15H31N2O6  [M+H]
+ 
335.2182, observed 335.2177. 
6.2.1.1  Synthetic  route  for  2-(2-(2-Hydroxy-ethoxy)-ethoxy)-ethyl)-
carbamic acid tert-butyl ester 85 
Methanesulfonic acid 2-(2-(2-hydroxy-ethoxy)-ethoxy)-ethyl ester
81 
HO
O
O
OMs 
Methanesulfonyl  chloride  (2.70  g,  23.6  mmol,  1  eq)  was  added  dropwise  to  a 
solution of 2-(2-(2-hydroxy-ethoxy)-ethoxy)-ethanol (3.54 g, 23.6 mmol, 1 eq) and 
NEt3 (3.3 mL, 23.6 mmol, 1 eq) in THF (25 mL) at 0 °C whereby a white precipitate 
was formed. The reaction mixture was warmed to 21 °C and stirred for 24 h. The 
precipitate was then filtered, the filtrate concentrated in vacuo and the liquid purified 
by column chromatography (8:2 EtOAc/PE) to give product as a colourless liquid 
(1.75  g,  7.68  mmol,  33  %  yield). 
1H  NMR  (500  MHz,  CDCl3)  δ  4.31  (m,  2H, 
CH2OMs), 3.73 (m, 2H, CH2OH), 3.65 (t, J = 4.0 Hz, 2H, OCH2), 3.62 (m, 4H, 
OCH2), 3.52 (t, J = 4.0 Hz, 2H, OCH2), 3.02 (s, 3H, CH3); 
13C NMR (150 MHz, 
CDCl3) δ 72.40 (t), 70.39 (t), 70.01 (t), 69.35 (t), 68.74 (t), 61.37 (t), 37.36 (q); IR 
(neat)  3448,  2939,  1739,  1347  cm
-1;  HRMS  (CI)  calcd  for  C7H17O6S  [M+H]
+ 
229.07458, observed 229.07412.  
2-(2-(2-Amino-ethoxy)-ethoxy)-ethanol
81 
HO
O
O
NH2 
Sodium  azide  (324  mg,  4.98  mmol,  1.5  eq)  was  added  to  a  stirred  solution  of 
methanesulfonic  acid  2-(2-(2-hydroxy-ethoxy)-ethoxy)-ethyl  ester  (0.76  g,  3.31 
mmol, 1 eq) in MeCN (15 mL) and the reaction mixture refluxed for 36 h. H2O (10 
mL) was then added and the organic product extracted into CH2Cl2. After drying 
with MgSO4, the solvent was removed in vacuo. The liquid was redissolved in the  
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minimum amount of EtOAc and passed through a short plug of silica, before again 
being concentrated in vacuo. THF (30 mL) was added to this liquid, followed in one 
portion by triphenylphosphine (3.91 g, 14.9 mmol, 4.5 eq) and the reaction mixture 
stirred at 21 °C for 4 h. The solvent was removed in vacuo and the residue purified 
by column chromatography (3:3:1 CHCl3/MeOH/NEt3) to give the amino-alcohol 
product as a light yellow oil (387 mg, 2.6 mmol, 78 % yield). 
1H NMR (500 MHz, 
CDCl3) δ 3.44 (m, 4H, OCH2), 3.36 (q, J = 4.5 Hz, 2H, OCH2), 3.32 (m, 3H), 2.85 
(m, 3H), 2.52 (bs, 2H, NH2); 
13C NMR (125 MHz, CDCl3) δ 72.80 (t), 72.59 (t), 
70.22 (t), 70.09 (t),  61.13 (t), 41.24 (t);  IR (neat)  3300, 3007, 2868, 1739 cm
-1; 
HRMS (CI) calcd for C6H16NO3 [M+H]
+ 150.11302, observed 150.11365.  
(2-(2-(2-Hydroxy-ethoxy)-ethoxy)-ethyl)-carbamic acid tert-butyl ester
81 85 
HO
O
O
NHBoc 
KOH (0.61 g, 10.9 mmol, 1.1 eq) was added to a solution of 2-(2-(2-Amino-ethoxy)-
ethoxy)-ethanol (1.47 g, 9.90 mmol, 1 eq) in H2O (10 mL) and the reaction mixture 
stirred for 5 min at 21 °C. It was then cooled to 0 °C and di-tert-butyl-dicarbonate 
(2.37 g, 10.6 mmol, 1.1 eq) in dioxane (5 mL) was added dropwise. After 1 h the 
solution was warmed to 21 °C and stirred for another 4 h. The mixture was then 
extracted with CH2Cl2, dried with MgSO4 and the solvent removed in vacuo to give a 
residue. Purification by column chromatography (8:2 EtOAc/PE) gave product 85 as 
a yellow oil (2.48 g, 9.90 mmol, 100 % yield). 
1H NMR (600 MHz, CDCl3) δ 3.75 
(q, J = 4.5 Hz, 2H, HOCH2), 3.65 (m, 4H, OCH2), 3.61 (q, J = 4.5 Hz, 2H, OCH2), 
3.56  (t,  J  =  4.5  Hz,  2H,  OCH2),  3.31  (t,  J  =  4.5  Hz,  2H,  NCH2),  1.44  (s,  9H, 
C(CH3)3); 
13C NMR (125 MHz, CDCl3) δ 155.72 (s), 78.82 (s), 72.03 (t), 69.97 (t), 
69.89 (t), 69.82 (t), 61.12 (t), 39.93 (t), 28.02 (q); IR (neat) 3339, 2932, 1688, 1519 
cm
-1; HRMS (ES+) calcd for C11H23NO5Na [M+Na]
+ 272.1474, observed 272.1482. 
Trifluoro-acetate-2-(2-(2-(3,4-dibromo-2,5-dioxo-2,5-dihydro-pyrrol-1-yl)-
ethoxy)-ethoxy)-ethyl-ammonium 87 
N
O
O
NH3
O
O
Br
Br
O CF3
O
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DIAD  (324  mg,  1.60  mmol,  1  eq)  was  added  dropwise  to  a  stirred  solution  of 
triphenylphosphine (420 mg, 1.60 mmol, 1 eq) in dry THF (10 mL) at -78 ºC under 
argon and the reaction mixture stirred at this temperature for 1 h, whereby a white 
precipitate was formed. (2-(2-(2-Hydroxy-ethoxy)-ethoxy)-ethyl)-carbamic acid tert-
butyl  ester  85 (0.60 g,  2.40 mmol,  1.5 eq) in dry THF (5 mL) was  then added, 
followed  by  3,4-dibromo-pyrrole-2,5-dione  (408  mg,  1.60  mmol,  1  eq)  in  one 
portion. The reaction was stirred for 15 min at -78 °C until the solution became clear 
and then at 21 °C for an additional 15 h. The solvent was then removed in vacuo to 
give a residue which was re-dissolved in CH2Cl2 (5 mL). To this solution TFA (5 
mL) was added and the reaction mixture stirred at 21 °C for 15 h. Toluene was then 
added (5 mL) and the solvent removed in vacuo to give a yellow oil. Purification by 
column chromatography (2:98 MeOH/CH2Cl2) gave product 87 as a light yellow oil 
(0.75 g, 1.50 mmol, 94% yield). 
1H NMR (600 MHz, CDCl3) δ 7.82 (br, 3H, NH3), 
3.81 (t, J = 5.5 Hz, 2H, OCH2CH2NH3), 3.68 (t, J = 5.5 Hz, 2H, OCH2CH2O), 3.64 
(t, J = 5.5 Hz, 2H, OCH2CH2O), 3.60 (bs, 4H, CH2OCH2CH2OCH2), 3.18 (br, 2H, 
C(O)NCH2); 
13C NMR (150 MHz, CDCl3) δ 164.11 (s), 129.44 (s), 69.99 (t), 69.59 
(t), 67.79 (t), 66.44 (t), 39.76 (t), 38.75 (t); IR (neat) 3450, 2970, 1726, 1205 cm
-1; 
HRMS (CI) calcd for C10H16N2O4Br2 [M+H]
+ 384.9399, observed 384.9402. 
6.2.2 Route 2 to mono- and di- bromomaleimides 
2,3-dibromo-maleic anhydride
69 90 
O
Br
Br
O
O  
Under an inert atmosphere, a solution of maleic anhydride (1.50 g, 15.3 mmol, 1 eq), 
aluminium trichloride (300 mg, 0.21 mmol, cat.) and bromine (4.95 g, 30.6 mmol, 2 
eq) was heated at 160 °C in a sealed ampule (note - blast shield) for 16 h. Upon 
cooling to 21 °C the reaction mixture was stirred for a further 24 h and carefully 
opened to air. EtOAc was added and the solid filtered off and repeatedly washed with 
further  EtOAc.  The  filtrate  was  finally  concentrated  in  vacuo  to  give  the  title 
compound 90 was a yellow solid which was used without further purification (3.05 g, 
11.9 mmol, 78% yield). m.p 107-110 °C; 
13C NMR (150 MHz, CD3OD) δ 163.33 (s),  
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125.28 (s); IR (MeOH) 1769, 1706, 1590 cm
-1; HRMS (CI) calcd for C4O3Br2 [M]
+ 
253.82087, 253.82082 observed. 
 
3-(3,4-Dibromo-2,5-dioxo-2,5-dihydro-pyrrol-1-yl)-propionic acid 91 
N
Br
Br
O
O OH
O
 
A mixture of β-alanine (1.00 g, 11.2 mmol, 1 eq) and 2,3-dibromo-maleic anhydride 
90 (2.84 g, 11.2 mmol, 1eq) in AcOH (10 mL) was heated to 150 °C for 3 h. The 
reaction mixture cooled to 21 °C and the precipitate filtered off and recrystallised in 
hot EtOAc to yield product 91 as a yellow solid (2.85 g, 8.74 mmol, 78%). m.p. > 
250 °C (dec); 
1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H, OH), 3.67 (t, J = 7.0 
Hz, 2H, CH2), 2.53 (t, J = 7.0 Hz, 2H, CH2); 
13C NMR (125 MHz, DMSO-d6) δ 
171.96 (s), 164.00 (s), 129.24 (s), 35.00 (t), 32.07 (t); IR (MeOH) 3363, 2800, 1725 
cm
-1; HRMS (CI) calcd for C7H6NO4Br2 [M+H]
+ 325.86636, observed 325.86743. 
6.2.3 Route 3 to mono- and di- bromomaleimides 
 
tert-Butyl N-(2-(2-(2-aminoethoxy)ethoxy)ethyl)carbamate
82 75 
 
H2N
O
O
NHBoc
 
A solution of di-tert-butyl-dicarbonate (1.10 g, 5.00 mmol, 1 eq) in CH2Cl2 (5 mL) 
was added dropwise to a solution of 2-[2-(2-aminoethoxy)ethoxy]ethanamine (7.32 
mL,  50.0  mmol,  10  eq)  in  CH2Cl2  (15  mL).  The  resulting  reaction  mixture  was 
stirred  at  21  °C  for  24  h.  The  CH2Cl2  was  then  removed  in  vacuo  to  leave  a 
colourless  residue.  Addition  of  EtOAc  (125  mL)  caused  formation  of  a  white 
precipitate, which was washed with a saturated solution of Na2CO3 (3 x 50 mL), 
dried  over  MgSO4,  and  concentrated  in  vacuo.  Further  purification  by  column 
chromatography (8:2 CH2Cl2/MeOH) furnished the desired monoprotected amine 75 
as a colourless oil (0.69 g, 2.80 mmol, 56% yield). 
1H NMR (500 MHz, CDCl3) δ 
5.27 (bs, 1H, NH), 3.54-3.52 (m, 4H, OCH2), 3.47-3.42 (m, 4H, OCH2), 3.23-3.22 
(m, 2H, NCH2), 2.80 (t, J = 5.0, 2H, NCH2), 2.05 (bs, 2H, NH), 1.35 (s, 9H, CH3);  
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13C NMR (125 MHz, CDCl3) δ 156.08 (s), 79.09 (s), 73.19 (t), 70.21 (t), 70.16 (t), 
41.59 (t), 40.32 (t), 28.40 (q), * 1 t missing; IR (neat) 3344, 2869, 1692 cm
-1; HRMS 
(CI) calcd for C11H25N2O4 [M + H]
+ 249.18143, observed 249.18251.  
 
tert-Butyl-N-(2-(2-(2-(5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno(3,4-d)imidazol-6-
yl)pentanoylamino)ethoxy)ethoxy)ethyl)carbamate
83 92 
N
H
O
O
NHBoc
O
S
NH
HN
O
 
A solution of biotin (0.59 g, 2.42 mmol, 1.5 eq), HBTU (0.79 g, 2.10 mmol, 1.3 eq) 
and DIEA (0.45 mL, 2.60 mmol, 1.6 eq) in DMF (15 mL) was stirred for 20 min at 
21  °C  before  being  added  dropwise  to  a  solution  of  tert-butyl-N-(2-(2-(2-
aminoethoxy)ethoxy)ethyl)carbamate 75 (400 mg, 1.61 mmol,  1 eq) in DMF (10 
mL). The reaction mixture was stirred for 2 h at 21 °C, after which the DMF was 
removed  in  vacuo  to  give  a  yellow  residue.  The  crude  product  was  purified  by 
column chromatography (gradient 2-10% MeOH/CH2Cl2) to yield 92 as a white solid 
(0.61 g, 1.29 mmol, 80% yield). m.p. 106-108 °C; [ʱ]D
20.0 +23.0 (c 0.6, CH2Cl2); 
1H 
NMR (500 MHz, CDCl3) δ 4.55 (dd, J = 5.0, 7.5 Hz, 1H, NHC(O)NHCH), 4.36 (dd, 
J  =  5.0,  7.5  Hz,  1H,  NHC(O)NHCH),  3.62  (bs,  6H,  OCH2),  3.59-3.55  (m,  2H, 
OCH2), 3.46 (m, 2H, NCH2), 3.31 (m, 2H, NCH2), 3.17 (dt, 3.0, 5.0 Hz, 1H, SCH), 
2.92 (dd, J = 5.0, 13.0 Hz, 1H, SCHH), 2.79 (d, J = 13.0 Hz, 1H, SCHH), 2.27 (t, J = 
7.0  Hz, 2H, NHC(O)CH2CH2CH2), 1.71 (m, 4H,  NHC(O)CH2CH2CH2CH2), 1.47 
(br, 11H, C(CH3)3 & NHC(O)CH2CH2CH2CH2); 
13C NMR (125 MHz, CDCl3) δ 
173.69 (s), 163.92 (s), 155.99 (s), 79.14 (s), 70.03 (t), 69.69 (br t), 61.58 (d), 60.06 
(d), 55.19 (d), 40.16 (t), 39.96 (t), 38.91 (t), 35.44 (t), 28.09 (q), 27.80 (t), 27.67 (t), 
25.23  (t),  *  2  t  absent;  IR  (neat)  3307,  2933,  1691  cm
-1;  HRMS  (ES)  calcd  for 
C21H38N4O6NaS [M+Na]
+ 497.2410, observed 497.2423. 
2-(2-(2-(5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno(3,4-d)imidazol-6-
yl)pentanoylamino)ethoxy)ethoxy)ethylammonium; 2,2,2-trifluoroacetate
83 93 
N
H
O
O
NH3
O
S
NH
HN
O
O CF3
O
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A  solution  of  tert-butyl  N-(2-(2-(2-(5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno(3,4-
d)imidazol-6-yl)pentanoylamino)ethoxy)ethoxy)ethyl)carbamate  92  (0.61  g,  1.29 
mmol) in CH2Cl2 (5 mL) and TFA (5 mL) was stirred at 21 °C for 24 h. Toluene was 
then added (x2) and the solvent removed in vacuo to yield 93 as an oil (0.63 g , 1.29 
mmol, 100% yield). [ʱ]D
20.0 +41.0 (c 0.49, MeOH); 
1H NMR (400 MHz, CD3OD) δ 
4.53  (dd,  J  =  5.0,  7.5  Hz,  1H,  NHC(O)NHCH),  4.33  (dd,  J  =  5.0,  7.5  Hz,  1H, 
NHC(O)NHCH), 3.71 (t, J = 5.0 Hz, 2H, OCH2CH2NH3), 3.65 (br, 4H, OCH2), 3.57 
(t, J = 5.0 Hz, 2H, OCH2), 3.38 (t, J = 5.0 Hz, 2H, OCH2), 3.22 (dt, J = 5.0, 8.5 Hz, 
1H, SCH), 3.13 (t, J = 5.0 Hz, 2H, C(O)NHCH2CH2O), 2.94 (dd, J = 5.0, 13.0 Hz, 
1H,  SCHH),  2.74  (d,  J  =  13.0  Hz,  1H,  SCHH),  2.24  (t,  J  =  7.5  Hz,  2H, 
NHC(O)CH2CH2CH2), 1.76-1.43 (m, 6H, NHC(O)CH2CH2CH2CH2); 
13C NMR (100 
MHz, CD3OD) δ 174.98 (s), 164.76 (s), 69.92 (t), 69.83 (t), 69.22 (t), 66.46 (t), 62.08 
(d), 60.36 (d), 55.59 (d), 39.65 (t), 39.24 (t), 38.77 (t), 35.29 (t), 28.29 (t), 28.06 (t), 
25.44 (t); IR (MeOH) 3300, 2941, 1686 cm
-1; HRMS (ES) calcd for C16H31N4O4S 
[M+H]
+ 375.2066, observed 375.2060.  
N-(2-(2-(2-(3,4-dibromo-2,5-dioxo-pyrrol-1-yl)ethoxy)ethoxy)ethyl)-5-(2-oxo-
1,3,3a,4,6,6a-hexahydrothieno(3,4-d)imidazol-6-yl)pentanamide 60 
N
H
O
O
N
O
S
NH
HN
O
O
O
Br
Br
 
Dibromomaleic anhydride 90 (108 mg, 0.42 mmol, 1 eq) was added in one portion to 
a  solution  of  2-(2-(2-(5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno(3,4-d)imidazol-6-
yl)pentanoylamino)ethoxy)ethoxy)ethylammonium  2,2,2-trifluoroacetate  93  (205 
mg, 0.42 mmol, 1 eq) in AcOH (10 mL) and the reaction mixture heated to 170 °C 
for 2 h. Upon cooling to 21 °C toluene was added and the AcOH azeotropically 
removed in vacuo (x2) to give crude product. Column chromatography (gradient 2-
7% MeOH/CH2Cl2) yielded pure product 60 as a white solid (123 mg, 0.20 mmol, 
48% yield). m.p. 100-102 °C; [ʱ]D
20.0 +71.0 (c 0.15, MeOH); 
1H NMR (600 MHz,  
CD3OD) δ 4.53 (dd, J = 5.0, 8.0 Hz, 1H, NHC(O)NHCH), 4.34 (dd, J = 5.0, 8.0 Hz, 
1H, NHC(O)NHCH), 3.82 (t, J = 5.5 Hz, 2H, OCH2), 3.70 (t, J = 5.5 Hz, 2H, OCH2), 
3.63 (m, 2H, OCH2), 3.59 (m, 2H, OCH2), 3.53 (t, J = 5.5 Hz, 2H, NCH2), 3.37 (t, J  
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= 5.5 Hz, 2H, NCH2), 3.24 (dt, J = 5.0, 8.0 Hz, 1H, SCH), 2.96 (dd, J = 5.0, 13.0 Hz, 
1H,  SCHH),  2.73  (d,  J  =  13.0  Hz,  1H,  SCHH),  2.26  (t,  J  =  7.5  Hz,  2H, 
NHC(O)CH2CH2CH2), 1.74 (m, 4H, CH2CH2CH2), 1.49 (quintet, J = 7.5 Hz, 2H, 
CH2CH2CH2); 
13C NMR (150 MHz, CD3OD) δ 174.83 (s), 164.71 (s), 164.06 (s), 
129.00 (s), 69.80 (t), 69.72 (t), 69.24 (t), 67.19 (t), 61.97 (d), 60.22 (d), 55.64 (d), 
39.67 (t), 39.03 (t), 38.56 (t), 35.42 (t), 28.39 (t), 28.11 (t), 25.47 (t); IR (MeOH) 
2970, 1724, 1365, 1217 cm
-1; HRMS (ES) calcd for C20H28N4O6NaSBr2 [M+Na]
+ 
631.9916, observed 631.9937. 
N-(2-(2-(2-(3-bromo-2,5-dioxo-pyrrol-1-yl)ethoxy)ethoxy)ethyl)-5-(2-oxo-
1,3,3a,4,6,6a-hexahydrothieno(3,4-d)imidazol-6-yl)pentanamide 61 
N
H
O
O
N
O
S
NH
HN
O
O
O
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Monobromomaleic anhydride (45.0 mg, 0.25 mmol, 1 eq) was added in one portion 
to  a  solution  of  2-(2-(2-(5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno(3,4-d)imidazol-6-
yl)pentanoylamino)ethoxy)ethoxy)ethylammonium  2,2,2-trifluoroacetate  93  (124 
mg, 0.25 mmol, 1 eq) in AcOH (10 mL) and the reaction mixture heated to 170 °C 
for 3 h. Upon cooling to 21 °C toluene was added and the AcOH azeotropically 
removed in vacuo (x2) to give crude product. Column chromatography (gradient 2-
10% MeOH/CH2Cl2) yielded 61 as a white solid (70.0 mg, 0.13 mmol, 52% yield). 
m.p. 95-98 °C; [ʱ]D
20.0 +65.1 (c 0.15, MeOH); 
1H NMR (600 MHz,  CD3OD) δ 7.17 
(s, 1H, CHCBr), 4.51 (dd, J = 5.0, 8.0 Hz, 1H, NHC(O)NHCH), 4.33 (dd, J = 5.0, 8.0 
Hz, 1H, NHC(O)NHCH), 3.77 (t, J = 5.5 Hz, 2H, OCH2), 3.68 (t, J = 5.5 Hz, 2H, 
OCH2), 3.63 (m, 2H, OCH2), 3.58 (m, 2H, OCH2), 3.53 (t, J = 5.5 Hz, 2H, NCH2), 
3.37 (t, J = 5.5 Hz, 2H, NCH2), 3.24 (td, J = 5.0, 8.0 Hz, 1H, SCH), 2.95 (dd, J = 5.0, 
12.5 Hz, 1H, SCHH), 2.73 (d, J = 12.5 Hz, 1H, SCHH), 2.26 (t, J = 7.0 Hz, 2H, 
NHC(O)CH2CH2CH2), 1.69 (m, 4H, CH2CH2CH2), 1.47 (quintet, J = 7.0 Hz, 2H, 
CH2CH2CH2); 
13C NMR (150 MHz, CD3OD) δ 176.12 (s), 170.13 (s), 166.97 (s), 
166.08 (s), 133.63 (s), 132.05 (d), 71.22 (t), 71.11 (t), 70.61 (t), 68.69 (t), 63.35 (d), 
61.61 (d), 57.03 (d), 41.09 (t), 40.31 (t), 39.09 (t), 36.75 (t), 29.78 (t), 29.50 (t), 26.87  
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(t); IR (MeOH) 3355, 2970, 1737 cm
-1; HRMS (ES) calcd for C20H29N4O6 NaSBr 
[M+Na]
+ 555.0889, observed 555.0905. 
6.2.4 Synthesis of fluorescein maleimide reagents 
3,4-dibromo-1-(3',6'-dihydroxy-3-oxo-spiro(isobenzofuran-1,9'-xanthene)-5-
yl)pyrrole-2,5-dione 62 
O
O
N
O
O
HO OH
O
Br
Br
 
Dibromomaleic anhydride 90 (77.0 mg, 0.30 mmol, 1 eq) was added in one portion 
to a solution of fluoresceinamine (105 mg, 0.30 mmol, 1 eq) in AcOH (10 mL) and 
the reaction mixture was stirred for 6 h at 21 ºC. The solid was then filtered off, 
washed with EtOAc, and redissolved in AcOH (10 mL). The reaction mixture was 
then heated to 170 °C for 3 h. Upon cooling to 21 °C toluene was added and the 
AcOH azeotropically removed in vacuo (x2) to give 62 as an orange solid (148 mg, 
0.25 mmol, 84% yield). m.p. > 220 °C (dec); 
1H NMR (400 MHz, CD3OD) δ 8.07 
(d, J = 1.5 Hz, 1H, ArH), 7.82 (dd, J = 1.5, 8.0 Hz, 1H, ArH), 7.34 (d, J = 8.0 Hz, 1H, 
ArH), 6.71 (d, J = 2.5 Hz, 2H, ArH), 6.59 (d, J = 9.0 Hz, 2H, ArH), 6.57 (dd, J =  2.5, 
9.0 Hz, 2H, ArH); 
13C NMR (150 MHz, CD3OD) δ 170.23 (s), 164.34 (s), 161.63 (s), 
154.18 (s), 152.93 (s), 134.59 (s), 134.19 (d), 131.01 (s), 130.35 (d), 129.25 (s), 
126.25 (d), 123.63 (d), 113.84 (d), 111.02 (s), 103.55 (d), * 1 s absent; IR (MeOH) 
3063,  2924,  1725,  1588  cm
-1;  HRMS  (ES)  calcd  for  C24H12NO7Br2  [M+H]
+ 
583.8980, observed 583.8964.  
3-bromo-1-(3',6'-dihydroxy-3-oxo-spiro(isobenzofuran-1,9'-xanthene)-5-
yl)pyrrole-2,5-dione 63 
O
O
N
O
O
HO OH
O
Br   
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Monobromomaleic anhydride (77.0 mg, 0.30 mmol, 1 eq) was added in one portion 
to a solution of fluoresceinamine (105 mg, 0.30 mmol, 1 eq) in AcOH (10 mL) and 
the reaction mixture was stirred for 24 h at 21 °C. The solid was then filtered off, 
washed with EtOAc, and redissolved in AcOH (10 mL). The reaction mixture was 
then heated to 170 °C for 3 h. Upon cooling to 21 °C toluene was added and the 
AcOH azeotropically removed in vacuo (x2) to give 63 as a yellow solid (98.0 mg, 
0.19 mmol, 65% yield). m.p. > 220 °C (dec); 
1H NMR (600 MHz, CD3OD) δ 8.00 
(d, J = 1.5 Hz, 1H, ArH), 7.78 (dd, J = 1.5, 8.0 Hz, 1H, ArH), 7.73 (s, 1H, CH), 7.44 
(d, J = 8.0 Hz, 1H, ArH), 6.69 (d, J = 2.0 Hz, 2H, ArH), 6.62 (d, J = 8.5 Hz, 2H, 
ArH), 6.59 (dd, J = 2.0, 8.5 Hz, 2H, ArH); 
13C NMR (150 MHz, CD3OD) δ 168.36 
(s), 168.07 (s), 164.91 (s), 160.06 (s), 152.23 (s), 151.95 (s), 134.10 (s), 133.46 (d), 
133.33 (s), 131.36 (d), 129.58 (s), 127.58 (d), 125.25 (s), 122.73 (d), 113.21 (d), 
109.52  (s),  102.74  (d),  *  1  d  absent;  IR  (MeOH)  3063,  2449,  1722,  1578  cm
-1; 
HRMS (ES) calcd for C24H13NO7Br [M+H]
+ 505.9875, observed 505.9852. 
6.2.5 Studies on the chemical modification of Grb2 SH2 domain  
General method for modification of Grb2 SH2 domain 37 with bromomaleimide 
reagent at pH 8 
To a solution of Grb2-SH2 (L111C) 37 (100 μL, [protein] 2.0 mg/mL, 100 mM 
sodium  phosphate,  150  mM  NaCl,  pH  8.0)  at  0  °C  was  added  bromomaleimide 
reagent (5 μL, 5.64 mM solution in DMF). The mixture was vortexed for 1 s then 
maintained  at  0  °C  for  2  h.  Analysis  using  LCMS  showed  that  Grb2-
bromomaleimide-conjugate had been formed in quantitative yield. 
General method for modification of Grb2 SH2 domain 37 with bromomaleimide 
reagent at pH 7 
To a solution of Grb2-SH2 (L111C) 37 (100 μL, [protein] 1.1 mg/mL, 100 mM 
sodium  phosphate,  150  mM  NaCl,  pH  7.0)  at  0  °C  was  added  bromomaleimide 
reagent (5 μL, 6.20 mM solution in DMF). The mixture was vortexed for 1 s then 
maintained  at  0  °C  for  2  h.  Analysis  using  LCMS  showed  that  Grb2-
bromomaleimide-conjugate had been formed in quantitative yield.  
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General  method  for  the  BME  mediated  cleavage  of  Grb2-bromomaleimide 
conjugates at pH 8 
The solution containing Grb2-bromomaleimide conjugate was treated with BME (5 
μL,  282  mM  solution  in  H2O)  at  0  °C.  The  mixture  was  vortexed  for  1  s  and 
maintained at 0 °C for 4 h, after which the mixture was analyzed by LCMS. Analysis 
showed that the Grb2-SH2 (L111C) 37 (mass = 14170) was formed in quantitative 
conversion. 
General  method  for  the  BME  mediated  cleavage  of  Grb2-bromomaleimide 
conjugates at pH 7 
The solution containing Grb2-bromomaleimide conjugate was treated with BME (5 
μL,  155  mM  solution  in  H2O)  at  0  °C.  The  mixture  was  vortexed  for  1  s  and 
maintained at 0 °C for 4 h, after which the mixture was analyzed by LCMS. Analysis 
showed that the Grb2-SH2 (L111C) 37 (mass = 14170) was formed in quantitative 
conversion. 
6.2.6 Studies on the chemical modification of Somatostatin 
General method for the bridging of somatostatin 112 with dibromomaleimide 
reagents 
Lyophilized somatostatin (mass = 1638) was solubilized in buffer (50 mM sodium 
phosphate, pH 6.2, 40% MeCN, 2.5% DMF) to yield a concentration of 152.6 μM 
(0.25 mg/mL) and reduced with 1.1 equiv of TCEP for 1 h at 21 °C. Completeness of 
the  reduction  was  confirmed  by  LCMS  (mass  =  1640);  1.1  equiv  of 
dibromomaleimide reagent was added and the reaction maintained at 21 °C for 1 h. 
Quantitative insertion of the maleimide into the disulfide bond to give somatostatin-
bridged-conjugate  was  confirmed  by  LCMS.  Note  -  Insertion  of  the  fluorescein 
dibromomaleimide into the disulfide bond to give conjugate 113 was confirmed by 
LCMS (mass = 2066) M
+1 peak of product above spectrometer threshold, M
+2 (m/z = 
1033) and M
+3 (m/z = 689) clearly visualized].  
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General  method  for  the  BME  mediated  cleavage  of  somatostatin-bridged-
conjugates 
The solution of somatostatin-bridged-conjugate was treated with BME (100 equiv) 
and the reaction maintained at 21 °C for 1 h. Analysis by LCMS showed complete 
cleavage of the conjugate, yielding reduced somatostatin 114 (mass = 1640). 
6.2.7 Synthetic route for Pd(IBu)(neopentyl)(Cl) dimer 143 
Neopentyl Lithium
132 
Li 
Lithium wire (0.59 g, 84.4 mmol, 4.5 eq) was cut up into small segments, added to a 
schlenk tube and sealed under argon.  Hexane (20 mL) was added, follo wed by 
neopentyl chloride (1.99 g, 18.8 mmol, 1 eq) and the reaction mixture stirred for 5 d 
at 60 °C under argon and reduced pressure.  After this time, the purple solution was 
filtered through flame-dried celite and the solvent removed in vacuo to yield a white 
solid which was used without further purifaction (0.95 g, 12.2 mmol, 65%). 
1H NMR 
(400 MHz, C6D6) δ 1.12  (s, 9H, C(CH3)3), -0.68 (s, 2H, CH2); 
13C NMR (400 MHz, 
C6D6) δ 37.00 (q), 26.31 (s), 23.32 (t). Neopentyl lithium found to be too reactive to 
obtain MS and IR. 
Pd(1,5-COD)(neopentyl)(chloride)
132 
Pd
Cl  
Pd(COD)Cl2 (300 mg, 1.05 mmol) was placed in a schlenk tube and dried under 
vacuum for 1 h before use.  It was then suspended in Et2O (20 mL), cooled to -75 
°C, 
covered in tin foil and neopentyl lithium (0.08 g, 1.05 mmol) in Et2O (5 mL) added 
dropwise via cannula over a period of 1.5 h.  The dark reaction mixture was stirred at 
-78 °C for a further 1 h and then slowly warmed to 21 °C over 1 h.  The reaction 
mixture was then stirred at this 21 °C for 3 h.  It was then filtered through flame-
dried celite and the yellow-orange solvent removed in vacuo to yield product as a 
brown solid (0.16 g, 0.5 mmol, 48%). 
1H NMR (400 MHz, CDCl3) δ 5.90 (q, J = 15  
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Hz, 2H, CH2CH), 5.17 (q, J = 15 Hz, 2H, CH2CH), 2.61 (m, 4H, CHCH2), 2.44 (m, 
4H, CHCH2), 2.23 (s, 2H, CH2), 1.13 (s, 9H, C(CH3)3); 
13C NMR (100 MHz, CDCl3) 
δ 125.41 (d), 100.74 (d), 37.43 (s), 35.91 (q), 32.94 (t), 27.36 (t); LRMS (ES+) 285.1 
[M–Cl]
+ 100%. 
Pd(IBu)(neopentyl)(Cl) dimer
132 143 
Pd
Cl
Cl
Pd
IBu
IBu
 
Pd(1,5-COD)(neopentyl)(chloride) (0.18 g, 0.5 mmol, 1 eq) was dissolved in THF 
(15 mL), cooled to 0 °C and IBu (0.09 g, 0.5 mmol, 1eq) in THF (5 mL) was added 
via cannula.  The reaction mixture was stirred at 0 °C for 30 min, and then 21 °C for 
15 min. The reaction mixture was filter cannulared to new a schlenk, the solvent 
removed in vacou and the residue washed with Et2O (15 mL) and hexane (2x10 mL), 
to yield the desired product as a white powder (298 mg, 0.38 mmol, 76%). 
1H NMR 
(400 MHz, THF-d8) δ 7.39 (s, 2H, CH), 2.17 (s, 18H, C(CH3)3 - IBu), 1.43 (s, 2H, 
CH2), 0.93 (s, 9H, C(CH3)3 – neopentyl); 
13C NMR (100 MHz, THF-d8) δ 170.00 
(s), 118.20 (d), 59.11 (s), 35.21 (s), 31.9 (q), 29.89 (q); LRMS (CI) 500.0 [M-Cl, 
IBu, CH2C(CH3)3]
+ 100%. 
6.2.8 
1H  NMR  reaction  of  Pd(IBu)(neopentyl)(Cl)  dimer  143  and 
lithium morpholide 
Pd(IBu)(neopentyl)(morpholide) 144 
Pd
N
O
IBu
 
In a glove box lithium morpholide (8.00 mg, 0.08 mmol, 2 eq) was added to an NMR 
tube containing Pd(IBu)(neopentyl)(chloride) dimer 143 (32.0 mg, 0.04 mmol, 1 eq) 
and tetrakis(trimethylsilyl)silane (10.0 mg, 0.03 mol, 0.79 eq) in THF-d8 (1 mL) and  
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an 
1H NMR run after 10 min, 30 min, 60 min, 90 min, and there after at 30 min 
intervals. 
1H NMR shown in figure 30. 
6.2.9  Synthesis  of  dansyl  piperazine  and  N-dansyl-4-
chlorobenzylamine 
Piperazine-1-carboxylic acid tert-butyl ester 174 
N HN Boc 
Di-tert-butyl-dicarbonate  (4.05  g,  18.6  mmol)  in  acetic  acid  (15  mL)  was  added 
dropwise over 7 h to a stirred solution of piperazine (1.60 g, 18.6 mmol) in acetic 
acid (30 mL) at 21 °C and the resulting reaction mixture stirred for a further 15 h. 
The reaction mixture was then poured onto water, causing a precipitate to form (di-
boc-protected piperazine 0.59 g, 3.15 mmol, 17% yield).  The filtrate was basidified 
by addition of NaOH(aq), the organic material extracted into CH2Cl2, and then dried 
with  MgSO4.    Filtration  and  removal  of  solvent  in  vacuo  led  to  the isolation  of 
desired piperazine-1-carboxylic acid tert-butyl ester 174 (2.84 g, 15.2 mmol, 82% 
yield) which was used without further purification. 
1H NMR (600 MHz, CDCl3) δ 
3.35 (t, J = 5.0 Hz, 4H, C(O)NCH2CH2), 2.78 (t, J = 5.0 Hz, 4H, C(O)NCH2CH2), 
1.72 (bs, 1H, NH), 1.43 (s, 9H, C(CH3)3); 
13C NMR (125 MHz, CDCl3) δ 155.0 (s), 
79.8 (s), 45.6 (t), 28.5 (q),
* 1 t absent; IR (neat) 3331, 2976, 2860, 1682 cm
-1; HRMS 
(ES+) calcd for C9H19N2O2 [M+H]
+ 187.1447, observed 187.1450. 
Piperazine-1,4-dicarboxylic acid benzyl ester tert-butyl ester
189 175. 
N N Cbz Boc
 
Benzyl chloroformate (0.51 g, 3.01 mmol) in CH2Cl2 (10 mL) was added to a stirred 
solution of piperazine-1-carboxylic acid tert-butyl ester 174 (0.51 g, 2.74 mmol) and 
NEt3 (330 mg, 3.29 mmol) in CH2Cl2 (20 mL) at 0 °C under argon. The reaction 
mixture was then stirred at 21 °C for 1 h before being concentrated in vacuo. The 
resulting  residue  was  taken  up  in  EtOAc  (30  mL)  and  washed  sequentially  with 
KHSO4 (1M, 2 x 30 mL), NaHCO3 (1M, 30 mL) and brine (15 mL). Drying with 
MgSO4, followed by filtration and removal of solvent in vacuo led to the isolation of  
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the desired piperazine-1,4-dicarboxylic acid benzyl ester tert-butyl ester 175 (0.87 g, 
2.74 mmol, 99% yield) which was used without further purification. 
1H NMR (600 
MHz,  CDCl3)  δ  7.32  (m,  5H,  ArH),  5.10  (s,  2H,  NC(O)OCH2),  3.39  (m,  4H, 
C(O)NCH2CH2NC(O)), 3.41 (m, 4H, C(O)NCH2CH2NC(O)), 1.42 (s, 9H); 
13C NMR 
(150 MHz, CDCl3) δ 155.9 (s), 154.3 (s), 136.2 (s), 128.7 (d), 128.5 (d), 127.9 (d), 
79.9 (s), 67.1 (t), 43.3 (bs, note 2x t), 28.4 (q); IR (neat) 2978, 2864, 2250, 1686, 
1457,  1416  cm
-1;  HRMS  (ES+)  calcd  for  C17H24N2O4Na  [M+Na]
+  343.1634, 
observed 343.1635. 
Trifluoro-acetate-4-benzyloxycarbonyl-piperazin-1-ium
189 176 
NH2 N Cbz O CF3
O
 
TFA  (2.5  mL)  was  added  dropwise  to  a  stirred  solution  of  piperazine-1,4-
dicarboxylic acid benzyl ester tert-butyl ester 175 (0.87 g, 2.74 mmol) in CH2Cl2 (10 
mL) at 0 °C. The reaction mixture was then stirred for 1 h at 21 °C and concentrated 
in vacuo affording trifluoro-acetate-4-benzyloxycarbonyl-piperazin-1-ium 176 (0.58 
g, 2.65 mmol, 97% yield), which was used without further purification. 
1H NMR 
(600 MHz, CDCl3) δ 7.28 (m, 5H, ArH), 5.08 (s, 2H, NC(O)OCH2), 3.71 (t, J = 5.0 
Hz, 4H, C(O)NCH2CH2NH2
+), 3.14 (bs, 4H, C(O)NCH2CH2NH2
+), 2.27 (s, 1H, NH); 
13C NMR (125 MHz, CDCl3) δ 154.9 (s), 135.6 (s), 129.2 (d), 128.8 (d), 128.3 (d), 
68.5 (t), 43.7 (bs, note 2x t); IR (neat) 3034, 2839, 2496, 1670, 1431 cm
-1; HRMS 
(ES+) calcd for C12H17N2O2 [M+H]
+ 221.1290, observed 221.1291. 
4-(5-dimethylamino-naphthalene-1-sulfonyl)-piperazine-1-carboxylic  acid 
benzyl ester
188 177 
N
S
O
O
N N Cbz
 
Dansyl chloride (1.22 g, 0.45 mmol) was added in one portion to a stirred solution of 
trifluoro-acetate-4-benzyloxycarbonyl-piperazin-1-ium  176  (0.10  g,  0.45  mmol), 
DMAP (3.00 mg, 0.03 mmol) and NEt3 (46.0 mg, 0.46 mmol) in CH2Cl2 (25 mL) at 
0 °C under argon. The now bright yellow reaction mixture was warmed to 21 °C and  
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stirred for 15 h. Distilled H2O was added and the organic material extracted with 
CH2Cl2,  which was  then  dried with  MgSO4. Filtration and removal of  solvent  in 
vacuo  afforded  desired  4-(5-dimethylamino-naphthalene-1-sulfonyl)-piperazine-1-
carboxylic acid benzyl ester 177 (1.63 g, 0.36 mmol, 80% yield) which was used 
without further purification. 
1H NMR (500 MHz, CDCl3) δ 8.56 (d, J = 8.5 Hz, 1H, 
ArH), 8.38 (d, J = 8.5 Hz, 1H, ArH), 8.19 (d, J = 8.5 Hz, 1H, ArH), 7.54 (t, J = 7.5 
Hz, 2H, ArH), 7.31 (m, 5H, ArH), 7.20 (d, J = 7.5 Hz, 1H, ArH), 5.07 (s, 2H, 
NC(O)OCH2),  3.54  (t,  J  =  5.0  Hz,  4H,  C(O)NCH2CH2NSO2),  3.18  (bs,  4H, 
C(O)NCH2CH2NSO2), 2.90 (s, 6H, N(CH3)2); 
13C NMR (125 MHz CDCl3) δ 171.2 
(s), 151.9 (s), 136.3 (s), 132.5 (s), 131.0 (d), 130.8 (d), 130.4 (s), 130.1 (s), 128.6 (d), 
128.3 (d), 128.1 (d), 123.3 (d), 119.5 (d), 115.4 (d), 67.5 (t), 45.5 (q), 43.5 (bs, note 
2x t) * 1x d from dansyl absent; IR (neat) 3457, 3016, 2970, 1739, 1435, 1366 cm
-1; 
HRMS (ES+) calcd for C24H28N3O4S [M+H]
+ 454.1801, observed 454.1810. 
Formate-4-(5-dimethylamino-naphthalene-1-sulfonyl)-piperazin-1-ium
188 178 
N
S
O
O
N H2N H O
O
 
5%  Palladium  on  carbon  (160  mg)  was  added  to  a  stirred  solution  of  4 -(5-
dimethylamino-naphthalene-1-sulfonyl)-piperazine-1-carboxylic  acid  benzyl  ester 
177 (1.00 g, 2.21 mmol) and formic acid (0.02 mL) in Et2O (50 mL) and the reaction 
heated to 95 °C for 3 h. Following this the reaction mixture was cooled to 21 °C and 
filtered through a short plug of Celite, with copious washing by Et2O to ensure all 
product flushed through. The filtrate was washed with distilled water, dried with 
MgSO4, filtrated and the solvent removed in vacuo to afford 178 (0.67 g, 2.21 mmol, 
100% yield) as a yellow solid. 
1H NMR (500 MHz, CDCl3) δ 8.56 (d, J = 8.5 Hz, 1H, 
ArH), 8.43 (d, J = 8.5 Hz, 1H, ArH), 8.19 (dd, J = 1.0, 7.5 Hz, 1H, ArH), 7.53 (dt, J = 
2.0, 7.5 Hz, 2H, ArH), 7.18 (d, J = 7.5 Hz, 1H, ArH), 3.15 (t, J = 5.0 Hz, 4H, 
C(O)NCH2CH2NSO2), 2.88 (bs, 10H, N(CH3)2 & C(O)NCH2CH2NSO2), 1.63 (s, 2H, 
NH2); 
13C NMR  (125 MHz, CDCl3)  δ 151.7 (s), 132.7 (s), 130.7 (d), 130.6 (s), 
130.13 (s), 128.0 (d), 123.2 (d), 119.9 (d), 115.3 (d), 46.5 (t), 45.6 (t), 45.5 (q), * 1 d 
absent; IR (neat) 3292, 2947, 2849, 1454 cm
-1; HRMS (ES+) calcd for C16H22N3O2S 
[M+H]
+ 320.1433, observed 320.1425.  
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5-Dimethylamino-naphthalene-1-sulfonic acid 4-chloro-benzylamide 179 
N
S
O
O
HN
Cl  
Dansyl chloride (0.72 g, 2.67 mmol) was added in one portion to a stirred solution of 
4-chloro-benzylamine (0.38 g, 2.67 mmol), DMAP (17.0 mg, 0.13 mmol) and NEt3 
(0.41 mL, 2.94 mmol) in CH2Cl2 (30 mL) at 0 °C. The reaction mixture was then 
warmed to 21 °C and stirred for 15 h. Distilled H2O was added and the organic 
material extracted into CH2Cl2, which was then dried with MgSO4. Filtration and 
removal of solvent in vacuo then afforded 179 (0.85 g, 2.30 mmol, 85% yield) as a 
yellow solid. 
1H NMR (500 MHz, CDCl3) δ 8.54 (d, J = 8.5 Hz, 1H, ArH), 8.25 (m, 
2H, ArH), 7.56 (t, J = 8.0 Hz, 1H, ArH), 7.50 (t, J = 8.0 Hz, 1H, ArH), 7.20 (d, J = 
7.5 Hz, 1H, ArH), 7.09 (d, J = 8.5 Hz, 2H, ArH), 6.97 (d, J = 8.5 Hz, 2H, ArH), 4.05 
(d, J = 6.5 Hz, 2H, S(O)2NHCH2), 2.91 (s, 6H, N(CH3)2); 
13C NMR (125 MHz, 
CDCl3) δ 151.0 (s), 134.6 (s), 133.6 (s), 132.0 (s), 130.7 (d), 130.0 (d), 129.9 (s), 
129.2 (d), 128.6 (d), 128.0 (s), 123.2 (d), 118.6 (d), 115.2 (d), 46.7 (t), 45.5 (q), 
* 1 d 
absent; IR (neat) 3286, 2971, 1738 cm
-1; HRMS (ES+) calcd for C19H20N2O2SCl 
[M+H]
+ 375.0934, observed 375.0930. 
6.2.10 General procedure for Pd catalysed aryl amination reaction 
Pd(IBu)2 (3.00 mg) was added in one portion to a stirred solution of amine (0.10 
mmol), aryl halide (0.10 mmol) and KO
tBu (0.12 mmol) in toluene (5 mL) under 
argon and the reaction mixture heated to 60 °C for 24 h. The reaction mixture was 
then filtered through Celite. Distilled water (5 mL) was added and the organic layer 
separated, washed with brine, dried with MgSO4, filtered and concentrated to yield 
product. 
Dimethyl-(5-(4-p-tolyl-piperazine-1-sulfonyl)-naphthalen-1-yl)-amine
188 180 
N
S
O
O
N N
 
Product isolated as a yellow solid, 32.0 mg, 0.08 mmol, 80% yield.  
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1H NMR (500 MHz, CDCl3) δ 8.56 (d, J = 8.5 Hz, 1H, ArH), 8.45 (d, J = 8.5 Hz, 1H, 
ArH), 8.23 (dd, J = 1.0, 7.5 Hz, 1H, ArH), 7.53 (m, 2H, ArH), 7.16 (d, J = 7.5 Hz, 
1H,  ArH),  7.02  (d,  J  =  8.0  Hz,  2H,  ArH),  6.75  (bs,  2H,  ArH),  3.33  (bs,  4H, 
C(O)NCH2CH2NSO2), 3.12 (bs, 4H, C(O)NCH2CH2NSO2), 2.87 (s, 6H, N(CH3)2), 
2.24 (s, 3H, CH3);
  13C NMR (125 MHz CDCl3) δ 151.2 (s), 132.5 (s), 130.9 (s), 
130.8 (d), 130.6 (s), 130.1 (s), 129.8 (d), 128.1 (d), 123.3 (d), 119.9 (d), 117.3 (s), 
115.4 (d), 50.0 (t), 45.7 (t), 45.5 (q), 29.8 (q) * 2x d absent; IR (neat) 3300, 2944, 
2832, 1574 cm
-1; HRMS (ES+) calcd for C23H28N3O2S [M+H]
+ 410.1902, observed 
410.1939. 
5-Dimethylamino-naphthalene-1-sulfonic  acid  4-morpholin-4-yl--benzylamide 
186 
N
S
O
O
HN
N O  
Product could not be obtained pure. 
5-Dimethylamino-naphthalene-1-sulfonic  acid  4-[4-(5-dimethylamino-
naphthalene-1-sulfonyl)-piperazin-1-yl]-benzylamide 193 
N
S
O
O
HN
N N S
O
O
N  
Product could not be obtained pure. 
6.2.11  General  procedure  for  ESI(+)-MS  Pd  catalysed  aryl 
amination reaction 
In a dry glove box Pd(IBu)2 (3.00 mg) was added in one portion to an ampoule 
containing a solution of amine (0.10 mmol), aryl halide (0.10 mmol) and KO
tBu 
(14.0 mg, 0.12 mmol) in toluene (5 mL).  The ampoule was then taken out of the 
glove box, attached to a schlenk line and heated to 60 °C. After 1, 2, 4, 8, and 24 h  
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intervals, 0.01 mL of reaction mixture was removed under a positive flow of argon, 
diluted with 0.99 mL of MeCN (HPLC grade) and injected directly into the ESI(+)-
MS probe. This process was repeated at least three times for each time interval. 
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